Skip to content
FrontierPicks

Dossiers · 827 published · 819 with a kill line · 8 archetypes · 40 themes

Thesis. Kill line. Catalyst. Per ticker.

Each dossier compresses thirty days of news, four quarters of earnings transcripts, and narrative-cluster classification into one read: thesis, kill line, archetype, conviction, catalyst calendar. Generated by a frontier model, dated, and graded against the line it published.

Watch lists

Conviction mix

  1. High 6 · 1%
  2. Medium 246 · 30%
  3. Low 568 · 69%
  4. None 7 · 1%

Archetype mix

  1. Compounder 99 · 12%
  2. Cyclical recovery 114 · 14%
  3. Theme leader 58 · 7%
  4. Special situation 234 · 29%
  5. Earnings inflection 195 · 24%
  6. Retail squeeze 54 · 7%
  7. Defensive 66 · 8%

Freshness · last analysed

  1. ≤ 7 days 563 · 68%
  2. ≤ 30 days 264 · 32%

conviction highmediumlownone

827 shown

No dossiers match your filters.

Held

27
HUM Humana Inc. fresh MEDIUM Margin-over-volume Medicare Advantage reset reclaimed its trend: the 2026-08-24 close of $386.61 is 2.0% above the prior session and back clear of the last 50-day value observed ($378.33, 2026-08-12), with RSI(14) at 64.6 from 52.5.… Compounder · Managed care & health services catalyst · IRDM Iridium Communications Inc fresh MEDIUM Deal-arb: $27.00 cash plus a collared RKLB stock leg marks a $54.00 package against the 2026-08-24 close of $47.30, a 12.41% discount. The S-4/A filed 2026-08-24 finally dated the special meeting (2026-09-24), but RKLB at $68.28 sits just… Earnings inflection · M&A & special situations · Space economy catalyst · MRCY Mercury Systems Inc fresh MEDIUM Defense-electronics turnaround still re-rating on record bookings and a promised FCF turn, but the stock has given back ~20% from its $128.45 ATH and now chops near the analyst median (~$103) into a binary ~Aug 10-18 Q4/full-year print.… Special situation · Defense & aerospace · Cyclical industrials catalyst · MU Micron Technology, Inc. fresh MEDIUM Contract-annuity leg intact — 16 take-or-pay deals, ~$100B minimum contracted revenue to late 2030 — but on 2026-08-24 the tape found a counter-narrative: reports the White House may let Apple source DRAM from CXMT ahead of Xi's ~09-24… Cyclical recovery · AI chips & memory catalyst · OKTA Okta, Inc. fresh MEDIUM Identity-security re-rating in its second, sell-side-led leg; the upgrade wave is still building nearly two months post-print — Wells Fargo lifted its target to $150 from $100 on 2026-07-20, collapsing the low-end dispersion. Cyber theme… Defensive · Cybersecurity · AI enterprise software catalyst · RXO RXO, Inc. fresh MEDIUM Freight-cycle recovery intact; sell-side has fully caught up into a $20–35 battleground — bears $20 (Goldman 07-16, Susquehanna 07-14), bulls $30–35 (BMO $35 initiation 07-14, Stifel/Truist/Citi $30). Narrative matured from mispriced to… Compounder · Freight & logistics · Cyclical industrials catalyst · ARCB ArcBest Corporation fresh LOW The twice-tested $135.76/$135.89 shelf lost on the 2026-08-24 close of $134.45, a 4.2% drop taken with the whole transport complex after Trump's 50% Canada auto/truck/parts/steel tariff post. No issuer catalyst until Q3 results… Special situation · Freight & logistics · Cyclical industrials catalyst · ATEX Anterix Inc. fresh LOW The 2026-08-21 reclaim at $93.25 gave back to $90.38 on 2026-08-24 with RSI(14) at 29.8, the $88.20 shelf still holding on closes. No spectrum sale agreement announced in the 126 days since 2026-04-21 and no company item filed since… Defensive · Industrial power & grid · Squeeze & momentum setups catalyst · CNC Centene Corporation fresh LOW Margin-repair guide raise of 2026-07-28 stays fully priced: the 2026-08-24 close of $65.65 is 2.7% under the 2026-08-14 close of $67.47 and 4.5% below the $68.72 52-week high, with no analyst target moved since Argus on 2026-08-11.… Earnings inflection · Managed care & health services catalyst · DAVE Dave Inc. fresh LOW Beat-and-raise fully modelled by 13 firms and sold on the day; the recovery has now stalled under $358–360 for three weeks, with the 2026-08-24 close at $354.79 and RSI(14) at 31.8. No rating action since 2026-08-17 and nothing operating… Compounder · Fintech & consumer credit · Squeeze & momentum setups catalyst · DELL Dell Technologies Inc. fresh LOW One-session reclaim failed: the 2026-08-24 close of $433.19 is back under the 2026-08-11 shelf of $440.97, RSI(14) 41.3, 12.4% below the 08-13 high of $494.51. Morgan Stanley's 08-24 raise to $434 sets a target at the market while Evercore… Cyclical recovery · AI datacenter infrastructure catalyst · HNGE Hinge Health, Inc. fresh LOW Digital-MSK profitability re-rate broke out in May and was pushed into open price discovery by the 2026-06-09 mid-quarter raise (Q2 to $200–202M, +45%; FY26 to $818–824M). But nine sell-side target hikes in two weeks plus accelerating… Compounder · Managed care & health services · AI enterprise software catalyst · HPE Hewlett Packard Enterprise Company fresh LOW The one green close failed: 2026-08-24 closed $52.43, undercutting the 08-20 low close of $52.89 and marking seven of eight sessions lower off the 2026-08-13 high of $59.82, with no dated HPE news since 2026-08-19. The 2026-09-02 Q3 print… Special situation · AI datacenter infrastructure · AI enterprise software catalyst · JBHT J.B. Hunt Transport Services, Inc. fresh LOW The $267 floor broke: the 2026-08-24 close of $259.88 is ~5.7% below the prior session, on the day Washington set Canada auto, truck and parts tariffs to 50% from 2027-01-01. The freight-recovery re-rating now has no company datapoint… Compounder · Freight & logistics · Cyclical industrials catalyst · LSTR Landstar System, Inc. fresh LOW Supply-driven truckload repricing still unconfirmed on the weekly tape, but declines decelerated: FTR Week 33 (ended 2026-08-21) showed dry van -2c vs -7c prior, reefer +1.3c, loads +0.8%, against truck postings +4.4% and the demand index… Defensive · Freight & logistics · Managed care & health services catalyst · MRVL Marvell Technology, Inc. fresh LOW Custom-silicon ASIC royalty story intact, but the AI-semi theme is mid-correction — chips posted their worst month vs software on record (7/17) with money rotating into energy. Buying a falling sector with no confirmed higher low is the… Cyclical recovery · AI datacenter infrastructure · AI chips & memory catalyst · NTAP NetApp, Inc. fresh LOW Three sell-side targets near $210 in eleven days (Goldman 08-13, Citi 08-18, Evercore 08-24) have stopped moving the tape: $186.86 on 2026-08-24, 9.8% below the $207.08 high, RSI 46.4, with the 20-analyst average target $186.31 sitting at… Special situation · AI datacenter infrastructure · AI chips & memory catalyst · OSCR Oscar Health, Inc. fresh LOW Still maturing and range-bound: the 2026-08-24 close of $31.81 is the sixth session without a new high since the 2026-08-14 closing high of $32.76, and it sits 4.6% above the $30.40 consensus mean target. Short interest fell to 17.83M from… Earnings inflection · Managed care & health services catalyst · SEZL Sezzle Inc. fresh LOW Growth leg was retired by management's own 2026-08-06 H2 guide and the −33.89% gap; only a re-rating argument is live at 19.68x forward on the 2026-08-24 close of $117.93. That close lost the $118.02/$118.00 shelf with RSI(14) at 21.5,… Compounder · Fintech & consumer credit catalyst · SIMO Silicon Motion Technology Corporation fresh LOW Controller mix re-rating still rests on the untouched 2026-07-29 Q3 guide of $519–541M against ~$431.8M consensus, but the 2026-08-24 close of $243.18 gave back the whole 08-19/08-21 bounce and sits on the $238.51 shelf after a… Cyclical recovery · AI chips & memory · AI datacenter infrastructure catalyst · SNX TD SYNNEX Corporation fresh LOW Second-order AI re-rating still unconfirmed by company data, and the tape has now taken it back: the 2026-08-24 close of $243.65 leaves a three-month price change of +1.7% with RSI(14) at 27.3. The 11-analyst panel has not revised since… Theme leader · AI datacenter infrastructure · AI enterprise software catalyst · STX Seagate Technology Holdings PLC fresh LOW Maturing AI-storage supercycle with sell-side still chasing: Wells Fargo upgrade to Overweight $1,100 (7/10) and Citi Street-high $1,240 (7/13). But the DRAM ETF is down ~30% and Seagate's Q4 FY26 print ~2026-07-22 is a binary about two… Cyclical recovery · AI chips & memory · AI datacenter infrastructure catalyst · TXG 10x Genomics, Inc. fresh LOW First lower close of the run: 2026-08-24 at $63.80, 2.0% under the 2026-08-21 record close of $65.12, with price still above every published target (high mark Stephens $65, 08-12; 16-analyst average $49.54). No company item since the 08-06… Special situation · Medtech & diagnostics · AI enterprise software catalyst · UMC United Microelectronic Corp. fresh LOW Silicon-photonics pivot re-rated the ADR ~3x, but the July blowoff to $28.96 round-tripped -26% to $21.25 in days while sell-side finally upgraded (Macquarie Outperform 2026-07-14) — late-stage distribution behaviour. The 2026-07-29 Q2… Special situation · Semi foundry & equipment · Networking & optical catalyst · WDC Western Digital Corporation fresh LOW The 29% bounce off the 2026-07-28 low stalled: WDC closed $527.22 on 2026-08-03, −3.23% on a day its sector rose 0.58%, back under a rising 50-day at $562.65. Consensus (~$3.69B / $3.31–$3.35) still sits above the company's own $3.65B… Cyclical recovery · AI chips & memory · AI datacenter infrastructure catalyst · XMTR Xometry, Inc. fresh LOW JP Morgan assumed coverage Overweight with a $120 target on 2026-08-24 — the highest posted on the name — and the close only moved $83.59 to $84.58, a fourth straight session under the $85.00 June follow-on level. Seven positive sell-side… Theme leader · Cyclical industrials · Physical AI & robotics catalyst · XPO XPO, Inc. fresh LOW Record 79.9% adjusted LTL operating ratio and a raised full-year guide (2026-07-30) now sit against two negative July industry prints — ATA tonnage -0.5% YoY and Cass shipments -4.8% YoY. The $197.01 shelf gave way on the 2026-08-24 close… Compounder · Freight & logistics · Cyclical industrials catalyst ·

Watchlist

33
CRWV CoreWeave, Inc. fresh MEDIUM Post-print repricing is holding but fading: the 2026-08-12 gap to $107.73 is unfilled after closes of $106.29 and $105.26, RSI 71.1. Q2 printed $128M adjusted operating income against a $30–90M guide, and the $2.6B facility closed… Compounder · GPU cloud & neoclouds catalyst · HOOD Robinhood Markets, Inc. fresh MEDIUM The 2026-08-21 breakout above the $97.28/$98.87 band held its weekly close at $108.13, then gave 4.2% back to $103.62 on 2026-08-24 — still above the band, follow-through above $109.25 rejected. The dated binary is the 2:15 p.m. ET cloture… Compounder · Crypto exchanges & financials catalyst · UUUU Energy Fuels Inc. fresh MEDIUM Mine-to-magnet milestone cadence still driving the tape, but paying less each time: the 2026-08-19 terbium qualification bought one session (08-21 close $15.14, +8.92%) then faded to $14.88 on 08-24, back under the 08-14 shelf of $15.10.… Compounder · Critical materials & rare earths · Nuclear & uranium catalyst · AAOI Applied Optoelectronics, Inc. fresh LOW The $110 shelf that defined the August leg is gone: the 2026-08-24 close of $107.63 fully unwinds the 2026-08-04 policy gap (pre-gap close $110.21), three sessions after a second $600,000,000 ATM was filed on 2026-08-21. Q2 revenue +86%… Cyclical recovery · Networking & optical catalyst · AEHR Aehr Test Systems fresh LOW Wafer-level burn-in toll on AI silicon: FY2027 guided $130–150M against $50.0M in FY2026, guide unamended. But the 2026-07-21 shelf at $98.91 gave way on the 2026-08-24 close of $96.43 — a fifth straight lower close from $145.61… Cyclical recovery · Semi foundry & equipment catalyst · AMSC American Superconductor Corporation fresh LOW Grid/advanced-conductor supplier to data-center and utility power; backlog still ~+40% YoY (~$280M), but the tape broke after the 2026-05-28 beat-and-soft-guide and a late-June Russell removal piled on passive selling. Below the lost ~$40… Cyclical recovery · Industrial power & grid catalyst · APLD Applied Digital Corporation fresh LOW BTC→AI landlord whose operating build (>1 GW contracted, ~$31B backlog, 175 MW live) has decoupled from an equity that halved from $49.65 to a $25.79 low, now bouncing off the $25.56 April base into a binary FY26 print on 2026-07-27.… Special situation · GPU cloud & neoclouds catalyst · ASML ASML Holding N.V. fresh LOW The $1,740 July band floor is being tested: the 2026-08-24 close of $1,740.13 sits on it after the $1,805 shelf reclaim failed. Consensus has been flat at $2,195 for a fourth reading, nothing ASML-dated resolves before 2026-10-14, and the… Cyclical recovery · Semi foundry & equipment catalyst · ASTS AST SpaceMobile, Inc. fresh LOW Deployment-cadence leg goes dead: the 2026-08-24 close of $62.35 (-9.2%, per GuruFocus) erased the 08-21 reclaim and broke below the 08-20 intraday low of $62.89, with BlueBirds 14/15/16 still undated 15 days after "ready to ship shortly."… Retail squeeze · Space economy catalyst · AVGO Broadcom Inc. fresh LOW The three-session bounce failed at the 200-day: $368.45 on 2026-08-21 gave way to $358.76 on 2026-08-24 with RSI(14) at 18.4 and no company-specific headline — a fourth straight close under a rising 200-day marked $369.20. The unwithdrawn… Cyclical recovery · AI chips & memory catalyst · AXTI AXT Inc fresh LOW The prior break level failed: 2026-08-24 closed $65.40, roughly a third below the 2026-08-17 intraday $97.79 and back at the $64.25 April secondary price, erasing almost the whole post-Q2 gap while contracted InP demand keeps building. The… Cyclical recovery · Semi foundry & equipment catalyst · CCJ Cameco Corporation fresh LOW Nuclear-uranium theme maturing and CCJ's structure has broken twice into improving news: mkt cap $44.79B (06-29) → ~$39.9B (07-25), ~$88, ~35% off the $135.24 high, absorbing a $17.5B federal AP1000 program and NJ's $24B plan. Barclays cut… Theme leader · Nuclear & uranium catalyst · CEG Constellation Energy Corporation fresh LOW Post-print reclaim still failing: $282.50 (2026-08-14) is the only close above the broken $281 shelf, and 08-24 printed $273.43 thirteen sessions after the beat-and-raise. Seven sell-side cuts since 07-27 against one raise, PJM's 2028/29… Theme leader · Nuclear & uranium catalyst · COIN Coinbase Global, Inc. fresh LOW Fourth session of the CLARITY repricing gave ground: adjusted close $179.48 on 2026-08-24 vs $186.49 on 08-21, RSI(14) 67.3 from 74.9, with the $160.20 gap floor still intact. The 08-24 tokenized-stocks launch on Base (Chainlink oracle,… Compounder · Crypto exchanges & financials catalyst · CRCL Circle Internet Group, Inc. fresh LOW Still a policy trade, but the first company-level support in weeks arrived: Bernstein's 2026-08-24 note reports USDC supply +$1.7B in a week after ~six months flat, reiterating $140 while Susquehanna raised to $92 on a Neutral. Circle has… Earnings inflection · Crypto exchanges & financials catalyst · IONQ IonQ, Inc. fresh LOW Broken gov-capital quantum leg, now publicly capitulated: seven-plus down weeks, an inverse-ETF complex up to +108%, and Cramer warning it off air on 2026-07-23. Washed out but not based, heading into a binary Q2 print (est. 2026-08-05 to… Retail squeeze · Quantum computing catalyst · IREN IREN Limited fresh LOW Neocloud re-rate has fully round-tripped: $33.62 close 7/17, -42% in 30 days, late-May Microsoft breakout base surrendered. Contracts intact ($9.7B MSFT, prepaid tranches) but Q3 AI revenue was only $17.3M vs a $3.4B ARR ambition, and… Special situation · GPU cloud & neoclouds catalyst · LITE Lumentum Holdings Inc. fresh LOW Optical-content-per-rack leg intact, but the cohort just repriced on a peer's dilution rather than on anything Lumentum said: the 2026-08-24 close of $830.17 sits 1.2% over the 2026-08-11 shelf at $820.59 after Applied Optoelectronics'… Cyclical recovery · Networking & optical catalyst · META Meta Platforms, Inc. fresh LOW Capex-into-revenue leg bought ~28% under the high while an Oakland courtroom sets the daily print. The 2026-08-24 close of $559.02 is the first close back above the $556 shelf broken 2026-08-19, RSI(14) 37.4. Executive testimony —… Compounder · Mega-cap AI platforms catalyst · MSTR Strategy Inc fresh LOW Eighth straight week with no bitcoin bought: the 2026-08-24 8-K shows ~$2.01B of common sold at an average near $109.88 into the rally, with 100% routed to STRC buybacks, a $5.1B USD Reserve and a new $1.59B "USD Cash" pool. Credit… Retail squeeze · Crypto exchanges & financials catalyst · MTUM fresh LOW The AI-memory leg MTUM rotated into at the May reconstitution has rolled over: SOX -20%+ from its June peak, memory names in a bear market, and the fund closed $302.09 on 2026-07-17, below the $310 shelf that defined the… Compounder · AI chips & memory · AI datacenter infrastructure catalyst · NNE Nano Nuclear Energy Inc. fresh LOW Nuclear-microreactor narrative has stopped converting news into demand: a Truist Hold/$22 initiation (7/14) and a Virginia consortium announcement (7/17) landed inside four sessions and NNE still printed a fresh 52-week low at $15.78… Compounder · Nuclear & uranium catalyst · OKLO Oklo Inc. fresh LOW Three straight cohort-driven sessions carried OKLO from the 2026-07-29 close of $36.84 to $43.33 on 2026-08-04, with no Oklo release behind any of them. The 2026-08-07 Q2 call is the binary. Earnings inflection · Nuclear & uranium catalyst · PL Planet Labs PBC LOW Every reported close since 8/14 has stepped down — $24.69 to $22.17 on 8/20 — the 50-day/200-day gap widened to $25.53 vs $26.55, and the 8/20 low of $21.57 sat four cents above the 8/3 close. The unrevised 6/4 guide (FY27 $425–441M, Q2… Compounder · Space economy catalyst · PLTR Palantir Technologies Inc. fresh LOW The 2026-08-21 breakout close of $179.94 did not hold: 2026-08-24 closed $175.89 (-2.25%), back inside the $171.04–$179.01 August range, with RSI(14) down to 60.9 from 79.0. No company input until roughly 2026-11-02, so the ~08-25 FINRA… Compounder · AI enterprise software catalyst · QBTS D-Wave Quantum Inc. fresh LOW Coverage supply keeps producing one-day rallies that do not hold: BMO's 2026-08-21 initiation at $35 closed shares $20.39 (+8.46%) on no company release, and 2026-08-24 gave it all back at $18.68 (-8.39%), also on no release. Three named… Retail squeeze · Quantum computing catalyst · QUBT Quantum Computing Inc. fresh LOW The 2026-08-21 group bounce round-tripped in one session — the 2026-08-24 close of $8.24 gave back the move to $8.92, with IonQ, Rigetti and D-Wave all off ~8.5% the same day. Price sits two cents above the $8.22 shelf, under a 50-day at… Retail squeeze · Quantum computing catalyst · RGTI Rigetti Computing, Inc. fresh LOW Quantum pure-play basket is in outright hype-cycle deflation: RGTI ~$14.19 (2026-07-17), -27% MoM, and the $14 shelf that held the May CHIPS-stake gap and the June executive-order pop has broken. Inverse quantum ETFs printing +108% and the… Retail squeeze · Quantum computing catalyst · SMR NuScale Power Corporation fresh LOW Funded wait on one unsigned ENTRA1–TVA power purchase agreement, with the company silent for twenty days since the 2026-08-05 Q2 release. The 2026-08-24 close of $9.05 gave back most of the bounce off the 2026-08-18 floor at $8.64 and… Earnings inflection · Nuclear & uranium catalyst · SPCX SpaceX (Space Exploration Technologies Corp.) fresh LOW Flight 14's ship catch is deferred (Musk, 2026-08-20); the mission is now a first orbital-class flight with ~20 Starlink V3, FCC window opening 2026-08-28. NVIDIA's 2026-08-24 release dated orbital compute — Starmind gen-1 on Vera Rubin… Compounder · Space economy · AI datacenter infrastructure catalyst · TSEM Tower Semiconductor Ltd. fresh LOW Picks-and-shovels silicon-photonics foundry leg has de-rated straight into the range where July's pre-arranged CEO sales printed: the 2026-08-24 close of $211.10 sits inside $210.33–$211.27 and 33.4% under the 2026-06-22 high, with no… Cyclical recovery · Semi foundry & equipment catalyst · TSLA Tesla, Inc. fresh LOW Cybercab has a hard date — 2026-09-03, Austin, invite-only — but the first session to price it went down: $348.95 on 08-24 vs $362.86 on 08-21, RSI(14) back to 61.0 from 72.7. Reporting says the rollout starts with employee rides, and… Compounder · EV & autonomous mobility catalyst · VST Vistra Corp. fresh LOW Weekly break confirmed but not extended: 2026-08-24 closed $135.66, 2.3% above the $132.66 May low that is also the 52-week floor. A Mizuho Outperform initiation at $169 and a reported CEO purchase of 2,000 shares at $135 both landed that… Theme leader · Nuclear & uranium catalyst ·

Recently exited

28
SNOW Snowflake Inc. fresh HIGH The June digestion resolved upward, not downward — SNOW cleared the ~$244 June high and printed a fresh 52-week high at $284.99 before settling at $268.90 (2026-07-17). Q1 FY27 product revenue re-accelerated to +34% and the street is still… Cyclical recovery · AI enterprise software · AI datacenter infrastructure catalyst · AMD Advanced Micro Devices, Inc. fresh MEDIUM AI-compute narrative re-accelerated on the 2026-07-23 analyst event — named multi-gigawatt Anthropic/OpenAI commitments, Helios rack-scale ramp, TAM lifted to $2T by 2030 — drawing a fresh upgrade cluster (Roth $650, Cantor $700, Futurum… Cyclical recovery · AI chips & memory catalyst · ATI ATI Inc. fresh MEDIUM Titanium/superalloy aero-defense supplier digesting a June breakout above the reclaimed $183.30 ATH shelf: ~9% off the $204.09 high, RSI cooled to ~66, consensus PT $200.33 back above spot. Q2 lands 2026-08-06; peer CRS prints 2026-07-30… Defensive · Critical materials & rare earths catalyst · NBIS Nebius Group N.V. fresh MEDIUM GPU-neocloud narrative re-accelerated after NVIDIA disclosed a 9.3% stake (7/20) and PT raises followed (Northland $410, Baird initiates Outperform $250); Alphabet's 7/22 "demand outpaces capacity" answers the Meta-Compute bear case. The… Compounder · GPU cloud & neoclouds catalyst · VRT Vertiv Holdings Co fresh MEDIUM Liquid-cooling/datacenter-power bottleneck story intact but the revision cycle has stalled — RBC cut its target and the two newest sponsors (Baird $370, KeyBanc $360 on 07-23) initiated at the bottom of the range as the theme cooled to… Cyclical recovery · AI datacenter infrastructure catalyst · WTI W&T Offshore, Inc. fresh MEDIUM War-premium crude expression left for dead in early July has violently re-fired: the June-17 US–Iran MOU collapsed, nine nights of US airstrikes and a July-7 Hormuz tanker attack drove WTI crude +~20% to $83 (Jul 20). Unlike May, the… Defensive · Oil, energy & geopolitical · Squeeze & momentum setups catalyst · WULF TeraWulf Inc. fresh MEDIUM Bitcoin-miner-to-HPC re-rate confirmed by Anthropic's 20-year ~$19B lease (2026-07-06); theme accelerating and cluster-confirmed (Hut 8's $9.8B deal, 2026-07-20). A ~$3.5B financing overhang, the NY hyperscale moratorium aimed at Lake… Special situation · GPU cloud & neoclouds catalyst · ARM Arm Holdings plc fresh LOW Data-center royalty doubled YoY for a second quarter, but Q2 FY27 royalty growth is guided to ~13% against 22% delivered. No Arm-specific disclosure has landed since 2026-07-29, so the bid is set by third parties — BofA's 2026-08-13… Cyclical recovery · AI chips & memory catalyst · BFLY Butterfly Network, Inc. fresh LOW Butterfly Embedded chip-licensing story got marquee validation — Midjourney's up-to-$74M/5yr full-body scanner on 40 Ultrasound-on-Chip modules (2026-06-18) plus 2nd partner Aleph Neuro (2026-06-25). Fundamentals still accelerating, but… Defensive · Medtech & diagnostics · AI chips & memory catalyst · COHR Coherent Corp. fresh LOW Copper-to-optical interconnect narrative intact as a business (bookings into 2028, ~$1.9B NVDA stake) but the positioning trade is in distribution — ~35% off the 2026-06-02 ATH after correlated basket flushes. Week-of-7/21 semi rebound is… Cyclical recovery · Networking & optical catalyst · GLW Corning Incorporated fresh LOW Optical/AI-infrastructure demand is intact (Q1 Optical +36% YoY; Amazon/Meta/Nvidia deals) but the tape broke — a 43% drop off the 2026-06-30 ATH of $271.78 to ~$155. The 2026-07-28 Q2 print is the binary; two trading days out, nothing in… Cyclical recovery · Networking & optical catalyst · GLXY Galaxy Digital Inc. fresh LOW Legacy crypto-financials name re-rating to AI-data-center landlord: Phase I ~200MW at the Helios campus was delivered to CoreWeave on 2026-07-06, turning the ~$4.5B/15-yr lease from promise into live contracted revenue while shares still… Special situation · AI datacenter infrastructure · Crypto exchanges & financials catalyst · HUT Hut 8 Corp. fresh LOW Bitcoin-miner-to-AI-datacenter-landlord re-rate is now financed fact ($4.25B IG notes 6/4, ~$16.8B contracted backlog), but the momentum leg rolled from ~$127 to ~$105 as peers WULF/IREN captured the marquee Anthropic tenant deals (7/6)… Special situation · AI datacenter infrastructure · Bitcoin miners catalyst · INTC Intel Corporation fresh LOW Funded legacy-pivot leg is holding the $101.65 pre-announcement shelf by under a dollar after the 2026-08-14 close of $102.50; CEO Tan's Form 4 (105,263 sh at $95.00) is the only fresh company datapoint in a week of 13F-derived coverage.… Special situation · Semi foundry & equipment catalyst · KYMR Kymera Therapeutics, Inc. fresh LOW Oral STAT6 degrader (KT-621) re-rated on early BROADEN2 enrollment (6/25) and the $10.9B AbbVie–Apogee read-through, but the analyst upgrade cycle topped with RBC's 7/13 downgrade to neutral and the binary topline is 2H-2026 — a maturing,… Defensive · Oncology & immunology · Precision biotech & therapeutics catalyst · LRCX Lam Research Corporation fresh LOW The WFE/AI-memory capex trade that ran Lam +119% YTD into June has rolled into a group-wide correction — the worst month for chip stocks since 2008, memory momentum broken (Micron/SanDisk). The ~2026-07-29 FQ4 print is now the binary: it… Cyclical recovery · Semi foundry & equipment · AI datacenter infrastructure catalyst · MP MP Materials Corp. fresh LOW US critical-minerals-independence trade keeps getting rejected: a bullish 2026-07-20 defense-sourcing executive order failed to lift MP, which fell 7.5% on 07-24 to a fresh 52-week low ~$41 (~58% off the Oct-2025 high). Best-case policy… Compounder · Critical materials & rare earths catalyst · NVDA NVIDIA Corporation fresh LOW July de-rating unresolved and now compounded by capex scrutiny — Alphabet's first cash-flow-negative quarter since 2004 and Intel's punished $20B capex plan raise the question of whether hyperscaler spend slows. Jensen's open-weight-AI… Cyclical recovery · AI chips & memory catalyst · ONTO Onto Innovation Inc. fresh LOW June breakout fully round-tripped: ATH $386.46 (6/30) to $279.85 (7/17), now below the 50-DMA at $294.49. The tell is non-participation — TSMC raised capex to $60-64B and ASML guided up twice on 7/15-16, and ONTO closed the week at its… Cyclical recovery · Semi foundry & equipment · AI chips & memory catalyst · PURR Hyperliquid Strategies Inc fresh LOW The gamma-squeeze/index leg is over: PURR is -42% from its 6/1 high of $11.62 to $6.68 (7/17), through the $7.70 shelf, and now trades at roughly 0.78x the value of its 17.6M HYPE stack — a treasury premium that has flipped to a discount,… Retail squeeze · Crypto exchanges & financials catalyst · QCOM QUALCOMM Incorporated fresh LOW The data-center re-rating already failed: QCOM spiked to a 52-week high of $259.92 on the ~2026-06-24 Investor Day $15B-by-2029 guide, then gave back ~34% in 17 sessions to $171.78 as Hold downgrades and Apple modem-attrition math… Special situation · AI datacenter infrastructure · AI chips & memory catalyst · RIOT Riot Platforms, Inc. fresh LOW BTC-to-AI-landlord re-rating is structurally intact — AMD $311M/50MW Rockdale lease, $33.2M Q1 data-center revenue, Citi reiterated Buy/PT $28 on 2026-07-08 — but the miner complex rolled over on a Q2 crypto rout and "fresh AI-pivot… Special situation · Bitcoin miners · AI datacenter infrastructure catalyst · RKLB Rocket Lab Corporation fresh LOW Defense-backlog re-fire interrupts the mid-July rollover: the 7/20 $17B NSSL Phase 3 Lane 1 qualification and 7/21 $266M suborbital award stabilized the tape after the 7/13 support break and Piper's 7/16 Neutral $83 cap. An unresolved… Compounder · Space economy catalyst · SHLS Shoals Technologies Group, Inc. fresh LOW Solar/BESS EBOS name re-rated as a 2nd-order AI-datacenter-power play on a record $758M Q1 backlog and the multi-GW ON.energy deal; price reclaimed the $10 pivot but consensus PT sits at spot (~$10.63 vs $10.02), so the confirmed… Theme leader · AI datacenter infrastructure · Solar & clean energy catalyst · SYRE Spyre Therapeutics, Inc. fresh LOW Two of three lead binaries (SPY001, SPY002 anti-TL1A) printed potential best-in-class; the stock absorbed a ~$399.7M director-fund block sale and sits back near its ~$102 ATH (~$95). Next legs — SPY003 IL-23 Part A (guided mid-2026,… Defensive · Precision biotech & therapeutics · Binary-catalyst biotech catalyst · TNGX Tango Therapeutics, Inc. fresh LOW Post-data digestion, not acceleration: the 92% ORR combo print is fully paid for and the tape has faded from $32.90 to ~$27.7, below the $30.00 June secondary. Sell-side keeps marking up (JPM Overweight $46 on 7/15, Mizuho $40 on 7/17)… Defensive · Oncology & immunology · Binary-catalyst biotech catalyst · TSM Taiwan Semiconductor Manufacturing Company Ltd. fresh LOW Q2 (7/16) beat every line and lifted FY26 growth guide above 40%, but the capex raise to $60–64B and a 2026-07-26 Samsung–Broadcom $200B foundry pact reopened the monopoly question. Theme cooled to maturing; price recovered to ~$415, still… Cyclical recovery · Semi foundry & equipment catalyst · WEST Westrock Coffee Company fresh LOW Conway extract/RTD/flavors platform inflecting capex-to-cash: Q1 (5/07) beat + record adj EBITDA + FCF-positive-H2 guide; the 6/30 debt-maturity extension cleared the refi wall. Stock re-rated to ~$9.50 near the $9.81 52-wk high. Q2… Special situation · Cyclical industrials · Consumer discretionary rotation catalyst ·

Dormant

739
CLSK CleanSpark, Inc. HIGH Spring's binary resolved bullish: CleanSpark signed a $6.6B, 20-year Georgia data-center lease (2026-07-14) with an unnamed "global technology company," converting the BTC-miner-to-AI-infrastructure pivot from speculation into contracted… Special situation · Bitcoin miners · AI datacenter infrastructure catalyst · MRX Marex Group plc HIGH Roll-up compounder in clean momentum continuation: the sell-side is now chasing price, with KBW $80, Barclays $76 and Piper $75 targets (Jul 9-15) leapfrogging the old $60 consensus, while the Bright Point clearing bolt-on (2026-07-09)… Cyclical recovery · M&A & special situations · Crypto exchanges & financials catalyst · PANW Palo Alto Networks, Inc. HIGH AI-security spend narrative accelerating with third-party confirmation: IBM missed Q2 ($17.2B vs $17.86B) on 2026-07-14 and blamed budget migration into Cybersecurity — PANW +6.4%, CRWD +10%, BUG +6% same session. New ATH close $357.53… Compounder · Cybersecurity · AI datacenter infrastructure catalyst · PSNL Personalis, Inc. fresh HIGH The MRD story has been overtaken by a live sale process: StreetInsider reported 2026-07-17 that Personalis retained Centerview, TD Securities and Cooley after takeover interest from Merck (already a >10% holder and 19% of Q1 revenue) plus… Earnings inflection · Medtech & diagnostics analysed · RVMD Revolution Medicines, Inc. HIGH Regulatory-clock narrative re-accelerating: the rolling NDA under the FDA National Priority Voucher is "nearing completion" (2026-07-07) and the EMA opened a phased CHMP review the same day, while the Street ceiling walked from ~$186 to… Compounder · Precision biotech & therapeutics · Oncology & immunology catalyst · ABT Abbott Laboratories MEDIUM De-rating unwind is now largely priced: $82.56 close on 2026-05-11 to $111.25 on 2026-08-14, RSI 72.2, with the 2026-08-11 Google Health/Lingo partnership and Wolfe's 2026-08-13 upgrade to $130 as the newest fuel. Nothing tests the… Special situation · Medtech & diagnostics · Precision biotech & therapeutics catalyst · ACIW ACI Worldwide, Inc. MEDIUM Special-situation breakup narrative accelerating: Reuters (2026-07-17) reports ACI exploring a ~$1.5B sale of its Biller unit, which would surface sum-of-the-parts value and re-rate the faster-growing Payments Software segment. Q1 beat +… Special situation · M&A & special situations · Fintech & consumer credit catalyst · ACLS Axcelis Technologies, Inc. MEDIUM Beat-and-raise on 2026-08-06 (Q2 rev $215.175M vs $204.985M est; Q3 guided $230.0M vs $214.846M) repaired the fundamental case, but price only recovered to the top of the July band at $140.15 (08-14), 26.9% under the $191.6 high. China… Earnings inflection · Semi foundry & equipment · AI chips & memory analysed · ADBE Adobe Inc. MEDIUM Deep-value AI-disruption leg in legacy software, now with an external validator: the 2026-08-13 Silver Lake–Workday take-private report put a sponsor price on marked-down per-seat SaaS. ADBE closed 2026-08-14 at $264.02, 28.2% off the… Special situation · AI enterprise software · AI datacenter infrastructure catalyst · ADPT Adaptive Biotechnologies Corporation MEDIUM clonoSEQ MRD pure-play inflecting to self-funding growth (MRD rev +53% YoY, profitability turning); June 15 Immune Medicine separation adds a value-unlock leg. But the tape just broke to fresh 52-wk highs (~$22.92) above the $20–22… Defensive · Precision biotech & therapeutics · Medtech & diagnostics analysed · AGIO Agios Pharmaceuticals, Inc. MEDIUM Mitapivat SCD label-expansion binary into a 2026-11-01 PDUFA, now with a real commercial leg under it: Q2 mitapivat revenue $44.7M vs $26.03M consensus (2026-07-30), yet the tape gave the beat back — $33.56 close on 2026-08-14, RSI 35.8,… Earnings inflection · Binary-catalyst biotech · Rare disease & gene therapy catalyst · AKAM Akamai Technologies, Inc. MEDIUM Legacy-CDN-to-AI-inference pivot got its first external validation since the failed July bounce: Q2 CIS +39% to $99M with >$2.8B YTD contract bookings (2026-08-06), then J.P. Morgan off Underweight to Neutral, PT $158 (2026-08-13). Price… Special situation · Cybersecurity · AI datacenter infrastructure analysed · AKTS Aktis Oncology, Inc. MEDIUM The "coverage is spent" read broke: Wedbush ($35) and BMO ($37) initiated Outperform on 2026-08-19, taking the cohort to five, and the 2026-08-13 Q2 reaffirmed Q1 2027 AKY-1189 data with $517.3M cash. Price did not follow — $24.07 on… Compounder · Oncology & immunology · Precision biotech & therapeutics analysed · ALAB Astera Labs, Inc. MEDIUM Q2 (2026-08-04) answered the July margin question: GM 73.7% vs ~73% guide, and Q3 guided $540–560M vs $416.5M consensus (~40% QoQ) with Scorpio X switches in volume production a quarter early. Price has not confirmed — the 2026-08-14 close… Cyclical recovery · AI datacenter infrastructure · AI chips & memory catalyst · ALGT Allegiant Travel Company MEDIUM Allegiant closed the $1.5B Sun Country acquisition (2026-05-13) to become the largest US leisure airline just as fuel flipped to a tailwind and the whole sell-side re-rated it to $142–$160; the move has more than doubled off the low, and… Special situation · Semi foundry & equipment · Travel & leisure analysed · ALKS Alkermes plc MEDIUM Legacy CNS base converting into an OX2R sleep franchise; the mechanism was validated by the FDA's 2026-08-05 approval of Takeda's ORZEYFUL, yet ALKS closed 2026-08-21 at $48.33, 12.5% under its $55.22 high. Catalyst-light until the… Special situation · Precision biotech & therapeutics analysed · AMBA Ambarella, Inc. MEDIUM Physical-AI pure-play narrative still accelerating (Rosenblatt top H2-2026 pick, PT $120; Zacks upgrade to #2 Buy 2026-07-21), but the post-Rosenblatt breakout to ~$80 round-tripped to ~$67.61 by 2026-07-24, forfeiting the $72 shelf on a… Cyclical recovery · Physical AI & robotics · AI chips & memory catalyst · AMC Amc Entertainment Holdings, Inc. MEDIUM Box-office recovery flipped from meme-squeeze dormancy to a fundamental earnings inflection: Q2 (2026-07-20) adj EPS $0.14 vs $(0.06) est, revenue $1.597B beat, plus a Wedbush $4 / Benchmark $3 upgrade cluster (2026-07-21). Narrative… Special situation · Freight & logistics · Consumer discretionary rotation analysed · AMPL Amplitude, Inc. MEDIUM Post-print re-rate extending: 2026-08-21 close $13.29 is 0.1% under the 52-week high after a 98.4% three-month move, with Morgan Stanley to $16 (2026-08-13) and BofA to $14 (2026-08-20) lifting the ceiling above the $13 post-earnings… Theme leader · AI enterprise software catalyst · AMRX Amneal Pharmaceuticals, Inc. MEDIUM Legacy-generics-to-specialty re-rate with both 2026 tests cleared — 2026-07-30 Q2 beat plus a second FY2026 raise, Kashiv closed 2026-08-10 on $350M of term loan and 28.9M Class A shares — but the tape has faded to a 2026-08-21 close of… Special situation · Precision biotech & therapeutics · Cyclical industrials analysed · AMZN Amazon.com, Inc. MEDIUM AWS reacceleration is now measured rather than hoped: +37% YoY to $42.2B on 2026-07-30, fastest in 18 quarters, and the stock took $3T at a record $284.02 close on 2026-08-03. Half that move was back by the 2026-08-14 close of $262.65; the… Compounder · Mega-cap AI platforms analysed · ANDG Andersen Group Inc. MEDIUM Post-IPO roll-up re-rate that survived its binary: Q2 revenue $217.7M beat $199.3M on 2026-08-12 and FY2026 was affirmed at $980M–$1.0B, with four target raises to $49–57 on 2026-08-13. The print is behind it and no dated catalyst sits… Defensive · Managed care & health services · Biofuels & low-carbon fuels analysed · APH Amphenol Corporation MEDIUM AI-interconnect content leg intact — orders $10.7B, book-to-bill 1.23:1, Q3 guided above consensus — but the flow turned: $169.18 on 2026-08-07 to $157.01 on 2026-08-21, including a 6.6% one-day drop on 2026-08-18 with no company news.… Cyclical recovery · AI datacenter infrastructure · Analog semiconductors catalyst · ARES Ares Management Corporation MEDIUM Private-credit compounder still saturated rather than broken: Q2 (2026-07-31) showed AUM $671B, $36B inflows and FRE $491.1M, yet the 2026-08-21 close of $141.25 sits 20.7% under the $178.13 trailing high. Since 2026-08-12 nothing has… Compounder · Biofuels & low-carbon fuels · AI datacenter infrastructure catalyst · ARXS Arxis, Inc. MEDIUM Sponsor carve-out compounding into a Defense & Space upcycle, but the 2026-07-29 guide raise to $1.96–1.98B is now in the price. Omnetics closed 2026-08-17 at $770M EV, paid principally in 13.35M Class A shares. Momentum has reset —… Cyclical recovery · Space economy · Freight & logistics analysed · ATEYY Advantest Corporation MEDIUM The 2026-07-29 Q1 print broke the H2 digestion flag: FY2026 guide raised to ¥1,714.0B sales / ¥846.0B operating income, CY2026 tester TAM lifted to $13.0–14.5B from $10.9–12.2B, and the ADR made a new 52-week high at $235.00 on 2026-08-14.… Cyclical recovery · Semi foundry & equipment · AI chips & memory analysed · ATRC AtriCure, Inc. MEDIUM Profitability-inflection leg now confirmed by price: the 2026-08-14 close of $44.30 is a fresh 52-week high on RSI(14) 76.0. The 2026-07-23 raise (FY2026 adjusted EPS $0.00–$0.04 to $0.24–$0.32 against $0.06 consensus) is three weeks old,… Compounder · Medtech & diagnostics analysed · AU AngloGold Ashanti plc fresh MEDIUM Gold-miner margin leverage at a fresh high: spot $4,607/oz on 2026-08-21 (+11.54% MoM) turned Q2 free cash flow to $727M and the balance sheet to $991M net cash, but the same 2026-07-31 print missed on EPS ($1.98 vs $2.18) and revenue.… Compounder · Critical materials & rare earths catalyst · AUR Aurora Innovation, Inc. MEDIUM Q2 (2026-07-29) cleared the binary without breaking the plan: >200 driverless trucks and ~$80M exit run-rate reaffirmed, FY26 revenue guided $14–16M, ~$1.2B cash after a $215M net ATM raise. Price reclaimed the broken ~$6.00 June shelf to… Defensive · Physical AI & robotics · Freight & logistics catalyst · AUTL Autolus Therapeutics plc fresh MEDIUM Commercial-execution re-rating still working on no new information: after the 2026-08-03 guidance raise to $140–150M and the 2026-08-11 Q2 beat ($45.7M vs $34.0M consensus), the shares printed a new 52-week high at $2.54 and closed $2.41… Defensive · Oncology & immunology analysed · AVAH Aveanna Healthcare Holdings Inc. MEDIUM Fourth FY2026 guide raise (2026-08-13: adj EPS $0.22 vs $0.17, EBITDA floor to >$365M) carried price to a $13.16 52-week high; eight days later J.H. The overhang now has a dated clearing price, and nothing is scheduled until the ~November… Special situation · Managed care & health services · Small-cap value rotation catalyst · AYA Aya Gold & Silver Inc. MEDIUM Silver back near $69.6/oz on 2026-08-21 from $64.96 a week earlier puts Q3 realized pricing above Q2's $64.22/oz AgEq, restoring the price leg the prior read had written off — but the equity lagged, closing CA$36.66 against a CA$40.16… Compounder · Critical materials & rare earths analysed · BABA Alibaba Group Holding Limited MEDIUM Cloud/AI re-rating leg picked up an Apple attachment — Reuters reported 2026-08-14 that Apple trained a China-specific LLM with Alibaba's support — Price faded the other way, $128.41 on 08-07 to $123.81 on 08-14, 34.0% under the 52-week… Compounder · AI enterprise software · AI datacenter infrastructure catalyst · BBAR Banco BBVA Argentina S.A. MEDIUM Argentina country trade re-accelerated: June CPI printed 1.9% MoM on 2026-07-14 (first sub-2% of the cycle) and country risk broke to 402bp, tightest since April 2018, carrying BBAR to a fresh 52-week high of $22.47. Price now sits above… Compounder · Emerging markets · Critical materials & rare earths catalyst · BBNX Beta Bionics, Inc. MEDIUM Q2 (2026-07-29) resolved the binary the right way: new patient starts rose sequentially (banded +10–20%) after Q1's decline, net sales $32.0M +38% YoY, FY26 gross-margin floor raised to 58.5–59.5%. The frame flipped from broken-growth to… Earnings inflection · Medtech & diagnostics · Cyclical industrials analysed · BE Bloom Energy Corporation MEDIUM Q2 (2026-07-28) beat and raised — revenue $1.065B +165.5% YoY, FY26 guide lifted to $3.9–$4.2B — yet the 2026-08-14 close of $229.94 sits 33.5% below the 52wk high after July's 32% Hunterbrook-driven drawdown. Accelerating P&L into a… Theme leader · Industrial power & grid · AI datacenter infrastructure analysed · BETA Beta Technologies, Inc. MEDIUM The 2026-08-12 print resolved the binary split: revenue $14.658M beat the $9.752M consensus and FY26 revenue was guided up to $42–50M from $39–43M, but EPS missed at $(0.64) and backlog dollars sat flat at $3.9B for a second quarter.… Compounder · EV & autonomous mobility · Freight & logistics analysed · BH Biglari Holdings Inc. MEDIUM Q2 10-Q (filed 2026-08-07) answered the dilution question early: six-month issuance proceeds of $14,920k do not exceed the $15,073k of ATM sales already disclosed through 2026-05-08, so nothing material was sold into the June run to… Special situation · Consumer discretionary rotation · M&A & special situations analysed · BHE Benchmark Electronics MEDIUM Beat-and-raise on 2026-07-29 (rev $756M +18% YoY, AC&C +71% YoY, FY26 lifted to ~$3B/+13%) was fully sold: price round-tripped from the $98.67 52-week high to $81.75 on 2026-08-14. The AI-cooling and lidar picks-and-shovels leg is… Cyclical recovery · AI datacenter infrastructure · Cyclical industrials analysed · BILL BILL Holdings, Inc. MEDIUM Self-help re-rate cleared its binary on 2026-08-19: Q4 core revenue +16%, 23% non-GAAP operating margin, FY2027 EPS guided $3.56–$3.79 vs $3.35 consensus — and the stock still fell 2.97% the next day, closing $47.82 on 2026-08-21 under all… Special situation · Fintech & consumer credit · AI enterprise software analysed · BLZE Backblaze, Inc. MEDIUM Neocloud storage pick-and-shovel: the five-year ~$335M CoreWeave B2 Neo deal (2026-06-23) re-rated BLZE from the high-$7s to a 52-week high near $18, and sell-side is still chasing (Citizens to $16, 2026-07-23). Narrative accelerating but… Cyclical recovery · GPU cloud & neoclouds · AI datacenter infrastructure catalyst · BMY Bristol-Myers Squibb Co. MEDIUM Legacy-pharma re-rate off the 2026-07-30 guidance reset ($49.0–50.0B sales, $6.75–7.00 adj EPS) is intact, but both attention legs are spent: the AstraZeneca merger was denied 2026-08-05 and the FDA approved ZENBEXUS on 2026-08-13, four… Special situation · Precision biotech & therapeutics · Oncology & immunology catalyst · BULL Webull Corporation MEDIUM June dormant-to-leader flip is confirming: the ~$7.52 breakout resolved up on the 2026-07-21 surge, Rosenblatt lifted its target to $13 (2026-07-16), and June ops printed 28.2M users / $800M net deposits. Theme accelerating; read is a… Retail squeeze · Crypto exchanges & financials · Fintech & consumer credit catalyst · BVS Bioventus Inc. MEDIUM Two weeks past the 2026-08-05 unsolicited-proposal disclosure the M&A leg is intact but undated: no committee update in 12 sessions, price consolidating at the 2026-08-21 close of $14.38 against the $15.26 high while RSI(14) unwound 70.5… Earnings inflection · Medtech & diagnostics · Small-cap value rotation analysed · BWLP BW LPG Limited MEDIUM Hormuz VLGC rate shock now hangs on one date: the 2026-08-28 H1 report tests ~85% of Q2 days pre-fixed near $81,000/day (guided 2026-06-02) against the -$31M Product Services quarter flagged 2026-07-16, and sets the Q2 dividend against… Compounder · Freight & logistics · Oil, energy & geopolitical catalyst · CACI CACI INTERNATIONAL CLA MEDIUM Services-to-defense-tech re-rate off the 2026-08-05 FY2027 guide reset (adj EPS $32.96–33.86 vs $30.78 consensus, FCF ≥$900M) is now digesting: the 2026-08-17 NITE-STAR award made no new high, and the 2026-08-21 close of $647.39 sits back… Special situation · Defense & aerospace analysed · CADL Candel Therapeutics, Inc. MEDIUM Pre-BLA re-rating re-armed: July's round-trip reversed, price reclaimed the June $11.36 high and closed 2026-08-14 at $11.72, 0.7% under the 52-week high, after the 8/13 Q2 print reaffirmed a Q4 2026 prostate BLA and $201.6M cash into Q1… Earnings inflection · Precision biotech & therapeutics · Oncology & immunology analysed · CAL Caleres Inc MEDIUM July chop resolved up: $11.78 (2026-07-24) to $13.37 (2026-08-14) reclaims the low-$13s shelf lost after the June print, while the ~$57.8M IEEPA refund moved from legal abstraction to a live CBP payment queue ($128.68B accepted for… Special situation · Consumer discretionary rotation · Small-cap value rotation catalyst · CCC CCC Intelligent Solutions Holdings Inc. MEDIUM Cheap, high-margin insurtech SaaS put in play: a Morgan Stanley-run sale process plus a fresh Elliott activist stake. Shares popped ~13% to ~$6 on the 2026-07-09 Reuters report yet still sit below a plausible PE take-out. The trade is… Earnings inflection · M&A & special situations · AI enterprise software analysed · CCS Century Communities, Inc. MEDIUM Post-Q2 re-rate is consolidating rather than extending: the 2026-08-21 close of $69.78 is 5.8% under the $74.04 high with RSI 52.4. August HMI ticked up to 35 and Freddie Mac fell a second week to 6.65%, but July single-family starts… Compounder · Housing, homebuilders & proptech · Cyclical industrials catalyst · CDNA CareDx, Inc. MEDIUM Post-LCD estimate-revision leg is intact but the flow has moderated: no company headline between 2026-08-07 and 2026-08-21, yet a new closing high of $48.61 with RSI(14) down to 53.3 from 70.1. The 2026-08-30 LCD effective date is a… Earnings inflection · Medtech & diagnostics · Binary-catalyst biotech catalyst · CERT Certara, Inc. MEDIUM Guidance held rather than got cut again: the 2026-08-04 Q2 print reaffirmed FY26 revenue $367-382M and adj EPS $0.31-0.36 despite a revenue miss, and the $6.87 premarket gap round-tripped to an $8.43 close on 08-21. The leg is self-help —… Special situation · AI enterprise software · Precision biotech & therapeutics analysed · CGEM Cullinan Therapeutics, Inc. MEDIUM CD19 T-cell-engager-in-autoimmune narrative re-rated CGEM ~3x off the $5.68 low on CLN-978 lupus/RA single-dose remissions; now drifting to ~$17.10 in a bull flag under the $19.43 high with the big data catalyst spent and no dated readout… Earnings inflection · Oncology & immunology · Precision biotech & therapeutics catalyst · CLDX Celldex Therapeutics, Inc. MEDIUM Single-asset binary: Phase 3 EMBARQ-CSU1/CSU2 topline guided to September/October 2026 at the 2026-08-06 print is the entire equity. The re-rating leg is built — 52-week high $44.87, three Overweight raises 07-29 to 08-07 — and has since… Earnings inflection · Binary-catalyst biotech · Oncology & immunology catalyst · CLF Cleveland-Cliffs Inc. fresh MEDIUM FCF-inflection thesis confirmed: Q2 (2026-07-23) delivered positive free cash flow and a sales beat, the stock gapped ~19%, and GLJ flipped to Buy ($15.6) — first above-spot target. The GOES-into-grid narrative is re-accelerating, but a… Special situation · Critical materials & rare earths analysed · CLOV Clover Health Investments, Corp. MEDIUM Q2 (2026-08-05) resolved the binary upward — revenue $743.2M +56%, adj EBITDA $41M, FY guide lifted on every line to $2.92–3.00B revenue and $20–35M GAAP net income — but the 52-week high of $5.41 was sold to a $4.60 close on 2026-08-14… Retail squeeze · Managed care & health services · Binary-catalyst biotech analysed · CLW Clearwater Paper Corporation MEDIUM SBS paperboard price inflection: two $60/ton increases plus ~300kt of capacity out YTD took Q3 adjusted EBITDA guidance to $20–30M from negative $8M in Q2. The overbought condition at the 2026-08-07 high of $23.31 has worked off — RSI(14)… Special situation · Cyclical industrials · Semi foundry & equipment catalyst · CMCO Columbus McKinnon Corporation MEDIUM First full combined quarter post-Kito Crosby beat hard (adj EPS $0.61 vs $0.27 est) and drove a guidance raise on all three lines on 2026-07-30; the leg being bought is deleveraging from 4.9x toward sub-4x by FY28 on $70M of synergies. No… Special situation · Cyclical industrials · Critical materials & rare earths analysed · CME CME Group Inc. MEDIUM Event-contract and 24/7 pivot got dates: NHL FutureSports futures 2026-09-28, Silicon Data H100/B200 compute futures 2026-10-05, 24/7 silver 2026-09-11 — all announced 2026-08-11. Price recovered to $274.98 (2026-08-21) but still sits… Special situation · Prediction markets & betting · Crypto exchanges & financials catalyst · CMG Chipotle Mexican Grill, Inc. fresh MEDIUM Outbreak drawdown is repairing: the federal count rose from 345 cases/27 states (2026-08-14) to 431/32 (2026-08-19) while the stock went from a $33.50 close on 08-14 to $36.90 on 08-21, reclaiming the $35 shelf. CDC dates illness onsets… Compounder · Consumer discretionary rotation analysed · CMPS COMPASS Pathways Plc MEDIUM Clinical binary resolved 2026-07-07; what trades now is regulatory execution — rolling NDA completion guided Q4 2026, H1 2027 launch, $433.3M cash into 2028. The empty calendar just filled: FDA holds a public hearing 2026-09-14 on… Earnings inflection · Precision biotech & therapeutics · Cannabis reclassification catalyst · CODI Compass Diversified MEDIUM Q2 (2026-08-10) reframed the name: adj EPS $(0.09) missed $0.09 est, but Subsidiary Adj EBITDA rose 12.6% to $91.5M and covenant leverage fell 5.3x to 4.8x. TD Cowen went $12.50→$18. Riley upgraded to Buy at $15 on 2026-08-11; three… Special situation · M&A & special situations · Consumer discretionary rotation analysed · COHU Cohu, Inc. MEDIUM Best fundamental print of the AI cycle (2026-07-30: rev $149M vs $144.08M cons.; Q3 guided $163–177M vs $146.33M) collided with a sector de-rate — the stock closed $52.88 on 2026-08-07, 28.5% under its $73.91 high and beneath the June… Cyclical recovery · AI datacenter infrastructure · Semi foundry & equipment catalyst · CRAI CRA International, Inc. MEDIUM Beat-and-raise from 2026-08-06 — record $210.8M quarter, FY26 constant-currency guide lifted to $805–820M — has only partly repriced: $176.90 on 2026-08-21, still 20.2% under the $221.74 high, with no company news since the print. The leg… Cyclical recovery · Managed care & health services catalyst · CRDO Credo Technology Group Holding Ltd MEDIUM Interconnect/AEC royalty narrative still accelerating, not fading — new 52-week highs on late-June initiations (Evercore $325, Stifel $350, BofA $340) plus the early-July AI-buildout rally. But it's now mainstream and widely held, entering… Cyclical recovery · Networking & optical · AI datacenter infrastructure catalyst · CRM Salesforce, Inc. MEDIUM De-rated Dow software incumbent on two dated legs: the $1.6B VA agentic ELA (2026-07-24) and Reuters' 2026-08-13 report of Silver Lake–Workday take-private talks, which put a private-market floor under mega-cap SaaS. Six target revisions… Special situation · AI enterprise software catalyst · CSTL Castle Biosciences, Inc. MEDIUM Mix-shift repair leg extended without new fundamental content: $29.62 on 2026-08-14 to $34.20 on 2026-08-21, with only an 08-17 Nasdaq Texas dual listing and an 08-20 conference schedule filed in between. TissueCypher +64% YoY still… Defensive · Medtech & diagnostics · Oncology & immunology catalyst · CTOS Custom Truck One Source, Inc. MEDIUM Utility T&D / grid-capex cycle with CTOS as the laggard specialty-rental picks-and-shovels name; the June breakout to $11.36 has stalled, retracing ~10% to retest the ~$10 shelf into a binary 2026-07-29 Q2 print. Theme now maturing and… Cyclical recovery · Industrial power & grid · AI datacenter infrastructure analysed · CVI CVR ENERGY, INC. MEDIUM Frame flipped since the 2026-08-08 note: a refined-products squeeze repriced CVI from $31.15 (2026-08-07) to $39.51 (2026-08-21), 0.6% off the 52-week high, on a record $102.20 diesel crack (2026-08-17) — not a company event. Consensus… Compounder · Oil, energy & geopolitical catalyst · CYRX CryoPort, Inc. MEDIUM Q2 (2026-08-06) split the read: revenue $49.0M beat $48.21M and FY26 guide affirmed at $192–196M with adjusted EBITDA crossing to +$0.4M, but commercial CGT growth halved to +9% YoY from +26%. The narrative leg is now the profitability… Cyclical recovery · Rare disease & gene therapy · Precision biotech & therapeutics analysed · DCTH Delcath Systems, Inc. MEDIUM Post-print leg held and extended — 2026-08-21 close $17.14, 1.3% under the 52-week high of $17.36 — while the news line went quiet after the 2026-08-11 conference appearance. Nothing company-confirmed is dated until ESMO (2026-10-23) and… Defensive · Oncology & immunology analysed · DFIN Donnelley Financial Solutions, Inc. MEDIUM Mix-shift leg intact and untested since the 2026-07-30 Q2 print — software 44.3% of net sales, record 36.7% adjusted EBITDA margin — with no company headline in the three weeks since. Shares closed $48.23 on 2026-08-21, 15.3% under the… Special situation · AI enterprise software · Cyclical industrials analysed · DGII Digi International Inc. MEDIUM Hardware-to-ARR re-rating accelerating: the 2026-08-05 Q3 print put ARR at $191M (+52% YoY) with a record 29.1% adj-EBITDA margin, and FY26 revenue guidance jumped to $529–533M from $490–508M. Price closed 2026-08-14 at $85.12, 0.1% off… Special situation · AI chips & memory · Bitcoin miners analysed · DINO HF Sinclair Corporation MEDIUM Post-print leg extended rather than renewed: a fresh 52-week high at $97.32 (2026-08-21), +40.1% over three months, built on the 2026-07-28 beat ($5.31 vs $4.54), the Lubricants spin-off plan and the 2026-08-11 $5B Western Gateway FID.… Compounder · Oil, energy & geopolitical · M&A & special situations analysed · DK Delek US Holdings, Inc. MEDIUM Record distillate cracks ($102.20/bbl diesel, 2026-08-17) converted a sold-off Q2 beat into a breakout: the 2026-08-21 close of $71.47 was up 11.60% in one session and a 52-week closing high, above the $64.00 12-analyst mean target.… Compounder · Oil, energy & geopolitical · Managed care & health services catalyst · DNTH Dianthus Therapeutics, Inc. MEDIUM Complement re-rate has gone quiet: no company disclosure since the 2026-08-04 Q2 print, a fresh 52-week high at $115.96 on a lower RSI than the early-August one, and the next dated binary — MoMeNtum MMN top-line — not until December 2026.… Earnings inflection · Rare disease & gene therapy · Oncology & immunology catalyst · DRTS Alpha Tau Medical Ltd. MEDIUM Head-and-neck re-acceleration: a 2026-06-23 first-ex-US glioblastoma treatment drove a +17.9% breakout to new 52-week highs (~$12.56 on 7/11), reclaiming the $11.99 Tolmar equity shelf. The 2026-07-21 AHNS podium with complete Alpha DaRT +… Earnings inflection · Oncology & immunology · Medtech & diagnostics analysed · DYN Dyne Therapeutics, Inc. MEDIUM maturing — nothing company-dated until the ~late-October Q3 print, then the 2027-01-21 PDUFA. Earnings inflection · Rare disease & gene therapy · Precision biotech & therapeutics catalyst · ELE Elemental Royalty Corporation MEDIUM Post-EMX royalty roll-up compounding fast: Q2 2026 revenue $23.8M vs $9.1M a year earlier, record 5,248 GEOs, guidance affirmed at 17,000–21,000 GEOs (2026-08-11), Vizsla Royalties silver leg targeted to close Q3 2026. Narrative… Cyclical recovery · Critical materials & rare earths · Semi foundry & equipment catalyst · ELF e.l.f. Beauty, Inc. MEDIUM Sell-side flipped from cutting to marking up in ten days — five PT raises 2026-07-10→07-17 (JPM $94, Canaccord $97, Citi $92, RJ $87, UBS $80) on the e.l.f. Hair launch and Rhode scaling, while the stock slipped to $72.25. Narrative… Earnings inflection · Consumer discretionary rotation · Semi foundry & equipment analysed · ELVN Enliven Therapeutics, Inc. MEDIUM Funded single-asset CML story broadening its shareholder base: Barclays initiated Overweight $78, William Blair Outperform and Mizuho raised to $73 all on 2026-08-18, yet the 2026-08-21 close of $59.82 sits 2.1% under the $61.11 high with… Earnings inflection · Oncology & immunology · Binary-catalyst biotech analysed · ENTG Entegris, Inc. MEDIUM June's sentiment re-rate rolled over; the 2026-08-04 beat-and-raise re-based the story on numbers — Q2 sales $883.2M vs $835.5M consensus, Q3 guide $905–935M vs $879.8M — and drew three target raises on 08-05 (UBS $215). At $152.08 the… Cyclical recovery · AI chips & memory · Analog semiconductors catalyst · ENVA Enova International, Inc. MEDIUM Credit-normalisation plus origination growth still working, but the repricing has stalled: $242.93 on 2026-08-21 is 8.5% under the $265.45 high with RSI 37.6 after a +54.2% three-month run. Two August filings cut funding cost (ABS priced… Compounder · Fintech & consumer credit · Precision biotech & therapeutics catalyst · EOLS Evolus, Inc. fresh MEDIUM Margin-inflection re-rating still paying: Q2 (2026-08-05) printed $84.1M revenue (+21% YoY) and a third straight positive adjusted EBITDA quarter, and price has since marked a new 52-week high at $8.60 (2026-08-21 close $8.39, RSI 77.3).… Defensive · Precision biotech & therapeutics catalyst · ETON Eton Pharmaceuticals, Inc. MEDIUM Q2 on 2026-08-13 resolved the binary upward — product sales $37.6M vs $27.1M consensus, FY26 guide to >$145M from >$120M — and four brokers raised targets inside four sessions. Accelerating, but priced into the top of the published targets. Defensive · Precision biotech & therapeutics catalyst · EVER EverQuote, Inc. MEDIUM The 2026-08-03 Q2 print resolved the plateau binary bullish: revenue $195.1M (+25% YoY) broke the three-quarter ~$190M band, adjusted EBITDA hit a record $30.1M, and Q3 was guided $198–208M above the $201.6M consensus. The leg is now… Defensive · Managed care & health services · Precision biotech & therapeutics catalyst · EXLS ExlService Holdings, Inc. MEDIUM Refinancing overhang cleared 2026-08-18 — a new up-to-$1.0B facility ($400M term loan, revolver to $600M, 2031 maturity) replaced the Citibank agreement that had $381.2M sitting in the current column — and EXLS broke its mid-$34s shelf to… Theme leader · AI enterprise software · Managed care & health services analysed · FA First Advantage Corporation MEDIUM Aug 6 flipped the frame: Q2 revenue $448.8M/+14.9% vs $415.0M consensus, adj EPS $0.35 vs $0.28, and the first FY guide raise of the cycle ($1.67–1.71B). Needham upgraded to Buy/$28, RBC to $24 — targets moved above spot for the first… Special situation · Prediction markets & betting · M&A & special situations catalyst · FET Forum Energy Technologies, Inc. MEDIUM Oilfield-equipment operating-leverage re-rating, now maturing: the 2026-07-30 Q2 beat ($1.16 adj EPS vs $0.56) and raised FY26 guide were reiterated at EnerCom on 2026-08-18 ($890M revenue, $120M EBITDA). Price made a $86.31 52-week high,… Cyclical recovery · Cyclical industrials · Semi foundry & equipment analysed · FIGS FIGS, Inc. MEDIUM Growth re-acceleration re-rated the name on the 2026-08-06 Q2 print (revenue +28.8% to $196.6M, FY2026 guide to $757.318M, buyback doubled to $200M), and eleven sessions later the gap is unfilled — the 2026-08-21 close of $14.68 sits above… Defensive · Consumer discretionary rotation catalyst · FORM FormFactor, Inc. MEDIUM Probe-card pick-and-shovel to the HBM4 test ramp; after a parabolic run to a fresh $160.27 ATH (2026-06-30) on Russell 1000 inclusion, the 2026-07-02 chip selloff cut FORM ~24% to ~$121. HBM inflection intact (record DRAM quarter, second… Cyclical recovery · Semi foundry & equipment · AI chips & memory catalyst · FOSL Fossil Group, Inc. MEDIUM The 2026-08-12 binary resolved bullish: Q2 sales $209.7M beat a $199.3M consensus, gross margin expanded 490bps to 62.4%, and FY2026 guidance was raised on sales (-3%/-5%), adjusted operating margin (4-6%) and free cash flow (positive).… Special situation · Consumer discretionary rotation · Small-cap value rotation analysed · FROG JFrog Ltd. MEDIUM Software-supply-chain-security plus AI-agent "trust layer" narrative keeps re-rating: the analyst cluster now leads price above $100 (UBS Buy $110 Jul 2, Truist Buy $105 Jul 9), confirming the continuation tell flagged in June.… Theme leader · Cybersecurity · AI enterprise software catalyst · FSLR First Solar, Inc. MEDIUM Section 232 supplied a new leg: the 2026-08-06 proclamation sets a $0.38/W minimum import price on modules from 2026-12-04, above the ~$0.36/W FSLR struck on Q2 US bookings. Baird upgraded 2026-08-11 with a target moved to $318 from $205.… Theme leader · Solar & clean energy · Cyclical industrials analysed · FSLY Fastly, Inc. MEDIUM The Q2 margin inflection finally got paid, five sessions late: shares moved ~21% on 2026-08-10 to $27.69 intraday, the highest since early 2024. Three insiders then disposed at $28.60–$30.00 on 2026-08-18 and the 2026-08-21 close was… Special situation · AI enterprise software · AI datacenter infrastructure analysed · FTK Flotek Industries, Inc. MEDIUM Legacy oilfield chemistry re-rating into a power/measurement business: Data Analytics hit 51% of gross profit in Q2 2026, the 2026-08-03 PREPA award adds ~$400M of 10-year expected backlog, and the 2026-08-04 guide went to $340–350M from… Special situation · Cyclical industrials · Oil, energy & geopolitical analysed · FTNT Fortinet, Inc. MEDIUM Q2 (2026-07-29) resolved up — revenue $2.047B vs ~$1.89B, product +52% YoY, FY26 guide raised to $8.020–8.180B — but price has gone nowhere since: $161.95 on 07-31, $160.01 on 08-14, still 4.9% under the $168.29 high. The 44-analyst mean… Theme leader · Cybersecurity · AI datacenter infrastructure catalyst · GCT GigaCloud Technology Inc MEDIUM Post-print leg digesting, not breaking: after the 2026-08-06 Q2 beat ($411.6M, +27.6% YoY; GM 25.6% vs 23.9%) took GCT to a 52-week-high close of $53.25 on 08-07, ten sessions with no company headline cooled it to $49.65 with RSI(14) back… Defensive · Consumer discretionary rotation · Managed care & health services catalyst · GEN Gen Digital Inc. MEDIUM Post-print leg holding on an empty calendar: Q1 FY27 (2026-08-06) beat and lifted FY27 to $5.375-5.475B, the 2026-08-17 ex-div session probed $27.41 and was reclaimed to $28.93 by 2026-08-21, and the $32.11 consensus has not moved since… Special situation · Cybersecurity · Fintech & consumer credit analysed · GERN Geron Corporation MEDIUM Narrative leg rotated on 2026-08-05/06: RYTELO revenue accelerated to $57.5M (+11% QoQ) and quarterly cash draw shrank to ~$14M from $60M, while management reframed IMpactMF's base case to the H2 2028 final OS analysis — so the… Earnings inflection · Oncology & immunology · Binary-catalyst biotech analysed · GH Guardant Health, Inc. MEDIUM Q2 (7/30) beat and lifted FY26 to $1.340–1.360B, but the second target wave on 8/3–8/4 (Stephens $195, Piper $193, MS $185) again failed to clear Citi's $215 from 7/8. Fundamentals still stepping up while the sell-side ceiling has been… Compounder · Medtech & diagnostics · Oncology & immunology catalyst · GHRS GH Research PLC MEDIUM Eli Lilly's up-to-$3.8B AtaiBeckley buy (2026-07-16) put a large-cap price on 5-MeO-DMT for depression; GHRS is now the last independent pure-play, with best-in-class inhaled GH001 Phase 2b data, that the sector is repricing as the next… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics analysed · GRND Grindr Inc. MEDIUM Q2 (2026-08-06) resolved the binary bullishly — revenue $138.1M +33% vs $132.4M consensus, FY guide to ~$540M/~$232M EBITDA, three PT raises 2026-08-07 — yet price faded from the ~$18 area on 2026-08-03 to a $16.01 close on 2026-08-14.… Special situation · Consumer discretionary rotation · AI datacenter infrastructure analysed · HIMX Himax Technologies, Inc. MEDIUM Q2 beat and an above-consensus Q3 guide (2026-08-06) plus Baird's $43 target (2026-08-07) failed to hold a price — $13.79 close on 2026-08-21, under the $14.61 post-print close, 42.0% below the $23.79 high. WiseEye's first commercial… Theme leader · AI enterprise software · Analog semiconductors analysed · HMY Harmony Gold Mining Company Limited fresh MEDIUM Gold-miner margin leverage with a new copper leg: the 2026-08-21 trading statement pre-released FY26 EPS up 90–108% in rand on US$3,811/oz received vs US$2,195/oz AISC, and spot gold at $4,607/oz sits well above that realised price. The… Compounder · Critical materials & rare earths catalyst · HNI HNI Corporation MEDIUM Steelcase synergy capture confirmed on the 2026-07-30 Q2 print — non-GAAP EPS $1.27 vs $1.04 consensus, FY2026 guide lifted to 20–25% growth from mid-teens — and the legacy-furniture value trap re-rated from $39.70 (2026-07-15) to $48.86… Special situation · Cyclical industrials · Housing, homebuilders & proptech analysed · HPK HighPeak Energy, Inc. MEDIUM Q2 (released 2026-08-10) answered the cash question: EPS $0.59 vs $(0.07) consensus on $272.4M revenue vs $232.2M, and the stock closed 2026-08-21 at $8.32, a 52-week high, versus $7.20 pre-print. The leg being bought now is the harvest… Compounder · Oil, energy & geopolitical · Small-cap value rotation analysed · HPP Hudson Pacific Properties, Inc. MEDIUM The refi binary now has a filed date: the 10-Q (2026-08-10) puts the Hollywood Media Portfolio loan maturity at 2026-09-09 with the longer-term extension still unresolved. Q2 beat ($0.35 Core FFO vs $0.26) and three August target raises… Earnings inflection · Freight & logistics · M&A & special situations catalyst · HRI Herc Holdings Inc. MEDIUM Second-order AI/power play: Herc rents the cranes and gensets that build data centers. Peer United Rentals raised FY26 guidance (2026-04-23), confirming an accelerating theme — but the stock sits +71% off its low and drifts into a binary… Theme leader · AI datacenter infrastructure · Industrial power & grid catalyst · HTZ Hertz Global Holdings, Inc MEDIUM The 2026-08-06 Q2 beat re-lit a squeeze the index deletion had just flushed: adjusted corporate EBITDA $81M cleared the top of a $50–80M guide, GAAP swung to +$64M, and the stock ran roughly 50% in two sessions amid 73.85%-of-float short… Retail squeeze · Squeeze & momentum setups · EV & autonomous mobility catalyst · HURN Huron Consulting Group Inc. MEDIUM AI-disruption discount still unwinding, but the last leg bought nothing new: price ran from the 2026-08-07 close of $152.05 to $161.64 on 2026-08-21 with no guidance change since the 2026-07-28 beat-and-raise — just a fifth covering… Theme leader · AI datacenter infrastructure · Managed care & health services analysed · ICLR ICON plc MEDIUM Restatement discount still unwinding, now with a balance-sheet leg: on 2026-08-06 ICON priced $2.15B of unsecured notes to repay the bridge facility, all secured term loans and the 5.809% 2027 notes, releasing collateral. The 2026-08-21… Cyclical recovery · Precision biotech & therapeutics · Oncology & immunology analysed · IDYA IDEAYA Biosciences, Inc. MEDIUM Approval leg intact but between catalysts: the OptimUM-02 win (HR 0.42, ASCO 2026-06-01) feeds a rolling NDA under FDA RTOR guided complete H2 2026, and Q2 (2026-08-04) showed ~$1.24B cash with runway into 2030. Nothing company-dated until… Earnings inflection · Oncology & immunology · Precision biotech & therapeutics analysed · IESC IES Holdings, Inc. MEDIUM Q3 FY26 (2026-07-31) resolved the post-index-inclusion fade in the bulls' favour — revenue $1.243B (+40%), backlog $4.53B (+91% since FY25 close), Communications +51% — and the 2-for-1 split distributing 2026-08-21 is the only dated event… Cyclical recovery · AI datacenter infrastructure · Industrial power & grid catalyst · IKT Inhibikase Therapeutics, Inc. MEDIUM Tape has caught up to the story: after FDA Orphan Drug Designation (2026-07-23) and a Q2 print (2026-08-11) showing 43 sites live across 26 countries and $159.0M cash, IKT closed $2.41 on 2026-08-14, 2.4% off its 52-week high. What is… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics analysed · ILMN Illumina, Inc. MEDIUM Post-print give-back fully reversed: $187.96 on 2026-08-07 to a 52-week-high close of $219.40 on 2026-08-21 (+51.9% over three months, RSI 66.3) with no new operating news since the 2026-07-30 beat-and-raise. Price now sits above the… Special situation · Medtech & diagnostics · Oncology & immunology analysed · IMAX Imax Corp MEDIUM Premium-large-format royalty narrative is maturing rather than breaking: price closed $52.74 on 2026-08-21, 1.8% off the $53.71 high, with RSI(14) cooling 74.5→55.5 since 2026-08-07 as Rosenblatt raised to $60 on 2026-08-10. No company… Compounder · Consumer discretionary rotation · Oil, energy & geopolitical catalyst · IMOS ChipMOS TECHNOLOGIES INC. MEDIUM Memory-cycle re-rating in an AI costume just re-accelerated: June 2026 revenue +37.2% YoY and Q2 +28.7% YoY (both records since 2014, reported 2026-07-10) erase the May deceleration scare, and price bought back the ~17% fade to sit ~$68… Theme leader · AI chips & memory · Semi foundry & equipment catalyst · INNV InnovAge Holding Corp. MEDIUM Post-sanctions PACE turnaround got its first sell-side validation above market: KeyBanc to Overweight, $13 target, 2026-08-21. The 2026-08-21 close of $10.96 reclaims the $10.50 shelf lost on the 2026-08-11 close of $10.23. The 2026-09-08… Special situation · Managed care & health services · Consumer discretionary rotation catalyst · JRSH Jerash Holdings (US), Inc. MEDIUM Sourcing-migration story now two-for-two on guidance: Q1 FY2027 revenue $50.23M (+26.7% YoY) beat consensus and the company's own guide on 2026-08-10, Q2 guided $49–51M vs $47.85M, DA Davidson to $6 on 2026-08-11. Since then the… Retail squeeze · Consumer discretionary rotation · Small-cap value rotation catalyst · KEYS Keysight Technologies, Inc. MEDIUM Analyst-migration re-rate's second leg (Morgan Stanley to Overweight, PT $400, 2026-07-13) has stalled — silent tape near 28x forward, empty calendar until the ~2026-08-19 Q3 FY26 print. The $290–300 breakout-shelf entry hasn't come;… Cyclical recovery · AI datacenter infrastructure · Networking & optical catalyst · KMTS Kestra Medical Technologies, Ltd. MEDIUM Wearable-defibrillator share-capture story accelerating: FY26 revenue $95.1M (+59%), fiscal Q4 $28.6M (+66%) with gross margin 54.8% vs 44.3%, plus JPMorgan's 2026-08-10 Overweight/$30 initiation. Price closed $26.99 on 2026-08-21, 4.8%… Defensive · Medtech & diagnostics catalyst · KMX CarMax Inc. MEDIUM Turnaround re-rating went live in July: KMX broke the $50–$53 shelf to close $57.33 on 2026-07-17 (+17.2% in five sessions) after a Q1 FY27 blowout (EPS $1.31 vs ~$0.95, revenue $8.01B +6.2%), CEO Keith Barr buying 9,400 shares at $53.005… Special situation · Consumer discretionary rotation · Fintech & consumer credit catalyst · KNSA Kiniksa Pharmaceuticals International, plc MEDIUM Post-print commercial re-rating still working but no longer fed by new information: the 2026-07-28 FY26 ARCALYST guidance raise to $980–995M and the 07-29/07-30 target ladder are three weeks old, the 08-12 Canaccord fireside produced no… Defensive · Rare disease & gene therapy · Precision biotech & therapeutics analysed · KODK Eastman Kodak Company MEDIUM AM&C inflection is now the entire story: the 2026-08-04 Q2 print put segment revenue at $105M (+40% YoY) and consolidated operational EBITDA at $36M vs $9M, and the ~$9.20 shelf reclaimed on that print has held — the 2026-08-21 close was… Special situation · Cyclical industrials · Industrial power & grid catalyst · KRO Kronos Worldwide, Inc. MEDIUM TiO2 earnings inflection printed 2026-08-05 (Q2 EPS $0.13 vs -$0.04 consensus, segment profit $41.0M vs $10.9M) is now two weeks old and consolidating rather than extending: 2026-08-21 close $8.20, 5.2% under the $8.65 52-week high, RSI… Defensive · Cyclical industrials · Managed care & health services catalyst · LAD Lithia Motors, Inc. MEDIUM Legacy dealer group re-rating on non-store earnings: the 2026-07-29 Q2 beat ($10.03 adj EPS vs $8.78) was carried by Driveway Finance while same-store revenue fell 1.6%. Since then only re-marking — Barclays $360 to $415 on 2026-08-19 —… Special situation · Consumer discretionary rotation · Semi foundry & equipment analysed · LBRX LB Pharmaceuticals Inc fresh MEDIUM Single-asset schizophrenia binary where the sell-side frame flipped above the tape: BMO $54 (2026-08-12), Stifel $53 (08-13), Clear Street $69 (08-20) against a 2026-08-21 close of $47.62 and an $51.5 eight-analyst average. The 2026-08-11… Earnings inflection · Precision biotech & therapeutics analysed · LFST LifeStance Health Group, Inc. MEDIUM Margin-inflection pivot is delivered and now being repriced by the sell-side rather than by the company: BTIG went to $18 on 2026-08-19, price closed 2026-08-21 at $12.47 (2.8% under the $12.83 high, RSI 71.9, +68.7% in three months), and… Special situation · Managed care & health services · Bitcoin miners catalyst · LIND Lindblad Expeditions Holdings Inc. MEDIUM Post-catalyst drift, not a broken story: the 2026-08-03 beat (revenue $199.2M vs $185.85M est, occupancy 91%) carried price to a $34.48 high, and with nothing scheduled before the ~2026-11-03 Q3 print it has bled to $31.09 with RSI 36.1.… Defensive · Consumer discretionary rotation · Travel & leisure analysed · LPG Dorian Lpg Ltd MEDIUM Hormuz truce collapsed 2026-07-08 — Iran re-struck shipping and re-closed the Strait, re-firing VLGC rates to fresh 2026 highs (BLPG3 $220/ton, TCE $125k/day, week of Jul 10). This pure-play VLGC name re-accelerated off its $36 late-June… Compounder · Freight & logistics · Oil, energy & geopolitical analysed · LRMR Larimar Therapeutics, Inc. MEDIUM Single-asset FA binary, now basing rather than breaking: the 2026-08-04 Q2 update held anaphylaxis at 10 of 43, reported no new urticaria after antihistamine premedication, and put cash at $156.3M with runway into Q3 2027. Rolling BLA… Earnings inflection · Rare disease & gene therapy · Binary-catalyst biotech analysed · MASS 908 Devices Inc. fresh MEDIUM Post-divestiture handheld chemical-detection pure play re-rating on the 2026-08-11 beat-and-raise (revenue $16.07M vs $15.37M est, FY floor lifted to $68–70M) plus Roth $13 / Stifel $12 target hikes on 08-12. The 2026-08-21 close of $10.68… Special situation · Medtech & diagnostics catalyst · MAX MediaAlpha, Inc. MEDIUM Q2 (2026-07-29) beat and the Q3 guide cleared consensus, yet price has drifted from $13.79 on the print to $12.94 on 2026-08-21, 9.3% under the $14.27 high. Two post-print target raises (RBC $15 on 08-05, Canaccord $17 on 08-12) against no… Theme leader · AI enterprise software analysed · MBX MBX Biosciences, Inc. MEDIUM Single-asset execution story: oPTimize Phase 3 in canvuparatide is guided to start by 2026-09-30 and sites are already screening. Since 2026-08-15 the sell-side re-rated on no new data — consensus $88.36 across 12 analysts (2026-08-23) vs… Earnings inflection · Rare disease & gene therapy · Precision biotech & therapeutics catalyst · MCS The Marcus Corporation MEDIUM Theatrical-recovery narrative has cooled from overbought without breaking: RSI(14) 40.8 at the 2026-08-21 close of $29.57 versus 87.0 two weeks earlier, while domestic box office YTD widened to $6.868B, +20.2% YoY (Box Office Mojo,… Compounder · Consumer discretionary rotation · Freight & logistics catalyst · MEI Methode Electronics MEDIUM Data-center power pivot is revenue-confirmed — record >$80M FY26 segment sales and an FY27 guide ($1.025–1.075B vs ~$952M Street) — but the post-print momentum leg has faded ~26% from the $20.38 high to ~$15. The re-rate is spent and the… Special situation · AI datacenter infrastructure · Industrial power & grid catalyst · MGNI Magnite, Inc. MEDIUM Q2 (2026-08-05) resolved the binary upward — CTV contribution ex-TAC $97.1M, +36% YoY, above the $90–92M guide; FY26 growth raised to 13–14% and eight target raises followed on 2026-08-06/07. The CTV/commerce-media compounding leg is… Theme leader · AI enterprise software catalyst · MGTX MeiraGTx Holdings plc MEDIUM The $400M Oberland royalty deal (2026-07-07) took dilution and runway risk off the table and spiked MGTX to a new 52-week high of $15.35 before a fade to ~$12.44 — a non-dilutive re-rate of a three-program AAV gene-therapy pipeline, but… Earnings inflection · Rare disease & gene therapy · Precision biotech & therapeutics analysed · MIRM Mirum Pharmaceuticals, Inc. MEDIUM Rare-disease franchise ran to a $125 ATH on FOP data, then cooled ~9% into a confirmed 2026-07-30 Q2 print. Base compounds (Q1 sales +43% YoY, FY guide $660–680M) with FOP PDUFA 2026-09-26 and HDV Phase 3 topline 2H26 stacked ahead — but… Earnings inflection · Rare disease & gene therapy · Precision biotech & therapeutics catalyst · MLKN MillerKnoll, Inc. MEDIUM July's stall under $23.18 resolved upward: new 52-week high $24.49, $23.83 close on 2026-08-14, with no new company data since the 2026-06-24 Q4 report. The leg is multiple expansion (~11.9x the $2.00 FY2027 midpoint) into Rule 144 notices… Special situation · Housing, homebuilders & proptech · Cyclical industrials analysed · MMED MiniMed Group, Inc. MEDIUM Carve-out re-rate extended: MMED closed $20.45 on 2026-08-21, through the prior $20.48 high, after Flex began U.S. shipment integrated with Abbott's Instinct sensor on 2026-08-17 — the last open product item. Reimbursement and integration… Special situation · Medtech & diagnostics · Precision biotech & therapeutics catalyst · MRNA Moderna, Inc. MEDIUM First-ever positive Phase 3 for an mRNA cancer therapy (INTerpath-001, 2026-08-19) re-rated MRNA 177.0% in one session to $174.38 and swapped the flu-vaccine binary for an oncology-platform story. The narrative is accelerating; the entry… Compounder · Oncology & immunology catalyst · MYRG MYR Group, Inc. MEDIUM AI/datacenter power-buildout supercycle lifting grid/electrical contractors; MYRG confirmed it with a record Q1 and a late-June breakout to fresh ATHs (~$487) above the $484.71 shelf. Theme accelerating + cluster-confirmed, but the Q2… Cyclical recovery · Industrial power & grid · AI datacenter infrastructure analysed · NAVN Navan, Inc. MEDIUM The wait-for-base setup flagged in July resolved upward: NAVN reclaimed the $25 IPO price and cleared the $28.22 post-IPO high, closing $29.25 on 2026-08-14 with RSI(14) at 78.5. Margin inflection on +34% Q1 growth is now confirmed by TD… Theme leader · AI enterprise software · Travel & leisure analysed · NEOG Neogen Corporation MEDIUM Post-3M-integration cleanup is in the numbers after the 2026-07-30 beat-and-raise, but the re-rating has stopped extending: $11.95 close on 2026-08-21, a marginal new high at $12.15, RSI 50.8, no target change since Piper Sandler's $13 on… Special situation · Medtech & diagnostics · M&A & special situations analysed · NESR National Energy Services Reunited Corp MEDIUM MENA national-oil-company capex via the only US-listed pure play; the 2026-08-05 $300M Kuwait award and the 2026-08-10 Q2 beat ($520.8M vs $446.97M) are fully in the tape. Headline flow stopped after the 2026-08-11 target raises and price… Cyclical recovery · Oil, energy & geopolitical · AI datacenter infrastructure analysed · NET Cloudflare, Inc. MEDIUM Q2 (2026-08-06) put a number on the agent-traffic toll thesis: revenue $696.1M +36% YoY vs a $664–665M guide, net retention 120% (+6pts), FY26 guide up to $2.864–2.870B — and six target raises to $346–400 followed. Narrative now maturing:… Cyclical recovery · AI enterprise software analysed · NGNE Neurogene Inc. MEDIUM Rett gene-therapy story is now fully financed — pro forma cash ~$360.2M after the July raise, runway into Q1 2029 — and the 2026-08-11 Q2 print added safety breadth (N=35 at 1E15 vg as of 08-10) but zero new efficacy. Next hard binary is… Earnings inflection · Rare disease & gene therapy analysed · NIQ NIQ Global Intelligence plc MEDIUM Beat-and-raise on 2026-08-10 flipped the frame: Q2 adjusted EBITDA margin 23.3% (vs 21.0% in Q1), FY26 adjusted EPS guided up to $1.08–1.12, net leverage 3.1x from 3.4x. The post-LBO deleveraging re-rate is now running, but +119.6% over… Special situation · AI enterprise software analysed · NKTR Nektar Therapeutics MEDIUM M&A read-through re-accelerating: AbbVie's $10.9B Apogee buyout (June 22, 2026) reframed NKTR as the next takeout-able Treg-IL-2 atopic-dermatitis asset, driving a ~25% run off the June low to ~$70. It's sympathy optionality, not fresh… Earnings inflection · Precision biotech & therapeutics · Binary-catalyst biotech catalyst · NRIX Nurix Therapeutics, Inc. MEDIUM Roche-partnered BTK degrader moved from validation to execution: first patient in the registrational Phase 3 DAYBreak CLL-306 on 2026-08-04, RBC to $36 on 2026-08-10, price to a new 52-week high on 2026-08-14. Narrative still accelerating,… Earnings inflection · Oncology & immunology · Binary-catalyst biotech analysed · NSP Insperity, Inc MEDIUM Q2 binary resolved constructively on 2026-07-29: adj EPS $0.34 beat $0.32, and the FY worksite-employee guide floor was raised to 305,000 from 303,000 — the first guide that did not cut volume. Margin-repair re-rating carried price to a… Special situation · Prediction markets & betting · Consumer discretionary rotation analysed · NTSK Netskope, Inc. MEDIUM Sell-side caught up to the post-lockup repair leg — six coverage actions between 2026-08-14 and 2026-08-21 lifted the average target from $16.11 to $17.25 — while the tape stalled at $14.51 (2026-08-21) versus $14.87 on 2026-08-07. The… Defensive · Cybersecurity · AI datacenter infrastructure catalyst · NVCR NovoCure Limited MEDIUM Post-TRIDENT commercial-inflection leg intact but undated: the 2026-07-23 Q2 print (rev $183.584M vs $172.437M cons., first positive adj. EBITDA $10.8M, FY guide to $710–725M) still sets the frame, and on 2026-08-22 Zacks flagged upward… Earnings inflection · Oncology & immunology · Medtech & diagnostics analysed · NXT Nextpower Inc. MEDIUM Falling knife has based and turned: after a -34% unwind from the $163 high to a ~$107 June base, a fresh cluster (Truist initiate Buy $140 07-14, Guggenheim upgrade Buy 07-15) plus a 07-15 surge is re-rating the M&A-drift story. The… Theme leader · Solar & clean energy · Industrial power & grid analysed · OII Oceaneering International Inc. MEDIUM Offshore earnings inflection (Q2 adj EBITDA $115M, FY guide $400–440M) is now fully re-rated: Citi's 2026-08-11 raise to $52 puts the anchor target at the tape, closing the sell-side gap that drove the July leg. Price $52.20 on 2026-08-14… Special situation · Oil, energy & geopolitical · Physical AI & robotics catalyst · OMDA Omada Health, Inc. MEDIUM Post-print re-rating has stalled into a two-week range — $23.89 on 2026-08-21 versus the $26.78 52-week high — after Q2 (2026-08-06) beat at $87.8M revenue (+43%) and lifted the FY guide to $334–340M. The 2026-09-10 first-ever Investor Day… Compounder · Managed care & health services · Precision biotech & therapeutics catalyst · ONC BeOne Medicines Ltd. MEDIUM Q2 print resolved bullish — revenue $1.705B vs $1.591B est., non-GAAP EPS/ADS $3.84 vs $1.44, FY26 guide raised to $6.6–6.8B — but the stock is still 7.9% under the $377.47 52-week high and the 2026-08-06 target wave was increments, not… Compounder · Oncology & immunology · Precision biotech & therapeutics analysed · OPRT Oportun Financial Corporation MEDIUM Margin-repair turnaround stalled at the highs rather than broken: after the 2026-08-05 Q2 beat ($0.42 adj EPS vs $0.33, adj EBITDA $49M vs a $34-39M guide) and an FY EBITDA raise to $160-175M, the stock peaked at $8.09 on 2026-08-07 and… Special situation · Fintech & consumer credit analysed · ORKA Oruka Therapeutics, Inc. MEDIUM Supply overhang cleared: the 2026-07-01 Fairmount $300M block at $84.43 was absorbed and price closed $92.70 on 07-17 (+11.6%), 5% off the 52-week high, with 19.85% short interest still rising. Long-acting I&I re-rated by the $10.9B… Earnings inflection · Oncology & immunology · Binary-catalyst biotech catalyst · OWL Blue Owl Capital Inc. MEDIUM Private-credit-stress bottom trade now digesting: price -1.7% from the 2026-08-07 close while RSI(14) unwound 83.9 to 58.1, and term funding reopened with $750M of 6.750% 2036 notes priced 2026-08-12. Nothing resolves the redemption… Compounder · Biofuels & low-carbon fuels · Crypto exchanges & financials catalyst · OXM Oxford Industries, Inc. MEDIUM Setup inverted since the June breakdown. OXM reclaimed its 200-day ($39.11) and 50-day ($39.94) off the $35.83 low, the CEO bought 2,500 shares at $36.90 on 2026-06-12, and ~$25M of filed IEEPA tariff-refund claims — 4% of market cap,… Special situation · Consumer discretionary rotation · M&A & special situations catalyst · PBF PBF ENERGY INC. MEDIUM Post-Q2 refining super-margin narrative has matured into a sell-side target chase — Goldman $71 → $81 on 2026-08-18 — while the >10% holder sold five tranches between 2026-08-11 and 2026-08-17, the last at $74.79 into the $75.20 high. With… Compounder · Oil, energy & geopolitical catalyst · PCOR Procore Technologies, Inc. fresh MEDIUM Post-2026-07-29 re-rating (Q2 double beat, first GAAP operating profit, FY27 25% margin target, $845M DroneDeploy deal) has extended to $63.49 on 2026-08-21 with no new information behind it — no press release since 2026-08-06, no rating… Theme leader · AI enterprise software analysed · PCTY Paylocity Holding Corporation MEDIUM Post-print re-rating leg: the 2026-08-04 Q4 FY26 beat ($1.84 adj. EPS vs $1.61 est.) triggered five price-target raises in 48 hours and a $150.42 close on 2026-08-07, +35.5% over three months. The buy is multiple recovery in mid-cap HCM… Theme leader · AI enterprise software analysed · PD PagerDuty, Inc. MEDIUM The read has flipped from value trap to ownership story. Price reclaimed the 200-DMA (~$10.30 on 2026-07-17, +13% in three weeks), Truist lifted its PT to $11 on 2026-07-09, and the 2026-07-14 addition of Alex Shootman — who sold Workfront… Special situation · AI enterprise software · M&A & special situations catalyst · PENG Penguin Solutions, Inc. MEDIUM Q3 (July 7) broke the model wide open: revenue $478.7M vs $405.5M consensus (+48% YoY), EPS $0.84 vs $0.54, FY26 growth guide lifted 12%→22% and FY27 pre-guided ~30%. The stock then round-tripped from $89.86 to ~$60 on the $750M… Cyclical recovery · AI datacenter infrastructure · AI chips & memory catalyst · PENN PENN Entertainment, Inc. MEDIUM Q2 (2026-08-06) kept the digital turnaround on schedule — interactive adj-EBITDA loss $9.5M (+$52.5M YoY), Q4-2026 profitability target and $1.963B retail EBITDAR midpoint intact — but the tape decoupled: prediction-market headlines took… Special situation · Prediction markets & betting · Crypto exchanges & financials catalyst · PGEN Precigen, Inc. MEDIUM PAPZIMEOS launch-ramp durability is the binary — the first FDA-approved RRP therapy printed $21.6M net product revenue in Q1 2026, and the now-confirmed Aug 4 Q2 print (announced Jul 21) grades whether the ramp compounds sequentially or… Earnings inflection · Oncology & immunology analysed · PK Park Hotels & Resorts Inc. MEDIUM The 2026-08-06 binary resolved upward — Q2 AFFO $0.70 vs $0.59 consensus, FY26 guide lifted to AFFO $1.90–$2.00 and RevPAR +3.0%–4.5%, July RevPAR tracking +8.5% Defensive · Travel & leisure · Freight & logistics analysed · PLMR Palomar Holdings, Inc. MEDIUM Beat-and-raise did not hold: Q2 (2026-08-04) printed GWP $630.5M +27% YoY, adjusted EPS $2.36 and a third FY26 guidance raise to $270–280M, yet the 2026-08-14 close is $128.21 against a $145.29 52-week high with RSI(14) 29.8. Earnings keep… Compounder · Managed care & health services · Small-cap value rotation catalyst · PLPC Preformed Line Products Company MEDIUM The July rollover read was voided by the 2026-07-29 Q2 print: sales $212.7M vs $193M consensus, EPS $4.49 vs $2.41, and a ~30% one-session repricing to a new all-time closing high of $480.77 (2026-08-11). Grid/AI-power second-order… Theme leader · Industrial power & grid analysed · PNRG PrimeEnergy Resources Corporation MEDIUM Geopolitical crude bid re-fired after the 2026-07-08 US strikes and Hormuz blockade — WTI back to ~$80 from $68.86, PNRG +8.9% MTD to $186.51 and above the 200-day. Structurally better than June: GCX in-service flipped Waha gas positive,… Retail squeeze · Oil, energy & geopolitical · Small-cap value rotation catalyst · PPTA Perpetua Resources Corp. MEDIUM Funded domestic-antimony story re-accelerating on the 2026-07-30 US Army/INL pilot plant and the 2026-08-06 gold-tungsten discovery (21.3 m @ 3.2 g/t Au, 0.9% W). But the 2026-08-14 close of $25.24 sits 32.2% under the $37.22 52wk high… Compounder · Critical materials & rare earths catalyst · PRCH Porch Group, Inc. fresh MEDIUM Reciprocal-pivot re-rate has largely printed: $9.26 (6/5) to $15.98, now consolidating at $13.68 after KBW's 7/13 valuation downgrade that still raised its target to $16.25. Narrative intact but maturing; the 2026-08-04 Q2 print is the… Special situation · Housing, homebuilders & proptech catalyst · PRGS Progress Software Corporation MEDIUM Disciplined software roll-up ("Total Growth Strategy") re-rated by a fresh catalyst cluster: Q2 beat + FY guide raise (2026-06-30) and the $400M Domo buy (2026-07-22). Special-situations theme active, but a maturing low-beta compounder —… Special situation · AI enterprise software · M&A & special situations analysed · PRM Perimeter Solutions, Inc. MEDIUM Monopoly wildfire retardant (PHOS-CHEK) into a season at national Preparedness Level 5 — 3.85M acres burned YTD (NIFC, 7/18), ~157% of the 10-yr average. JPM initiated Overweight $50 on 7/9, lifting the 4-analyst average target to $45.… Defensive · Managed care & health services · M&A & special situations catalyst · PTGX Protagonist Therapeutics, Inc. MEDIUM De-risked dual-royalty story accelerating into a binary: icotrokinra (oral IL-23, J&J) already approved and paying 6–10% royalties; rusfertide (PV, Takeda) into a Q3 2026 PDUFA. Stock at a fresh ATH ($143.29, Jul 20) as the PV theme runs —… Earnings inflection · Precision biotech & therapeutics · Rare disease & gene therapy catalyst · PUBM PubMatic, Inc. MEDIUM Ad-tech SSP growth inflection re-rated as an AI story: Q2 2026 revenue $78.593M (+11% YoY) beat a $68.875M consensus and the Q3 guide of $75–77M cleared $71.092M consensus. Two weeks on, the 2026-08-07 gap has held — the 2026-08-21 close… Special situation · AI enterprise software catalyst · PVLA Palvella Therapeutics, Inc. MEDIUM First-approved-therapy-for-microcystic-LM story still working: the 2026-08-04 Q2 update reaffirmed rolling-NDA completion in H2 2026 and potential approval H1 2027, and the stock closed $156.13 on 2026-08-14, 1.0% under its 52-week high.… Earnings inflection · Precision biotech & therapeutics · Rare disease & gene therapy analysed · QNST QuinStreet, Inc. MEDIUM The Aug 6 binary resolved up: Q4 revenue $373.9M (+43% YoY) beat $359.9M consensus, FY2027 guided to $1.45–1.55B revenue / $150–160M adj EBITDA, and the stock gapped +35.9% on Aug 7 to a fresh 52-week high of $22.02. Carrier ad-spend… Cyclical recovery · Fintech & consumer credit analysed · QTWO Q2 Holdings Inc MEDIUM Post-print re-rate has stalled into consolidation: the 2026-07-29 beat-and-raise (FY26 $881–886M, 28.6% adj. EBITDA margin, +$350M buyback) still stands, but no analyst action since 2026-07-31, RSI decay from 70.4 to 55.6, and two officer… Cyclical recovery · AI enterprise software · Crypto exchanges & financials analysed · RAPP Rapport Therapeutics, Inc. MEDIUM RAPP broke to all-time highs at $42.62 (2026-07-17, +6.2%) on zero company news — the move is pure sell-side re-rating (BTIG reiterated Buy/$65 on 7/16, consensus PT $56.64, 12 desks Strong Buy) with Phase 3 FOCUS now enrolling globally.… Earnings inflection · Precision biotech & therapeutics · Binary-catalyst biotech analysed · RCKT Rocket Pharmaceuticals, Inc. MEDIUM First clean RP-A501 datapoint in 15 months — three Danon patients dosed at the recalibrated 3.8×10¹³ GC/kg with no TMA or capillary leak (2026-08-03) — turned a bleeding chart into a mid-range one. The re-rate still needs the undated H2… Earnings inflection · Rare disease & gene therapy · Binary-catalyst biotech analysed · REAL The RealReal, Inc. MEDIUM The 2026-08-06 binary resolved bullish — record GMV $617M (+22%), adj EBITDA $13.5M at a 7.0% margin, FY GMV guide lifted to $2.535–2.565B — and the tape did not re-rate: $11.40 on 2026-08-14 versus ~$11.37 on 2026-07-23, still 32.5% under… Special situation · Consumer discretionary rotation · Managed care & health services analysed · RELY Remitly Global, Inc. MEDIUM Operating-leverage leg still working: Q2 on 2026-08-05 delivered Adjusted EBITDA +79% on revenue +20% and a raised FY guide of $1.978–1.988B / $410–415M. Since then the only new information has been supply — directors sold 2026-08-12… Compounder · Fintech & consumer credit · Crypto exchanges & financials catalyst · RLAY Relay Therapeutics, Inc. MEDIUM Coverage-driven leg intact but thinning: HC Wainwright's $29 raise (2026-08-20) was the fourth in 14 days and the first that failed to make a new high, with the 2026-08-21 close at $19.44 versus a $20.75 52-week high. No dated company… Earnings inflection · Oncology & immunology analysed · RMAX Re/Max Holdings, Inc. fresh MEDIUM Merger arb that finally got a date. DOJ granted HSR early termination 2026-07-13 and both special meetings are set for 2026-08-14, removing the regulatory leg. RMAX $11.10 vs ~$11.86 blended (5.150 REAX at $2.21 plus the prorated $13.80… Earnings inflection · M&A & special situations catalyst · RPD Rapid7, Inc. MEDIUM Q2 (2026-08-10) flipped RPD from a pure take-private probe to a cost-out re-rating: ARR still -2.0% YoY at $824M, but EPS beat $0.44 vs $0.35, a 12% headcount cut targets 20% Q4 operating margin, and FY26 EPS guide went to $1.78-1.83.… Earnings inflection · Semi foundry & equipment · AI enterprise software analysed · RRGB Red Robin Gourmet Burgers, Inc. fresh MEDIUM Deleveraging turnaround repricing: ~$96M / 116-unit refranchising cuts net debt ~$147M→~$51M, removing the going-concern tail that pinned RRGB near $2.46. Tape +38.7% since the ~2026-05-20 Q1 print, into the low-$7s near the $7.89 high.… Special situation · Consumer discretionary rotation catalyst · SCZM Santacruz Silver Mining Ltd. MEDIUM Silver-zinc producer re-rating: Nasdaq debut 2026-01-21, Glencore's US$40M base price cleared October 2025, Q1 2026 revenue $127.5M (+81% YoY), Q2 silver output +17% QoQ. RSI(14) 80.5 on the 2026-08-14 close of $8.85 after a flat quarter —… Compounder · Critical materials & rare earths · Small-cap value rotation catalyst · SE Sea Limited MEDIUM Three-engine re-acceleration — Shopee GMV +30%, Monee loan book +71%, Garena's best quarter in 5 years — drove a Q1 beat (2026-05-12) and a +19% one-month recovery off the $77 low. Fundamentally accelerating, but the stock is short-term… Compounder · Emerging markets · Fintech & consumer credit catalyst · SEPN Septerna, Inc. MEDIUM Re-accelerated on the 2026-08-10 Q2 beat (revenue $26.746M vs $17.875M est; EPS $(0.29) vs $(0.43)) plus SEP-479 Phase 1 PK color: new all-time high $48.19, close $44.50 on 2026-08-14, and five broker target raises in four sessions… Defensive · Precision biotech & therapeutics analysed · SHIP Seanergy Maritime Holdings Corp. MEDIUM Capesize spot printed $40,170/day on 2026-08-20, roughly 30% above the ~$30,998/day the company guided for Q3 on 2026-07-30 — yet the stock closed $17.50 on 2026-08-21, still 3.7% under its $18.17 high. No company print until… Compounder · Freight & logistics · Managed care & health services catalyst · SIBN SI-BONE, Inc. MEDIUM The 2026-08-03 binary resolved bullish: Q2 revenue $56.01M (+15.2% YoY vs +11.2% in Q1), EPS −$0.09 vs −$0.15 est, FY26 floor raised to $231M, three target hikes on 2026-08-04. Price cleared the $17.05 shelf that capped June–July.… Defensive · Medtech & diagnostics analysed · SKWD Skyward Specialty Insurance Group, Inc. MEDIUM Q2 beat on 2026-08-04 (op EPS $1.30 vs $1.17 est, combined 89.5%, 19% operating ROE) cleared the binary, but four target raises through 2026-08-11 met a lower price — $59.80 on 2026-08-14, 8.9% under the $65.63 high, RSI 45.3. maturing:… Defensive · Managed care & health services · Small-cap value rotation analysed · SMRT SmartRent, Inc. MEDIUM RSI(14) cooled 87.8→74.7 while price only slipped $1.49→$1.43, so the momentum extreme unwound sideways. Still no dated catalyst until the ~November Q3 print. Special situation · Small-cap value rotation · Housing, homebuilders & proptech analysed · SNAP Snap Inc. fresh MEDIUM Q2 (2026-08-03) inverted the broken-pivot frame: revenue +19% YoY to $1.6B, adj EBITDA $250M (+$208M YoY), Other Revenue +85%; ten desks lifted targets 2026-08-04 and the uniform $5 wall became $5.25–$8. The buy is a… Special situation · Mega-cap AI platforms analysed · SNDK Sandisk Corporation MEDIUM Cycle stock re-rating into a contracted-revenue story: Q4 (2026-08-05) revenue $8.965B, +372% YoY, GM 84.6%, and the 2026-08-13 Investor Day's ~$94B of guaranteed-volume customer agreements re-accelerated a theme that read saturated in… Cyclical recovery · AI chips & memory analysed · SNDR Schneider National, Inc. MEDIUM The 2026-07-30 print resolved the binary in the bulls' favour — adj EPS $0.29 vs $0.23 consensus, FY26 guide raised to $0.90–$1.10 from $0.70–$1.00 — yet the 2026-08-14 close of $36.10 sits 6.6% under the 2026-06-08 high, with SONAR… Defensive · Freight & logistics · Cyclical industrials catalyst · SNDX Syndax Pharmaceuticals, Inc. MEDIUM Menin-inhibitor commercial ramp accelerating: Revuforj + Niktimvo franchise cleared $100M/quarter with revenue +224% YoY, and the leg being bought is frontline AML label expansion (~10x TAM). Stock coils below 52-week-high resistance… Earnings inflection · Oncology & immunology · Precision biotech & therapeutics catalyst · SPSC SPS Commerce, Inc. MEDIUM De-rating-repair leg: Q2 (2026-07-30) beat on adjusted EPS $1.27 vs $1.09 with EBITDA +19% on 6% revenue growth, while the FY26 revenue band was cut on the 2026-06-30 3P divestiture. Price reclaimed the ~$70 200-day, but the fresh Morgan… Special situation · AI enterprise software · Freight & logistics analysed · SPXC SPX Technologies, Inc. MEDIUM Q2 beat-and-raise on 2026-07-30 was the strongest print of the cycle — HVAC backlog $919M (+59% organic), 2026 data-center revenue set at $430M, capacity target lifted to $1.1B from $750M — yet the 2026-08-14 close of $217.32 sits 11.8%… Cyclical recovery · Industrial power & grid analysed · TBLA Taboola.com Ltd. MEDIUM Legacy open-web ad network repricing as a toll booth on AI answer surfaces: the 2026-06-16 DeeperDive ad-network launch (35% take rate, open to third-party LLMs/agents) plus the 2026-07-01 Wikitree win drove a breakout to 52-week highs… Special situation · AI datacenter infrastructure · AI enterprise software analysed · TEAM Atlassian Corporation MEDIUM The "agentic AI kills seat-based software" de-rating just reversed: Q4 FY26 (2026-08-06) put cloud +31% and $6,606M subscription ARR behind the Rovo/MCP agent story, and the stock gapped 30%+ on 2026-08-07 to close $149.07. The… Theme leader · AI enterprise software catalyst · TNET Trinet Group, Inc. MEDIUM The 2026-07-30 binary resolved bullish: Q2 ICR 86% vs 90%, adj EPS $1.55 vs $0.93 est, FY adj-EPS guide raised to $4.50-5.10. Shares made a 52wk high at $71.67 and sit 4.1% under it. The leg now being bought is durability, not recovery —… Earnings inflection · Managed care & health services analysed · TOI The Oncology Institute, Inc. MEDIUM Q2 (2026-08-06) delivered the first positive adjusted EBITDA (+$0.2M) and a FY26 guide raise to $650–670M revenue with the EBITDA floor lifted to $2M, but the July refi spike already round-tripped and RSI was 32 into the print. Shares also… Special situation · Managed care & health services · Small-cap value rotation analysed · TRVI Trevi Therapeutics, Inc. MEDIUM Second breakout leg confirmed: TRVI cleared the June $18.17 all-time high and printed $20.22 on a +9.85% July 17 session (8.3M shares, $19.07 close), lifting the tape ~+45% in six weeks on Phase 3 launch mechanics and institutional… Earnings inflection · Precision biotech & therapeutics · Binary-catalyst biotech analysed · TTMI TTM Technologies, Inc. MEDIUM The 2026-08-05 binary resolved bullishly — Q2 revenue $1.004B beat both the $930–970M guide and $962M consensus, book-to-bill rose to 1.49, Q3 guided $1.100–1.140B vs $1.073B consensus. Yet the 2026-08-14 close of $140.0 is 36.8% below the… Cyclical recovery · AI datacenter infrastructure · Defense & aerospace analysed · TVTX Travere Therapeutics, Inc. MEDIUM Q2 beat on 2026-08-04 ($169.6M revenue vs $159.6M consensus; FILSPARI US sales +96% YoY to $141.1M) re-opened sell-side headroom — six target raises 08-05→08-10 into a $70–85 band while the 2026-08-14 close of $62.14 sits 1.0% under the… Earnings inflection · Rare disease & gene therapy · Precision biotech & therapeutics catalyst · TWLO Twilio Inc. MEDIUM Legacy CPaaS repricing as voice/agentic-AI engagement infrastructure; sell-side re-clustered higher into the print — Cowen $245, Mizuho $240, Citizens $250 (2026-07-17/20) — but the 2026-07-30 Q2 report is now the binary deciding whether… Special situation · AI enterprise software · AI datacenter infrastructure catalyst · TWST Twist Bioscience Corporation MEDIUM Synthetic-DNA-as-AI-input narrative went vertical: the failed $70 breakout reclaimed and ran to a $105.47 high, +200%+ YTD with 85% of it since the 2026-05-21 analyst day. Targets now $102-$120 but price sits above the $85.50 consensus and… Theme leader · Medtech & diagnostics analysed · U Unity Software Inc. MEDIUM Legacy pivot has now printed: Q2 (2026-08-06) Grow revenue $329.0M +63% YoY, Vector past $1B ARR two quarters early, GAAP breakeven pulled into Q3 2026, four Hold-to-Buy upgrades on 2026-08-07. But the 2026-08-14 close of $46.25 sits… Special situation · AI enterprise software analysed · UFPT UFP Technologies, Inc. MEDIUM MedTech outsourcing compounder re-rated on the 2026-08-03 Q2 beat — organic growth 12.4% vs 6.8% for the first half, adj EPS $2.92 vs $2.50 consensus — carrying price to within 3.9% of the $334.84 52-week high. Narrative accelerating,… Cyclical recovery · Medtech & diagnostics · Freight & logistics analysed · UGP Ultrapar Participacoes S.A. MEDIUM Q2 (6-K 2026-08-12, call 2026-08-13) delivered the margin re-rate — Ipiranga EBITDA R$2.782B at R$451/m³, record cash flow, leverage 0.9x, lowest since 2008 — then management guided Q3 margins below that level. Price faded to 6.1% under… Special situation · Emerging markets · Biofuels & low-carbon fuels analysed · UHAL U-Haul Holding Company MEDIUM Storage-plus-capital-return re-rating held through a weak print: Q1 FY2027 (2026-08-05) missed on EPS ($0.58 vs $0.69 est.) yet the stock made a new 52-week high at $75.27, helped by disposal losses reversing $24.0M to a $1.9M gain. Now… Special situation · Housing, homebuilders & proptech · Managed care & health services catalyst · ULCC Frontier Group Holdings, Inc. MEDIUM Fuel-relief leg replaced by an earnings-delivery leg: the 2026-07-29 Q2 print put adjusted EPS at $(0.10) against a $(0.60)–$(0.45) May guide on record $1,279M revenue, and guided 2H to breakeven-or-better. The catch is that guide assumes… Earnings inflection · Travel & leisure · Oil, energy & geopolitical analysed · URGN UroGen Pharma Ltd. MEDIUM The 2026-08-05 binary resolved upward: ZUSDURI Q2 net revenue $50.4M (+73% QoQ off the $29.2M Q1 base), total revenue $72.456M vs $63.526M consensus, and a ~22% one-day gap to a $49.00 52-week high. The ramp now runs into an empty calendar… Compounder · Precision biotech & therapeutics · Oncology & immunology catalyst · UROY Uranium Royalty Corp. MEDIUM Corporate re-rating from the 2026-07-27 Sweetwater close is now fully priced-in news; RSI(14) 79.9 on 2026-08-21 with no company headline since 2026-08-07, and no combined-company financials exist before the ~2026-09-14 first quarterly… Cyclical recovery · Nuclear & uranium · Precision biotech & therapeutics catalyst · VAC Marriott Vacations Worldwide Corporation MEDIUM Q2 (2026-08-06) resolved the turnaround binary upward: contract sales $545M +22%, adj EPS $2.31 vs $1.97 est, FY adj EBITDA guide lifted to $805–830M from $755–780M. Price cleared the July $105.97 high to a $120.99 close (2026-08-14) and… Special situation · Travel & leisure · Consumer discretionary rotation analysed · VCYT Veracyte, Inc. MEDIUM Sell-side is now chasing a move it missed: VCYT broke to a 52-wk high $60.91 (closed $59.13 on 2026-07-17, +124% YoY) as Piper initiated Overweight $66 (07-15) and Canaccord lifted a Hold PT $42→$60. Fundamentals still accelerating (Q1 rev… Cyclical recovery · Medtech & diagnostics · Oncology & immunology catalyst · VET Vermilion Energy Inc. MEDIUM European gas did the work: TTF above €65/MWh on 2026-08-20 (+~130% YTD) with EU storage at a record-low 57.1% for the date on 2026-08-01, and the shares moved from the 2026-08-07 close of $10.86 to $12.73, now 11.1% under the $14.32 high.… Compounder · Oil, energy & geopolitical catalyst · VG Venture Global, Inc. MEDIUM LNG-export narrative re-accelerating on Europe's winter gas scramble plus a Middle East risk premium; VG ran +23% off the $12 mid-July shelf to $14.31 as Plaquemines ramps and CP2 advances. The 2026-08-11 pre-market Q2 print is the binary… Compounder · Oil, energy & geopolitical · AI datacenter infrastructure analysed · VLO Valero Energy Corporation MEDIUM Refiner crack spreads at a record ~$70/bbl 3-2-1 as a Hormuz/Iran supply shock idles ~10% of global refining; VLO is the pure-play margin leverage and the fundamental leg is accelerating. But sell-side (6 PT raises in 11 days) and CNBC… Compounder · Oil, energy & geopolitical · Biofuels & low-carbon fuels catalyst · VOYG Voyager Technologies, Inc. MEDIUM Defense-space order flow re-rating: Q2 (2026-08-03) delivered record $113.0M bookings, 2.1x book-to-bill, $335.5M backlog and an FY26 guide raise to $275–305M, followed by Raytheon SM-3 and Space Force awards. Starlab/NASA optionality sits… Compounder · Space economy · Defense & aerospace catalyst · VSTM Verastem, Inc. MEDIUM Post-Q2 the narrative is confirmed and the tape has flattened: $6.74 on 2026-08-07 to $6.89 on 2026-08-21 while three banks cut targets with ratings held. The 2026-08-28 Oberland closing funds $50M inside 30 days; the October VS-7375… Earnings inflection · Oncology & immunology · Precision biotech & therapeutics catalyst · WEX WEX Inc. MEDIUM Hated fuel-card/fintech inflecting: the 2026-07-22 Q2 beat (Adj EPS $5.35 vs $5.05) and FY26 guide raise to $19.68-$20.08 discredit the EV-kills-fuel-cards and rate-cut-kills-float bear case; PTs jumped to $200-210 (Mizuho/KBW, 7/24).… Special situation · Fintech & consumer credit · Cyclical industrials analysed · WIX Wix.com Ltd. fresh MEDIUM Base44 margin inversion is the live leg and the market is now paying up for it: after the 2026-08-04 beat ($563.1M, +15%; adj EPS $1.39 vs $1.16) and the ~60% 2H gross-margin guide, price ran from the 2026-08-07 close of $60.20 to $66.14… Special situation · AI enterprise software catalyst · WNC Wabash National Corp. MEDIUM The tariff re-rating now has a fundamental leg under it: Q2 (2026-07-29) beat on revenue at $417.2M and backlog rose 14% q/q to $956M, the first Q2 order-book build. The binary is regulatory — Commerce's final China AD/CVD determination is… Special situation · Cyclical industrials · Freight & logistics catalyst · WTTR Select Water Solutions, Inc. MEDIUM Q2 (2026-08-04) underwrote the produced-water re-rate — record $101.6M Water Infrastructure revenue, $92.7M Adjusted EBITDA, EPS $0.17 vs $0.13 — and shares made a new 52-week high $22.18 before easing to $20.86. Consensus PT ~$22.29 is… Special situation · Oil, energy & geopolitical · Critical materials & rare earths analysed · XNCR Xencor, Inc. MEDIUM Two overhangs closed in three weeks: the $105M Alexion settlement (2026-07-29) ended the Ultomiris dispute and pushed runway through 2028, and Q2 revenue of $51.2M vs $18.9M consensus (2026-08-05) drew three price-target raises on 08-06.… Earnings inflection · Oncology & immunology analysed · YETI YETI Holdings, Inc. MEDIUM Tariff-margin-recovery turnaround now getting sell-side confirmation: Goldman upgraded to Buy/$63 on 2026-07-20 (vs Canaccord's $45 Hold a month earlier), pushing YETI through the $51.89 multi-year high. The leg still hinges on the… Special situation · Consumer discretionary rotation · Freight & logistics analysed · ZBIO Zenas BioPharma, Inc. MEDIUM First-in-disease B-cell modulator: obexelimab BLA (IgG4-RD, 56% flare cut, HR 0.44) hit the FDA 2026-05-28, and the ~60-day filing determination — acceptance plus a possible Priority Review grant — is due within days, a fresh near-term… Earnings inflection · Binary-catalyst biotech · Oncology & immunology analysed · ZETA Zeta Global Holdings Corp. fresh MEDIUM Palantir Foundry re-platforming now has a management clock — phase one guided complete within 30–40 days of the 2026-07-06 Citi event, landing on the ~2026-08-04 Q2 print. Price reclaimed the $21 shelf that capped the June recovery (+14%… Theme leader · AI enterprise software analysed · ZURA Zura Bio Limited MEDIUM Q2 print (2026-08-11) added a third tibulizumab indication — polymyalgia rheumatica, NEXUS-PMR Phase 2 by YE2026 — and Wedbush ($22) plus Guggenheim ($20) raised targets on 2026-08-12; the $5.57 close on 2026-08-14 has not paid for it. The… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics analysed · AA Alcoa Corporation fresh LOW Policy leg (Section 232 onshoring, 2026-07-20) still bid, but the driver has rolled: LME aluminum $3,360/t on 08-11 to $3,248.75/t on 08-21 while the shares rose from $49.98 to $51.85. Nothing company-dated resolves before the Q3 print… Defensive · Critical materials & rare earths analysed · AAON AAON, Inc. LOW Beat-and-raise on 2026-08-10 (Q2 sales $627.0M, +101.2%; FY guide up to $2.235–2.307B) landed with gross margin 24.3% vs 26.6% and the FY margin guide cut to 25–26%. Targets were cut the next day and the entire 2026-05-07 re-rating gap has… Cyclical recovery · AI datacenter infrastructure · Industrial power & grid analysed · AAPL Apple Inc. LOW July's rotation-crown has slipped — Polymarket now gives Apple 20% odds of ending 2026 as the largest company (7/24) and semis are breaking out again (NVDA 7/23). The live narrative is the 'anti-CapEx AI trade' as Alphabet turns… Earnings inflection · Mega-cap AI platforms catalyst · ABCL AbCellera Biologics Inc. LOW Binary resolved positive: ABCL635 Phase 2 hit both primaries on 2026-08-10 (placebo-adjusted −5.3 hot flashes/day, p<0.001), and the stock re-rated to a 52-week-high $11.38 close on 2026-08-14 at RSI 97.4. The company priced $200M of… Earnings inflection · Precision biotech & therapeutics · AI enterprise software analysed · ABEO Abeona Therapeutics Inc. LOW The 2026-08-13 Q2 print missed both lines — revenue $11.38M vs ~$12.24M, EPS -$0.35 vs -$0.23 — and price has given back 18.4% from the $7.46 high. But treated patients rose to five from three and the QTC network hit its seven-center 2026… Earnings inflection · Rare disease & gene therapy · Precision biotech & therapeutics analysed · ABNB Airbnb, Inc. fresh LOW Post-Q2 re-acceleration re-rating now confirmed on price: the 2026-08-21 close of $187.30 is a new 52-week closing high, clearing the $185.13 shelf. But the last company disclosure was 2026-08-11 (Tripadvisor), the target-revision wave… Compounder · Consumer discretionary rotation catalyst · ABVX Abivax SA LOW Post-binary single-asset UC biotech that has now lost the $125.00 placement shelf — 2026-08-14 close $118.96 — despite a positive 2026-07-30 pre-NDA FDA interaction. Sell-side sits ~$161.55 average against the tape, the CEO has framed a… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics analysed · ABX Abacus Global Management, Inc. LOW Q2 beat everything management guides to — revenue $73.020M vs $66.088M consensus, adj EPS $0.28 vs $0.24, FY $1.00–1.05 affirmed (2026-08-06) — and bought no price: $9.27 close on 2026-08-14, 22.8% off the high and through the $10 shelf.… Special situation · Crypto exchanges & financials · Small-cap value rotation catalyst · ACB Aurora Cannabis Inc. LOW Frame flipped 2026-08-11: Curaleaf's unsolicited proposal — 0.3463 CURLF shares + US$0.75 cash, implied US$4.00, capped at US$5.00 — turned a broken Canadian LP into a live take-over situation. No formal bid has been commenced, the board… Earnings inflection · M&A & special situations · Semi foundry & equipment catalyst · ACDC ProFrac Holding Corp. LOW Hormuz beta re-coupled in August: WTI settled $82.40 and Brent $88.52 on 2026-08-14 with the strait still shut, dragging ACDC to $5.37 at RSI 74.4. But the 2026-08-06 Q2 print missed (-$0.44 vs -$0.30), liquidity is ~$72M against $1,083.6M… Earnings inflection · Oil, energy & geopolitical analysed · ACHC Acadia Healthcare Company, Inc. LOW Post-scandal turnaround re-rate resolved its binary and faded. Q2 (2026-07-28) beat its own guide and lifted the FY26 floor, but printed adj. EBITDA $149.2M vs $201.8M YoY on a $28.6M settlement reserve build. Price gave back two-thirds of… Special situation · Managed care & health services analysed · ACHR Archer Aviation Inc. LOW The 2026-08-10 Boeing-subsidiary re-rating has fully retraced: the 2026-08-21 weekly close of $6.30 sits 0.6% above the $6.26 pre-announcement reference, so the market is valuing >$200M of acquired Insitu revenue at roughly nothing. Compounder · Defense & aerospace · Physical AI & robotics analysed · ACMR ACM Research, Inc. LOW Beat-and-raise on 2026-08-07 (revenue $292.9M +36% YoY, EPS $0.61 vs $0.34, FY26 floor lifted to $1.125B, H1 orders +105% YoY) was sold: the stock round-tripped to $80.42 on 2026-08-14, -36.6% from a $126.89 52-week high. Order curve… Cyclical recovery · Semi foundry & equipment · AI datacenter infrastructure analysed · ACN Accenture PLC LOW Post-crash re-rating leg has extended — $176.89 on 2026-08-14 vs the $118.15 June low — helped by a time-boxed $7.5B buyback and an $821M Pentagon War Data Platform award on 07-28. But RSI(14) is 73.1, the close sits within ~1% of the… Special situation · AI enterprise software catalyst · ADI Analog Devices, Inc. LOW The $405 post-Q2 shelf has broken — the 2026-08-14 close of $389.39 sits 12.6% under the $445.48 52-week high while every published target ($405–$550) is now above spot. Analog recovery plus the Empower AI-power option is a fully told… Theme leader · AI chips & memory catalyst · ADSK Autodesk, Inc. LOW Legacy CAD franchise trying to re-rate on an asset-operations pivot: the $3.6B MaintainX deal closed 2026-08-03, yet the 2026-08-14 close of $251.66 is still 23.0% under the $326.79 high. Two desks picked up coverage in three weeks —… Special situation · AI enterprise software · Housing, homebuilders & proptech catalyst · ADTN ADTRAN Holdings, Inc. LOW ADVA margin-recovery turnaround is finished as a narrative: the 2026-08-03 final Q2 confirmed the July pre-announcement (rev $281.1M vs $290.2M consensus, non-GAAP EPS $0.04 vs $0.10, op margin 3.8% vs 6.9% in Q1), the $9 shelf gave way,… Special situation · Networking & optical · Cyclical industrials analysed · AEIS Advanced Energy Industries, Inc. LOW Datacenter-power picks-and-shovels re-rating is now fully mainstream — Morgan Stanley initiated Overweight $421 (07-22) atop Wells $465 and Susquehanna $535 — yet the stock fell 12.65% on 07-02 and is sitting on its 200-day while analyst… Cyclical recovery · Industrial power & grid catalyst · AEM Agnico Eagle Mines Ltd. LOW Gold-equity operating leverage re-accelerating: spot gold ran from clearing $4,200 on 2026-08-05 to $4,577.49 on 2026-08-21, and Agnico's TTM net income is already +98.5% at $5.87B. The catch is timing — RSI(14) 91.9 and the 2026-08-21… Compounder · Critical materials & rare earths catalyst · AESI Atlas Energy Solutions Inc. LOW Frac-sand legacy pivoting to behind-the-meter gas power for AI data centers, but the story is DORMANT and the structure broken: shares fell from $16.73 (6/29) to an $11.96 close (7/24, -8.5%), losing the ~$15 base and $13 shelf on… Special situation · AI datacenter infrastructure · Industrial power & grid analysed · AFRM Affirm Holdings, Inc. LOW The +80%-off-March recovery re-rate has matured and rolled over: Morgan Stanley pulled its Overweight ('valuation call') on 2026-06-25, and price faded ~30% from the $100 high back onto the reclaimed 200-day near $70 while targets stayed… Compounder · Fintech & consumer credit · Consumer discretionary rotation catalyst · AGX Argan, Inc LOW AI-data-center gas-EPC theme still accelerating (4.1+ GW gas backlog, $973.6M cash, zero debt), but AGX has round-tripped from the $805.75 ATH to $563, losing both the ~$675 breakout and ~$600 shelves. Mean reversion toward the pre-run… Cyclical recovery · AI datacenter infrastructure · Industrial power & grid catalyst · AGYS Agilysys, Inc. LOW Hospitality vertical-SaaS recovery has re-accelerated into its print: AGYS ran ~+18% to $108.98 (2026-07-10) off the June ~$92 base, clearing the two lowest analyst targets ($100/$110) ahead of a confirmed 2026-07-27 Q1 FY2027 binary that… Special situation · AI enterprise software catalyst · AIP Arteris, Inc. LOW Q2 (2026-08-06) beat and raised — revenue $24.1M +46%, TTM variable royalties $8.6M +65%, FY26 guide lifted to $95-98M — and the stock still closed $28.32 on 2026-08-14, 41.7% under the 6/30 high. The $33 weekly break fired while the… Cyclical recovery · AI chips & memory catalyst · AIRO AIRO Group Holdings, Inc. LOW Policy leg intact, price leg fading: the 2026-08-13 Section 232 drone tariffs (up to 100%, most effective 2026-09-03) plus a Q2 beat of $43.180M vs $31.212M consensus have stopped attracting a bid — $8.60 on 2026-08-21 against a $9.57… Defensive · Defense & aerospace · Small-cap value rotation catalyst · AKBA Akebia Therapeutics, Inc. LOW VOICE outcomes win (USRC trial stopped early, June 2026) de-risked Vafseo's dialysis-anemia case, but the tape bled to ~$1.22, only ~48% above the $0.82 low and still fading; the late-July/early-August Q2 print is the binary —… Earnings inflection · Precision biotech & therapeutics analysed · ALGM Allegro MicroSystems, Inc. LOW The June AI data-center power-attach re-rate has flipped from being marked up to marked down: TD Cowen cut its target to $66 (2026-07-13) and Barclays downgraded to Equal-Weight at $48 (2026-07-20), the first target below the June range —… Cyclical recovery · Analog semiconductors · AI datacenter infrastructure analysed · ALHC Alignment Healthcare, Inc. LOW Profitable-MA-disruptor narrative broke on 2026-07-08: a whistleblower suit from a former Chief Transformation Officer alleges the +88% adjusted-EBITDA inflection was manufactured by reclassifying opex as capex across FY2024-25. Shares… Earnings inflection · Managed care & health services · Oil, energy & geopolitical analysed · ALK Alaska Air Group, Inc. LOW The $44–47 shelf failed: the 2026-08-21 close of $40.41 grades the prior break condition as met, with RSI(14) at 22.0 and price 36.7% under the $63.86 high. Special situation · Travel & leisure · Cyclical industrials catalyst · ALLE Allegion Public Limited Company LOW Post-Q2 gap intact but the leg is cooling: $162.31 on 2026-08-21 with RSI(14) back to 51.9 from 61.1 a week earlier, and price now under the $164.75 mean target while every post-print broker update stays Neutral/Equal Weight.… Special situation · Housing, homebuilders & proptech · AI datacenter infrastructure analysed · ALMS Alumis Inc. LOW Psoriasis leg is fully told — 2026-08-10 ONWARD3 48-week data (75% PASI 90 / 54% PASI 100) left the stock 16.5% under its $30.30 52-week high. The only re-rating leg left is the undated LUMUS Phase 2b lupus topline, reaffirmed for Q3 2026… Earnings inflection · Oncology & immunology · Precision biotech & therapeutics catalyst · ALNT Allient Inc. LOW Record-orders story intact — Q2 2026 bookings $201.3M (+49% YoY), 1.31x book-to-bill, backlog $298.0M — but the supply picture changed after the note: the CEO's trusts sold 70,000 shares at $112.49–$115.765 on 2026-08-10 and 13D holder… Cyclical recovery · Cyclical industrials · Physical AI & robotics catalyst · ALOT AstroNova, Inc. LOW Terminal merger-arb pin. Arcline's $29.00 all-cash take-private cleared its HSR condition on 2026-07-31 and goes to a shareholder vote on 2026-08-25; the 2026-08-14 close of $28.91 leaves $0.09 of gross spread against a break tail toward… Earnings inflection · M&A & special situations · Semi foundry & equipment catalyst · ALTO Alto Ingredients, Inc. LOW Ethanol-to-specialty/low-carbon pivot re-rated ~6x off $0.92, but both fuel catalysts — the June 45Z cash sale and the Russell index add — are spent, and price has round-tripped from the $6.11 July high to ~$4.64, losing the $5.10-$5.20… Special situation · Biofuels & low-carbon fuels · Cyclical industrials catalyst · AMAT Applied Materials, Inc. LOW Record Q3 FY2026 (revenue $9.12B, +25% YoY; Q4 guide $10.25B ±$0.50B) keeps de-rating anyway: $507.18 on 2026-08-14, $492.32 on 2026-08-21, 31.8% under the $722.23 high, with every published target from $585 to $740 above the market. No… Cyclical recovery · Semi foundry & equipment · AI datacenter infrastructure catalyst · AMBQ Ambiq Micro, Inc. LOW Q2 (2026-08-11) delivered net sales $33.9M, +89.7% YoY, and a Q3 guide above Street — yet the 2026-08-14 close of $64.51 sits 28.7% under the $90.48 high and below the spent $70 shelf. Fundamental acceleration has stopped buying price;… Defensive · AI chips & memory · Small-cap value rotation analysed · AMKR Amkor Technology, Inc. LOW A second anchor — the $1.5B Nvidia advanced-packaging/test partnership (2026-07-23) stacked on the 2026-06-16 TSMC 10-yr Arizona deal — is re-rating Amkor from single-customer Apple OSAT toward US AI back-end anchor. But every catalyst… Cyclical recovery · Semi foundry & equipment · AI chips & memory analysed · AMLX Amylyx Pharmaceuticals, Inc. LOW Single-asset binary, now inside the guided window: Amylyx reaffirmed on 2026-08-06 that Phase 3 LUCIDITY topline for avexitide in post-bariatric hypoglycemia arrives late August or early September 2026. Sell-side marked targets up into it… Earnings inflection · Precision biotech & therapeutics catalyst · AMN AMN Healthcare Services LOW Healthcare-staffing cyclical recovery, real but maturing and now at the highs: ~$32.9 (2026-07-24), just off a fresh 52-wk high $36.27 (~+120% off $14.87). Truist's 2026-07-22 lift to a Street-high $40 Buy is the first target leading… Special situation · Managed care & health services analysed · AMP Ameriprise Financial, Inc. LOW Wealth-platform operating leverage still delivering — Q2 (2026-07-23) adjusted operating EPS $11.07 +22%, ROE 55%, record $1.81T AUM/AUA — but the August leg is pure multiple expansion: no disclosure since 07-23, new 52-week high… Cyclical recovery · AI enterprise software · Cyclical industrials analysed · ANAB AnaptysBio, Inc. LOW The dateless wait acquired a docket: a 2026-07-28 stipulation set post-trial briefing to an Oct 20 Chancery argument, and ANAB has rebuilt from ~$54 (Jul 24) to $58.47 (Aug 14) on no company news. The written opinion deciding Jemperli… Earnings inflection · M&A & special situations · Precision biotech & therapeutics catalyst · ANRO Alto Neuroscience Inc. LOW Precision-psychiatry TRD re-rate broke to new highs on a low-information 2026-08-12 Q2 print (EPS -$0.65 vs -$0.73 est) and two same-week target revisions (BTIG $37 Buy, Wedbush $26 Neutral). The 2026-08-14 close of $32.14 sits 0.5% under… Earnings inflection · Precision biotech & therapeutics analysed · AOSL Alpha and Omega Semiconductor Limited LOW Post-parabola digestion. The Apr–May "second-order AI power-semi" re-rate (~3x to $54.34) is fully priced, above the $30.50 consensus PT with no fresh company catalyst in 11+ weeks; the 2026-07-15 pop was a newsletter-driven volume spike,… Cyclical recovery · AI datacenter infrastructure · AI chips & memory analysed · APGE Apogee Therapeutics, Inc. LOW HSR expiry (2026-08-05) and shareholder approval (2026-08-11) cleared the last stated conditions on AbbVie's $135.11 all-cash takeout, so what trades now is terminal merger-arb carry into a company-guided Q3-2026 close — capped at the bid,… Earnings inflection · M&A & special situations · Oncology & immunology analysed · APPN Appian Corporation fresh LOW Second-order agentic-AI re-rating has extended past the print without new numbers: after the 2026-08-06 beat and FY26 raise to $845–853M, price ran from a $30.41 pre-print close to $38.30 on 2026-08-21 with RSI(14) 81.5. DA Davidson's… Theme leader · AI enterprise software analysed · ARCT Arcturus Therapeutics Holdings Inc. LOW CSL exit hands back global KOSTAIVE plus flu/RSV/EBV rights, $12M cash and ~$16M of released liabilities, against $191.5M cash and runway guided through end-2028 — a platform-repossession re-rating that has run 91.3% in three months into… Earnings inflection · Oncology & immunology catalyst · AREC American Resources Corporation fresh LOW Critical-minerals refining narrative still producing dated milestones — $25M Department of War investment 2026-07-14, first commercial-scale germanium column 2026-08-07, Minor Source air permit for all planned Marion lines 2026-08-19 — but… Cyclical recovery · Critical materials & rare earths catalyst · ARHS Arhaus, Inc. LOW Written-order inflection is the leg: Q2 comparable written sales +12.5% vs delivered +4.0% (2026-08-06), with $226M cash and no long-term debt. Against it: the EPS beat carried a $23.8M one-time tariff refund, Q3 revenue is guided below… Defensive · Consumer discretionary rotation · Freight & logistics analysed · ARX Accelerant Holdings LOW Signed all-cash take-private at $20.25; the 2026-08-21 close of $19.59 leaves a fixed-price insurance-regulatory arb with the ceiling contractually set. Newly visible merger terms — go-shop ending 2026-09-22, outside date 2027-08-13… Earnings inflection · M&A & special situations · Managed care & health services catalyst · ASST Strive, Inc. LOW Treasury-premium narrative still inverted: the 2026-08-10 Q2 print booked a $257.6M loss, 94.1% mark-to-market, against a $94,761 average cost versus the $64,812 Strive itself paid in early August. Buying restarted (147 BTC, 08-03 to… Retail squeeze · Crypto exchanges & financials catalyst · ASX ASE Technology Holding Co., Ltd. LOW Advanced-packaging pricing power is real — quotes raised 20%+ (2026-07-01), 2026 capex hiked to US$8.5B, CoWoS-equivalent capacity tripling to 25k wpm — but the tape topped at $45.51 the same day and sits ~15% lower inside a 13% semi… Cyclical recovery · Semi foundry & equipment · AI datacenter infrastructure catalyst · ATAI AtaiBeckley Inc. LOW Lilly takeout is now a process, not a story: DEFM14A filed, special meeting 2026-09-08, HSR filed 2026-07-29, close guided Q3 2026. The 2026-08-14 close of $7.26 sits $0.51 over the $6.75 cash leg, so all remaining return is an unread CVR… Earnings inflection · Precision biotech & therapeutics · Semi foundry & equipment catalyst · ATEN A10 Networks Inc LOW AI-security re-rate off the 2026-06-15 TrojAI deal has stalled: ATEN churning ~$35 below the $37.36 ATH, momentum cooling as Mizuho lifts its target to $34 but stays Neutral — analyst catch-up, not fresh conviction. The 2026-08-05 Q2 print… Theme leader · AI datacenter infrastructure · Networking & optical analysed · ATHM Autohome Inc. LOW Cash-return re-rating in a shrinking business, now at negative enterprise value: US$2.62bn market cap against US$2.67bn cash, EV -US$36.57m (2026-08-16), a US$400m buyback authorised 2026-07-28 and an RMB1.5bn 2026 dividend floor. The… Special situation · Emerging markets · Semi foundry & equipment catalyst · ATKR Atkore Inc. LOW Cyclical-repair frame is closed: the 2026-08-02 definitive all-cash merger with Prysmian at $95.00/share pins the stock, and the 2026-08-14 close of $93.80 leaves $1.20 of gross spread. The read is now completion timing — HSR plus… Earnings inflection · Industrial power & grid analysed · AUGO Aura Minerals Inc. LOW Gold/copper producer basing $53–$76 under a broken ~$72 shelf after a ~45% fall from the $110 high. Q2 output slipped 8% QoQ — first sequential drop after a record Q1 — as gold cools to the low-$4,000s and sell-side keeps trimming (JPM to… Compounder · Critical materials & rare earths analysed · AVLN Avalyn Pharma Inc. LOW Post-IPO re-rating in an inhaled-antifibrotic single-asset story: the 2026-08-14 close of $39.25 is +118% over the $18.00 April IPO price with RSI(14) at 89.2, yet the MIST Phase 2b FVC readout that sets the value is guided to 2H 2027.… Earnings inflection · Precision biotech & therapeutics catalyst · AVNS Avanos Medical, Inc. LOW Resolved, not pending: AIP completed the $25.00/share all-cash take-private on 2026-07-27 and AVNS ceased NYSE trading the same day (EV ~$1.272B). Holders received cash; there is no listed security, no narrative leg and no catalyst left.… Earnings inflection · M&A & special situations · Medtech & diagnostics analysed · AVR Anteris Technologies Global Corp. LOW Post-catalyst drift: the CMS/first-patient/France de-risking sequence is spent, and Q2 (reported 2026-08-12) missed both lines — EPS $(0.30) vs $(0.21), revenue $1.009M vs $1.500M — yet the 2026-08-14 close held $9.40 with RSI 66.9.… Defensive · Medtech & diagnostics analysed · AVTR Avantor, Inc. LOW The post-print re-rating is digesting rather than extending: $13.66 on 2026-08-14 versus $13.59 on 2026-08-07, RSI(14) cooling 77.0 to 69.5, and the 2026-07-30 target cluster of $14–$16 already reached. Management's Q3 guide — about 250 bp… Special situation · Medtech & diagnostics · Precision biotech & therapeutics analysed · AVTX Avalo Therapeutics, Inc. LOW The July soft catalyst has passed: Q2 landed 2026-08-06 and delivered a schedule — registrational Phase 3 in hidradenitis suppurativa initiating H1 2027 — so the post-LOTUS story now sits in a ~10-month gap with no company-dated clinical… Earnings inflection · Precision biotech & therapeutics analysed · AVXL Anavex Life Sciences Corp. LOW Governance, not approval, is the leg: PVG's six-nominee GOLD slate meets the board's WHITE slate at the 2026-09-24 annual meeting. Since 2026-08-15 the contest kept filing (8-K 08-17, DFAN14A 08-19) while price stalled — $3.24 on… Earnings inflection · Binary-catalyst biotech · Crypto exchanges & financials catalyst · AZTA Azenta, Inc. LOW No new company information since the Aug 4 print, yet price ran from $33.39 (Aug 11) to $37.40 (Aug 21) with RSI(14) at 81.5 and the six-analyst consensus target of $34.80 now below spot. The self-help leg ($529M cash, no debt, $50.0M… Special situation · Medtech & diagnostics · M&A & special situations analysed · AZZ AZZ Inc. fresh LOW Beat-and-raise fired 2026-07-08 — Q1 adj EPS $1.85 vs $1.69, FY27 guide lifted twice on Metal Coatings momentum — but the catalyst is now behind the stock, which sits at all-time highs (~$157), ~23x forward and above consensus, with Wells… Cyclical recovery · Industrial power & grid catalyst · BAK Braskem S.A. LOW Q2 2026 (released 2026-08-14) printed US$1.043B recurring EBITDA on a Middle East supply shock management called tactical — and the ADR closed $1.95, pricing the capital structure rather than the P&L. The 2026-06-26 São Paulo shield… Earnings inflection · Biofuels & low-carbon fuels · Emerging markets catalyst · BAND Bandwidth Inc. LOW Late-stage small-cap CPaaS squeeze: +360% YoY into the mid-$70s, ~5% below the $79.08 high, with Citizens ($86, 2026-07-20). Riley ($85) both lifting targets in July. A confirmed Q2 print on 2026-07-29 is a binary two trading days out —… Retail squeeze · GPU cloud & neoclouds · AI datacenter infrastructure catalyst · BB BlackBerry Limited LOW Q1 FY27 gave the pivot real numbers (QNX $72.3M vs the $60-64M guide, FY27 raised to $594-621M), but the parabola broke: after a $13.59 high the stock fell ~37% to ~$8.54 on a meme unwind plus insider selling. Narrative maturing, price… Retail squeeze · AI enterprise software · Cybersecurity analysed · BBBY Bed Bath & Beyond, Inc. LOW Lemonis "Everything Home" roll-up keeps closing deals — Container Store now wholly owned (2026-07-08), TwoPonds folded in (2026-07-01) — but the tape has bled from $5.83 to ~$4.96 and sits on the $4.26 52-week low as shares balloon past… Special situation · Cyclical industrials · Consumer discretionary rotation analysed · BBWI Bath & Body Works, Inc. LOW Citi upgraded to Buy at $25 on 2026-08-18 and JPMorgan lifted to $24 the same day, but the 6.5% pop to $20.04 fully retraced to $19.45 by 2026-08-21 — attention arrived without a lasting bid. The 2026-08-26 Q2 print is the binary:… Special situation · Consumer discretionary rotation · Small-cap value rotation catalyst · BBY Best Buy Company, Inc. LOW Tape flipped since early July: BBY broke to a fresh 52-week high $87.35 (~$85.41 on 2026-07-17, +27.6% YTD) on RGB-LED TV exclusivity plus an AI-PC/MacBook refresh cycle. But price sits ~8% above the $79.15 consensus target while Loop… Special situation · Consumer discretionary rotation · AI datacenter infrastructure catalyst · BCAX Bicara Therapeutics Inc. LOW Bifunctional EGFR/TGF-β narrative in HPV-negative head & neck cancer stalled after the ASCO 2026 three-year-OS re-rate: $27.76 close is ~10% off the $30.99 high on roughly half prior turnover, consensus PT ~$31.46 sits only 13% above spot,… Earnings inflection · Oncology & immunology · Binary-catalyst biotech analysed · BHC Bausch Health Companies Inc LOW Levered deleveraging/separation stub: $2.41B equity on $20,239M long-term debt principal, with an 87% Bausch + Lomb stake as the main asset. The 2026-07-29 beat-and-raise (adj EPS $1.26 vs $1.04, FY sales guide to $10.790–11.040B) drove… Special situation · Precision biotech & therapeutics · Binary-catalyst biotech analysed · BHVN Biohaven Ltd. LOW Binary-catalyst biotech: the re-rate off the $7.48 Nov-CRL low stalled at ~$16 in early July and drifted to $13.85 on 2026-08-21. The undated 2H-26 RISE3 topline now races a live $350.0M J.P. Morgan ATM (424B5, 2026-05-04) against ~$270.5M… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics analysed · BIDU Baidu, Inc. ADS fresh LOW Q2 print confirmed for 2026-08-18 pre-market is the binary. The ADR bleed flattened — cap $37.10B (08-10) vs $37.21B (07-24) — but the 2026-08-14 close of $103.67 sits under the $110 shelf, -36.2% from the $162.52 high, RSI 45.7.… Special situation · Mega-cap AI platforms analysed · BIOA BioAge Labs, Inc. LOW The ESC venue hypothesis failed: ZEUS is absent from the published ESC 2026 Hot Line programme (Munich, 2026-08-28 to 08-31), so the full dataset that would separate NLRP3 from IL-6 blockade does not land in August and no substitute date… Earnings inflection · Precision biotech & therapeutics · Oncology & immunology catalyst · BIRK Birkenstock Holding plc LOW The August frame's $36 weekly level broke — the week ending 2026-08-21 closed $35.64, retracing the entire 2026-08-13 beat-and-raise reaction ($41.01 premarket, then a −4.02% close at $39.35 on 2026-08-14). Fundamentals still guide to 15%… Defensive · Consumer discretionary rotation · Oil, energy & geopolitical analysed · BJRI BJ's Restaurants, Inc. LOW The 2026-07-30 re-acceleration (comps +6.5%, traffic +8.3%, FY comp guide raised to +3–4%) is priced; no new operating datapoint or target revision since 2026-07-31, and the next print is ~10 weeks out. Special situation · Consumer discretionary rotation · Freight & logistics analysed · BKNG Booking Holdings Inc. LOW Capital-return compounder re-rated on the 2026-08-04 Q2 print (adj EPS $2.54, +15%, on +8% revenue and $3.7B repurchased), but the sell-side reset ended with Argus at $245 on 2026-08-10 and price has stalled — $212.06 on 2026-08-14, RSI… Compounder · Travel & leisure · AI enterprise software catalyst · BKSY BlackSky Technology Inc. LOW Gen-3 subscription ramp landed in Q2 (2026-08-06): revenue $33.316M vs $30.68M est, +50% YoY, adjusted EBITDA $4.7M, FY26 guide affirmed at $130–150M. But EPS missed at $(0.54) vs $(0.36), cash is $36.9M against a $50–60M capex guide, and… Defensive · Space economy analysed · BLDP Ballard Power Systems, Inc. LOW Q2 (release 2026-07-31) delivered the backlog inflection — $156.6M, +38.8% QoQ, 20% gross margin — and the stock still made new lows at $2.70 (2026-08-14), -57.7% from the $6.38 high. The £275M GeoPura deal converts the turnaround into an… Special situation · Solar & clean energy · Industrial power & grid analysed · BLKB Blackbaud, Inc. LOW Buyback-driven re-rating extended rather than stalled: $47.52 on 2026-08-21 versus $45.45 on 2026-08-11, with RSI(14) cooling from 80.1 (2026-08-07) to 62.8 while price rose. Price now sits within ~2% of the $48.50 consensus average… Special situation · AI enterprise software analysed · BLMN Bloomin' Brands, Inc. LOW Margin-repair re-rating off the 2026-08-05 raise (FY26 adj EPS to $0.90–$1.00) is holding but no longer expanding: $10.55 close 2026-08-14, RSI cooled 71.1→66.0, flow down to two hold-rated $12 targets. Brinker's 2026-08-12 print showed… Special situation · Consumer discretionary rotation analysed · BMA Banco Macro S.A. LOW Credit-recovery leg broke on the company's own numbers at the 2026-08-19 Q2 print: NPLs 6.25% (from 5.40%), coverage 95.39% (from 109.8%), FY cost-of-risk guide raised to 6.5–7% and real loan growth cut to 2–5% from ~20%. ADR closed $72.84… Compounder · Emerging markets · Biofuels & low-carbon fuels catalyst · BMNR BitMine Immersion Technologies, Inc. LOW Premium-to-NAV funding engine is closed; the 2026-08-10 release shows capital flipping from coin to float — 7,391 ETH bought for $14.3M (smallest week of 2026) against 3.0M shares retired, with cash down to $104M from $173M. The narrative… Compounder · Crypto exchanges & financials catalyst · BOLD Boundless Bio, Inc. LOW Merger-arb wrapper, not an oncology stock: the object is a planned $44–48M pre-close cash dividend plus a 3.69% stub in the AATD base-editing NewCo. Week of 2026-08-14 added owners (ADAR1 13G at 8.8%) but no deal documents — still no S-4,… Earnings inflection · M&A & special situations · Rare disease & gene therapy analysed · BRBR BellRing Brands, Inc. LOW The $11–12 post-print shelf broke on no news: $11.56 on 2026-08-07 to $10.75 on 2026-08-14, RSI 27.9, -74.8% off the $42.68 high. A third FY26 EBITDA cut ($275–295M from $315–335M) killed the margin narrative; the repair — a double-digit… Defensive · Fintech & consumer credit · Consumer discretionary rotation analysed · BRKR Bruker Corporation LOW Post-ASMS instrument re-rate broke back toward the $64.54 high and added a second leg: semiconductor-metrology strength (orders +20% YoY) pulled Leerink to $70 and top targets to $65–70. But at ~$62 the name sits ~13% over its 50-DMA and… Special situation · Medtech & diagnostics · AI chips & memory analysed · BROS Dutch Bros Inc. LOW Drive-thru coffee comps re-accelerating (Q1 +8.3%, FY guide raised) and the sell-side is now catching up — Stephens initiated Overweight $80, Morgan Stanley to $88 in mid-July. But June's run to ~$72 cooled to the mid-$60s, and the… Defensive · Consumer discretionary rotation analysed · BSIN Big Sky Industrial Inc. LOW Helium/45Q pivot still on schedule after the 2026-08-11 Q2 print; the 2026-08-20 Sidoti deck added a first Phase 1 EBITDA figure (~$15M/yr). Same day a final 13D/A put Sage Road Capital at 4.9%. Price $1.40 against the $1.43 closing high,… Special situation · Oil, energy & geopolitical · Industrial power & grid analysed · BTBT Bit Digital, Inc. LOW Both legs of the wrapper are now rolling over: WhiteFiber (WYFI, ~70.5% owned) de-rated from $38.50 to $27.57 as the June neocloud mania cooled, and BTBT slid to ~$1.50, a step above its $1.25 low. SOTP discount still ~49% (~$745.6M WYFI… Special situation · GPU cloud & neoclouds · AI datacenter infrastructure catalyst · BTDR Bitdeer Technologies Group LOW Spring miner-to-AI re-rate has fully unwound: BTDR lost the $15 shelf to $12.56 (2026-07-09) as AI-cloud ARR plateaued at ~$69M for a 2nd month. A signed-but-not-effective Tydal colocation lease (2026-06-29) and a $36M Nevada plant are the… Special situation · Bitcoin miners · AI datacenter infrastructure catalyst · BTE Baytex Energy Corp. LOW July's Hormuz flare re-armed the oil-geopolitical premium, but it has since drained — WTI slipped to the low $70s and the 2026-07-17 sanctions wind-down passed with no barrel shortage, a contained-conflict bid rather than a supply shock.… Compounder · Oil, energy & geopolitical catalyst · BTGO BitGo Holdings, Inc. LOW Broken IPO that cleared its 2026-07-21 lockup without a supply flood but is grinding on the $4.665 all-time low with no bounce; Goldman cut its target to $7.75, and the undated $100M Galaxy verdict plus the ~2026-08-26 Q2 print are the… Earnings inflection · Crypto exchanges & financials · M&A & special situations catalyst · BWIN The Baldwin Insurance Group, Inc. LOW Take-private premium is bleeding while sell-side chases it higher: price slipped to $27.25 (2026-07-17) from $28.41 (2026-07-02) even as KBW went to $31 and JPM to $30. Nothing is signed, and the 2026-07-30 Q2 print (guide $485–490M,… Earnings inflection · Semi foundry & equipment · AI enterprise software analysed · BWMN Bowman Consulting Group Ltd. LOW Not a growth story — a cash-deal spread. Bernhard Capital's $43.00 all-cash take-private (signed 2026-08-10) caps the name; the 2026-08-21 close of $42.61 is $0.39 under it, down from a $0.70 gap on 2026-08-14. The go-shop expires 5:00… Earnings inflection · M&A & special situations · AI datacenter infrastructure catalyst · BXC BlueLinx Holdings Inc. LOW Housing-distribution margin inflection in a 7.86M-share float has stopped generating headlines: after a 52-week high at $91.41, the 2026-08-21 close of $84.60 sits back inside the $83–$84 target band raised 2026-08-06, and the 2026-08-18… Cyclical recovery · Housing, homebuilders & proptech catalyst · CAI Caris Life Sciences, Inc. LOW Oncology molecular-profiling re-rate: the 2026-08-05 Q2 beat ($263.7M vs $238.1M est) plus an FY26 guide lift to $1.030–1.040B and positive adjusted EBITDA of $55.7M flipped the story to self-funding growth, driving a 68.9% three-month… Theme leader · Medtech & diagnostics analysed · CAKE Cheesecake Factory Incorporated (The) LOW Casual-dining re-rate got a genuine second leg: Citi's 2026-07-10 raise to a street-high $90 (Buy) on a rewards/app traffic-inflection thesis gapped shares 7% to all-time highs (~$86, 52wk high $86.66 on 2026-07-18). For the first time the… Special situation · Consumer discretionary rotation catalyst · CARG CarGurus, Inc. LOW Post-print re-rate has stalled and faded: $38.98 on 2026-08-07 (0.1% under the $39.03 52-week high) to $36.85 on 2026-08-21, with RSI back to 49.7. Seven desks now carry $39–$44 targets and zero upgrades, two insiders sold into the level,… Special situation · Managed care & health services · Consumer discretionary rotation catalyst · CBLL CeriBell, Inc. LOW August re-rating is reimbursement-driven: CMS granted an NTAP of up to $2,171 per eligible Medicare case for the Ceribell Delirium Monitor on 2026-08-03 (effective 2026-10-01) and FY26 guidance went to $114–117M on 2026-08-10. Narrative… Defensive · Medtech & diagnostics · Managed care & health services analysed · CBRL Cracker Barrel Old Country Store, Inc LOW Legacy-diner turnaround where the leadership leg is now spent: Deno took over 2026-08-10 and price went nowhere (2026-08-07 close $57.79 → 2026-08-21 $57.65) while RSI(14) reset from 63.9 to 49.6. The sell-side chased in late July (Piper… Special situation · Consumer discretionary rotation · Managed care & health services catalyst · CBZ CBIZ, Inc. LOW Deal-completion story now, not an operating one: the 2026-08-21 close of $54.66 sits $0.34 under the signed $55.00 all-cash terms, in from $0.54 on 2026-08-14. The go-shop expiring 11:59pm ET 2026-08-27 is the only mechanism that can print… Earnings inflection · M&A & special situations · Semi foundry & equipment catalyst · CCRN Cross Country Healthcare, Inc. LOW Situation settled: the Knox Lane take-private became effective 2026-07-21 at $13.25 cash, Nasdaq suspended trading that morning and filed Form 25 the same day. No listed security, no residual claim, no forward catalyst — any CCRN bar dated… Earnings inflection · M&A & special situations · Managed care & health services analysed · CCXI Churchill Capital Corp XI LOW De-SPAC humanoid pure-play now maturing: Unitree's 2026-08-19 STAR debut (+487% close, ~$53B) lifted CCXI for one session before the move fully round-tripped — $17.07 on 2026-08-14 to $14.57 on 2026-08-21, RSI 73.4 to 43.5. Still no public… Earnings inflection · M&A & special situations · Physical AI & robotics analysed · CDNL Cardinal Infrastructure Group Inc. LOW Post-blowoff digestion is deepening: the ~4x data-center site-work roll-up has bled from a $96 high back to its $63 average analyst target, now below the $73 secondary price and the 50-DMA. Q1 organic +64% and an $854M backlog keep… Cyclical recovery · AI datacenter infrastructure · Cyclical industrials analysed · CDW CDW Corporation LOW Second-order AI-server reseller whose ~37% recovery off the $97 low has stalled: a mid-July push to $144 round-tripped to $133 by 2026-07-17, right in the fairway of the ~$145 consensus target. The re-rate (JPM, MS $170, Citi $145) is… Theme leader · AI datacenter infrastructure · AI enterprise software catalyst · CECO CECO Environmental Corp. LOW 2nd-order AI-power name — Q1 orders +97% YoY and a first-ever >$1B backlog (2026-04-28) feed the datacenter/electrification capex wave, and the closed Thermon merger doubled EBITDA. But price rolled over ~25% off the $101.24 ATH to $75.63,… Theme leader · Industrial power & grid · AI datacenter infrastructure analysed · CERS Cerus Corporation LOW Profitability inflection intact — 9th straight positive adjusted-EBITDA quarter (+$3.0M) and a $30M term-loan paydown at the 2026-07-30 Q2 print — but product growth halved to +10% YoY from +24% in Q1 and gross margin fell to 51.4% from… Special situation · Precision biotech & therapeutics · Small-cap value rotation analysed · CEVA CEVA, Inc. LOW Edge-AI IP momentum leg has broken: June's reclaim to within ~3% of the $51.60 high failed, and the mid-July AI-capex scare (Moonshot model) drove shares back through the ~$44 base to the mid-$30s. Sell-side still carries $48–$55 targets,… Cyclical recovery · AI chips & memory · Physical AI & robotics analysed · CGC Canopy Growth Corporation LOW The rescheduling binary CGC trades on came and went: the DEA hearing closed 2026-07-15 with no verdict, briefs due 2026-08-17 and the ALJ recommendation undated into H2 2026, likely litigated into 2027. Shares closed $0.89 on 2026-07-24,… Earnings inflection · Cannabis reclassification · Crypto exchanges & financials catalyst · CHYM Chime Financial, Inc. LOW Busted-IPO fintech: operations accelerating (Q1 rev +25% to $647M, first GAAP profit, FY guide raised to $2.66–2.69B) but the stock trades ~19% below its $27 IPO and bases near post-IPO lows — a compressed multiple, not an accelerating… Earnings inflection · Fintech & consumer credit analysed · CIEN Ciena Corporation fresh LOW The 1.6T WaveLogic demand cycle is intact at the order book, but the trade has broken: $627.00 (06-02) to ~$370 (07-18) is a ~41% de-rating, and the $455–$467 shelf that framed the prior read is gone. Multiple compression from 54x forward,… Cyclical recovery · Networking & optical catalyst · CLFD Clearfield, Inc. LOW The May earnings-miss squeeze has fully round-tripped to a dead tape in the mid-$30s, below the ~$36 gap base, with the retail-sentiment narrative spent. The sole live driver is the 2026-08-05 fiscal-Q3 print — guided to a sharp sequential… Retail squeeze · Networking & optical · AI datacenter infrastructure analysed · CLMT Calumet, Inc. LOW Deleveraging-plus-SAF-ramp re-rate extended to a new 52-week high at $50.81 after the 2026-08-07 Q2 print; Goldman's second raise in 19 days ($45 on 2026-08-18) still lands below the 2026-08-21 close of $49.01. Nothing dated resolves the… Special situation · Oil, energy & geopolitical · Solar & clean energy analysed · CLPT ClearPoint Neuro, Inc. LOW Picks-and-shovels delivery play on CNS gene therapy: ClearPoint's SmartFlow cannula and MRI navigation are the standard route to the brain for uniQure's AMT-130 Huntington's BLA (soft Q3-2026 window). The June re-rate held near $18.72… Cyclical recovery · Medtech & diagnostics · Rare disease & gene therapy analysed · CLS Celestica, Inc. LOW AI-datacenter EMS picks-and-shovels story still fundamentally climbing after the 2026-04-27 Q1 crush (rev +53% to $4.05B, FY26 guide raised to $19B), but the tape broke ~21% off its $474 June high and heads into a binary 2026-07-27 Q2… Cyclical recovery · AI datacenter infrastructure · Cyclical industrials catalyst · CLYM Climb Bio, Inc. LOW Anti-CD19 autoimmune re-rate: budoprutug's 2026-06-11 EHA ITP data (>90% B-cell depletion, n=15) plus $239.2M cash funding into 2H 2028 lifted CLYM to a 52-week high at $16.33 on 2026-08-14. The 2026-09-03 R&D Spotlight (CLYM116 Phase 1… Earnings inflection · Precision biotech & therapeutics catalyst · CMBT CMB.TECH NV LOW July's non-confirmation resolved upward: CMBT closed 2026-08-14 at $17.24, a 52-week high on the adjusted series, RSI 79.4, into a confirmed 2026-08-27 Q2 print whose rates were pre-disclosed on 2026-05-19 (81% of VLCC days at… Special situation · Oil, energy & geopolitical · Freight & logistics catalyst · CNMD CONMED Corporation LOW Six weeks on, the deal leg is still the only unresolved one: no process headline since 2026-07-10, no sell-side action since 2026-07-30, no company event dated inside 30 days — yet price drifted to $51.07 on 2026-08-21, 10.9% above the… Earnings inflection · Medtech & diagnostics · M&A & special situations analysed · CNTA Centessa Pharmaceuticals plc LOW Closed cash-plus-CVR takeout; nothing trades. Lilly's scheme ($38.00 cash plus a non-transferable CVR of up to $9.00) went effective 2026-06-24, Form 15-12G dated 2026-07-06. New since the last note: ClinicalTrials.gov lists a Phase… Earnings inflection · M&A & special situations · Precision biotech & therapeutics analysed · COCO The Vita Coco Company, Inc. LOW Q2 FY26 (2026-07-23) beat on every line — net sales $216.2M +28.1%, EPS $0.82 vs ~$0.55, FY guide raised to $790–805M — and the stock still closed $62.25 on 2026-08-07, -25.9% from the post-print high. Beat-and-raise absorbed by sellers;… Compounder · Consumer discretionary rotation · Cyclical industrials analysed · COMP Compass, Inc. LOW Now stretched into a binary ~2026-07-29 Q2 print ($4.0–4.2B guide) with an open NY AG antitrust probe. Special situation · Housing, homebuilders & proptech · Cyclical industrials catalyst · CORT Corcept Therapeutics Incorporated LOW Lifyorli oncology launch (approved 2026-03-25, NCCN preferred) re-accelerated the tape to fresh 52-week highs near $92, and the 2026-06-17 Cushing's relacorilant resubmission (~Dec PDUFA) adds second-approval optionality. But a fresh entry… Earnings inflection · Oncology & immunology · Binary-catalyst biotech catalyst · COTY COTY INC LOW De-lever leg stalled rather than broke: FY26 net debt fell to $2,912.1M but leverage still printed 3.4x as EBITDA fell 22% to $846.9M, and management withheld FY27 guidance until the Consumer Beauty review closes by end-CY26. RBC cut to… Special situation · Consumer discretionary rotation catalyst · CPIX Cumberland Pharmaceuticals Inc. LOW Deal-arb thesis is now spent: the $100M Apotex asset sale closed 2026-07-01 after a 99.84% shareholder vote on 2026-06-24, so the dated binary that drove the ~3.2x off $1.85 to a $7.36 high is consumed. What remains is a cash-rich clinical… Special situation · M&A & special situations · Precision biotech & therapeutics analysed · CRCT Cricut, Inc. LOW Hardware-to-platform crossover still holding the 2026-08-05 gap: Platform revenue $85.0M now exceeds Products $71.3M, but the Q2 margin fuel was $26.7M of one-time credits and the CEO sold ~360k shares between 2026-08-03 and 2026-08-19.… Special situation · Consumer discretionary rotation · Bitcoin miners analysed · CRL Charles River Laboratories International, Inc. LOW Post-2026-08-05 demand-recovery leg extended to a new 52wk high at the 2026-08-21 close of $295.19 (RSI 86.6, +84.1% over three months) with no rating action since TD Cowen's $300 on 08-10 — price is now inside the $282-$310 target band.… Special situation · Medtech & diagnostics · Precision biotech & therapeutics catalyst · CRNX Crinetics Pharmaceuticals, Inc. LOW Not a narrative any more: the Vertex $85.00/share cash takeout cleared HSR on 2026-08-12, the stockholder vote is 2026-08-28, and closing is guided to early September. At the 2026-08-14 close of $84.70 the gap to terms is $0.30 against… Earnings inflection · M&A & special situations · Rare disease & gene therapy catalyst · CROX Crocs, Inc. LOW Legacy-brand turnaround with fundamentals intact and the tape unwinding: after the 2026-07-30 beat-and-raise (FY2026 adj EPS $13.70–$14.00), shares fell from $131.72 on 2026-08-14 to $122.11 on 2026-08-21, RSI(14) 32.9, -13.5% from the… Special situation · Consumer discretionary rotation · Cyclical industrials catalyst · CRS Carpenter Technology Corp LOW Aero-defense superalloy pricing cycle intact (three contracts at >30% hikes; Q4 op-income guide $205-210M, +37% YoY), but the July flush to $532 has been bought back to ~$603 straight into the 2026-07-30 Q4 print — now four sessions out… Cyclical recovery · Critical materials & rare earths analysed · CRSR Corsair Gaming, Inc. LOW Post-print margin leg has lost its price structure: after a 2026-08-07 close of $14.35 (52-wk high), CRSR closed 2026-08-21 at $10.93, -23.8%, and Goldman initiated at Sell with an $11 target on 2026-08-19 over AI-driven DRAM cost… Special situation · Consumer discretionary rotation · AI chips & memory catalyst · CRTO Criteo S.A. LOW Takeover-premium leg is dead and the tape kept going: the 2026-07-06 Vista/Quinti gap is fully filled, no party has confirmed anything in 46 days, and the 2026-08-05 guide cut re-based FY26 contribution ex-TAC to $1.034–1.058B from… Earnings inflection · M&A & special situations · AI enterprise software analysed · CRVS Corvus Pharmaceuticals, Inc. LOW Calendar still empty until 2027 after the 2026-08-06 push-out (PTCL futility Q1 2027, no data released; SIERRA1 topline Q3 2027), but the tape has recovered: $14.46 close on 2026-08-21 with RSI 62.4 versus $13.92 and RSI 47.5 on… Earnings inflection · Oncology & immunology · Binary-catalyst biotech analysed · CRWD CrowdStrike Holdings, Inc. LOW The August breakout leg has been given back: price closed 2026-08-21 at $191.95, 14.9% under the $225.53 52-week high, while eleven brokers set targets between $205 and $250 in the same five sessions. The binary was pulled forward — Q2… Compounder · Cybersecurity · AI datacenter infrastructure catalyst · CSCO Cisco Systems, Inc. LOW Legacy-networker AI re-rate intact and now at its binary: the $118–120 shelf held through July, price closed $121.43 on 2026-08-07 with RSI(14) at 78.4, and five sell-side target raises landed 07-22 → 08-06 (Citi $112→$139) ahead of the Q4… Special situation · AI enterprise software · Networking & optical catalyst · CSIQ Canadian Solar Inc. LOW Reshoring leg still bidless: the 2026-08-18 dismissal with prejudice of Maxeon's US TOPCon suit and the 2026-08-12 Carwarp COD followed the 2026-07-24 cell-plant opening, and the 2026-08-21 close of $14.55 broke under the 2026-07-08 low of… Special situation · Solar & clean energy · Cyclical industrials catalyst · CTRN Citi Trends, Inc. LOW Sales were pre-released on 2026-08-10 ($211.6M, comps +10.5%), so the 2026-08-25 print is now a pure margin-and-guidance binary. Price faded from $73.91 (08-14) to $71.71 (08-21) with RSI back to 55.6 and no new high above $76.18 — the… Retail squeeze · Consumer discretionary rotation · Biofuels & low-carbon fuels catalyst · CTSH Cognizant Technology Solutions Corporation LOW Legacy IT-services franchise being re-underwritten as an enterprise-AI deployment partner; the leg still works — $61.87 on 2026-08-21, up 18.0% over three months — but the sell-side revision wave ended 2026-07-30, price now sits ~3% under… Special situation · AI enterprise software · AI datacenter infrastructure analysed · CVLG Covenant Logistics Group, Inc. LOW The margin-inflection leg broke at its own catalyst: Q2 (2026-07-29) adjusted OR 95.9% vs 94.6% PY — second straight quarter of YoY deterioration — revenue $332.9M missed $340.4M, and Stephens cut its 23-day-old target to $54 on 07-31.… Defensive · Freight & logistics · Managed care & health services catalyst · CXT Crane NXT, Co. LOW Beat-and-raise on 2026-08-05 has been fully sold: the ~$56.23 post-print quote gave way to a $50.20 close on 2026-08-21, RSI 39.3, and 2026-08-19 opened $48.06 with no company release behind it. Organic growth was only 2.8% of the 22%… Special situation · M&A & special situations · Cyclical industrials catalyst · DDD 3D Systems Corporation LOW June's $50M raise at $3.05 (16.4M sh) is already underwater: shares last $2.775 (2026-07-02), below the offering floor, with ~$50M shelf undrawn and soft Q2 guidance (rev $93–95M, adj. EBITDA still negative) into the 2026-08-10 print. A… Special situation · Defense & aerospace · Critical materials & rare earths analysed · DDOG Datadog, Inc. LOW June's sell-side upgrade wave has exhausted and the first cut printed — Bernstein to Market Perform (PT $226, 2026-07-06) as the stock rolled over. AI-observability narrative intact but maturing; the $278.71 parabola round-tripped and the… Theme leader · AI enterprise software · GPU cloud & neoclouds catalyst · DFTX Definium Therapeutics, Inc. LOW Voyage GAD read out positive on 2026-08-12 — HAM-A 5.4 points over placebo at Week 12, p<0.0001, Cohen's d 0.81 — and eight target actions followed inside seven sessions. Yet the 2026-08-21 close of $44.91 sits under the pre-readout $46.14… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics catalyst · DIOD Diodes Incorporated LOW The AI-server/auto power-content re-rate that carried DIOD to a ~$126 all-time high (June 18) has round-tripped: a double-top, an analyst downgrade, more insider selling and a sector-wide semi selloff pushed it to ~$96 by July 10, through… Theme leader · Analog semiconductors · AI datacenter infrastructure analysed · DJT Trump Media & Technology Group Corp. LOW Fusion pivot is the leg: the 2025-12-18 all-stock TAE Technologies merger (>$6B, ~50/50 fully diluted) is what's actually being bought, while the crypto-treasury leg was terminated 2026-08-07. The S-4 was still unfiled as of 2026-08-05,… Special situation · Cyclical industrials · AI datacenter infrastructure analysed · DLTR Dollar Tree Inc. LOW Guide-raise leg resolves in four sessions: the 2026-08-27 Q2 print (8:00 a.m. ET call, Dollar General the same morning) is the binary. At the 2026-08-21 close of $131.48 the stock trades above both aggregated mean targets ($127.32 /… Special situation · Consumer discretionary rotation · M&A & special situations catalyst · DNUT Krispy Kreme, Inc. LOW Attention returned before the fundamentals changed: BofA lifted its target to $4.90 on 2026-08-10 and the Pokémon collection hit shops 2026-08-18, carrying the close from $3.33 (08-14) to $3.59 (08-21) with RSI(14) at 69.9. The… Retail squeeze · Consumer discretionary rotation · M&A & special situations catalyst · DOCN DigitalOcean Holdings, Inc. LOW The $117 condition from the 2026-08-08 note broke: the 2026-08-21 weekly close is $115.64, under the $117.54 July placement price, with the 200-day at $113.47 just below. Theme leader · GPU cloud & neoclouds · AI datacenter infrastructure analysed · DOCU DocuSign, Inc. LOW Legacy e-signature base re-wrapped as AI agreement management: IAM went 10.8%→12.6% of ARR in a quarter and is guided to ~18% by 2027-01-31, while total growth is still guided to decelerate to ~8%. The 2026-09-03 Q2 print is now confirmed… Special situation · AI enterprise software catalyst · DRD DRDGOLD Ltd. fresh LOW Unhedged tailings-retreatment gold leverage: FY2026 (reported 2026-08-19) beat guidance at 155,577 oz with R2.3bn free cash flow, zero debt, and Vision 2028 guiding toward six tonnes by 2028. But the catalyst already fired — the ADR closed… Compounder · Critical materials & rare earths catalyst · DSGN Design Therapeutics, Inc. LOW A new 52-week high of $15.94 printed in August with no company release since the 2026-08-03 Q2 update, which pushed the next hard data to Q1 2027. RSI(14) 73.9 at the $14.99 close (2026-08-21) and +21.9% for the month, into a 30-day… Earnings inflection · Precision biotech & therapeutics · Rare disease & gene therapy analysed · DUOT Duos Technologies Group, Inc. LOW The pivot is now structural: the rail subsidiary was sold 2026-08-05 (related party — interim CFO owns 50% of the buyer), leaving an edge-colocation operator carrying a 2026-07-16 five-year 10 MW hyperscaler contract worth >$111M. The tape… Special situation · AI datacenter infrastructure · GPU cloud & neoclouds catalyst · DVA DaVita Inc. LOW The $175 weekly-close level from the prior note broke: DVA closed 2026-08-21 at $173.82, 27.9% under the $240.96 high, RSI(14) 10.9, with no company news or filing since the 2026-08-04 Q2 print. The census-recovery re-rate is dead;… Special situation · Managed care & health services analysed · DXC DXC Technology Company LOW Legacy IT-services decliner re-rated on an AI-centric pivot, now digesting: the partnership headline run stopped 2026-08-06, Paul Taylor's presidency took effect 2026-08-10, and price went flat ($10.84 on 08-07 to $10.80 on 08-21) while… Special situation · Cyclical industrials · AI enterprise software analysed · DXCM DexCom, Inc. LOW CGM leader's recovery has aged from catalyst-pop to an analyst-revision grind — Mizuho $90 (7/15), Truist $87 (7/16) into a ~7% two-day pop to $76.65 — but price is high-$70s still under the 200-EMA and the confirmed July 30 Q2 print is… Defensive · Medtech & diagnostics · Precision biotech & therapeutics analysed · DXYZ Destiny Tech100 Inc. LOW Scarcity premium re-underwritten on Anthropic, not SpaceX: DXYZ ran $22.51 (2026-07-28) to $34.43 (2026-08-21), back above the last reported $24.56 NAV (2026-03-31), on Anthropic's June S-1 and $65B July run rate. RSI 89.6, the $1B ATM is… Retail squeeze · AI datacenter infrastructure · Space economy catalyst · EDRY EuroDry Ltd. LOW Dry-bulk operating leverage ran ahead of its own driver: EDRY closed at a 52-week high $46.85 on 2026-08-21 with RSI(14) 91.2, while the BDI sat at 2,841 versus 3,046 on 2026-08-11 and Panamax spot earnings of $18,790/day (2026-08-20) fell… Compounder · Small-cap value rotation · Freight & logistics analysed · EFOR Everforth, Inc. LOW Legacy IT-services base re-rating on an AI-delivery pivot. Since the 2026-07-30 print-day +16.3%, the move has digested rather than reversed: RSI(14) unwound from 94.5 (2026-08-07) to 66.9 at the 2026-08-21 close of $32.70 with price flat.… Special situation · Defense & aerospace · Managed care & health services catalyst · ELVR Elevra Lithium Limited LOW Lithium-recovery narrative re-accelerating off a low base: GFEX carbonate turned (LC2609 CNY 146,360/t on 2026-08-10, +6.24% in six sessions) and on 2026-08-21 Elevra signed a binding 7-year, 144,000 dmt/yr take-or-pay offtake with… Compounder · Critical materials & rare earths · Freight & logistics catalyst · EMBC Embecta Corp. fresh LOW Post-collapse levered stub has now run past its own sell-side: the 2026-08-21 close of $5.23 sits above the highest of four published 12-month targets ($5.00), short interest rose to 12.20% of float from 10.99% on 2026-08-11, and the… Special situation · Medtech & diagnostics analysed · ENOV Enovis Corporation LOW Post-Colfax orthopedic pure-play turnaround: LimaCorporate integration plus FCF-conversion recovery (43% in 2024 toward a 70–80% target) is the self-help story, but price has rolled over from $34 toward $27 while three brokers cut targets.… Special situation · Medtech & diagnostics · Cyclical industrials analysed · ENPH Enphase Energy, Inc. LOW IQ SST AI-data-center pivot (announced 2026-04-28) that drove a spring squeeze has stalled — stock de-rated ~16% in a month to ~$45 (2026-07-09), sell-side uniformly neutral with PTs on top of price (Susquehanna $45, 2026-07-10), and SST… Special situation · Solar & clean energy · Industrial power & grid analysed · EPAM EPAM SYSTEMS, INC. LOW Compounder narrative broken on 2026-08-06: FY26 organic constant-currency growth cut to 2.0%–3.0%, Q3 guided to ~1.7% YoY. Price has stalled rather than extended lower ($99.90 close 2026-08-11 vs $97.43 on 2026-08-07), but the AI-native… Special situation · Cyclical industrials · Managed care & health services analysed · EPC Edgewell Personal Care Company LOW Two legs: a refused $30 take-private approach (2026-06-22) and a first clean quarter (fiscal Q3 organic +1.1%, adjusted EPS $0.72 vs $0.62). Sixty days on there is no competing bid, no process and no 13D, and the shares have coiled within… Earnings inflection · M&A & special situations · Consumer discretionary rotation catalyst · EQNR Equinor ASA LOW European winter gas-security theme re-accelerating; Equinor, the swing Norwegian pipeline supplier, held ~$40 through a Q2 double-miss on a $1.125B buyback bid. Defensive · Oil, energy & geopolitical · Cybersecurity catalyst · ERAS Erasca, Inc. LOW Funded pan-RAS story with part of its calendar restored: the 2026-08-11 Q2 release dates ERAS-4001 BOREALIS-1 preliminary Phase 1 data to H2 2026, ahead of the H1 2027 ERAS-0015 cut. But the 2026-08-21 close of $17.63 sits on the $17.50… Earnings inflection · Oncology & immunology · Binary-catalyst biotech analysed · ERO Ero Copper Corp. LOW Copper-squeeze beta finally re-rated: the 2026-08-21 close of $39.42 is a new 52-week high (RSI 78.1, +46.1% over three months) clearing the prior $38.03 high — but it printed in the week the LME squeeze unwound (backwardation above… Cyclical recovery · Industrial power & grid · Critical materials & rare earths analysed · ESPR Esperion Therapeutics, Inc. LOW Resolved and off the tape. ARCHIMED's take-private closed 2026-07-13 at $3.16 cash plus a non-tradeable CVR of up to $100M; Nasdaq was asked to file Form 25 the same day and reporting duties are being suspended by Form 15. The early-August… Earnings inflection · M&A & special situations · Precision biotech & therapeutics analysed · ESTC Elastic N.V. fresh LOW AI-retrieval-layer narrative accelerating: Q4 FY26 total RPO $1.98B grew 28% YoY against revenue +16%, and the 2026-07-30 OpenAI partnership re-rated the name 56.8% in three months. The 2026-08-27 Q1 FY27 print is the binary — company… Theme leader · AI enterprise software catalyst · EVC Entravision Communication LOW Smadex AI-DSP re-rate broke to a new 52-week high of $13.48 with no dated company news since 2026-07-12 — an anticipatory leg into the 2026-08-10 Q2 print, the binary on whether Q1's +204% ATS growth and ~22% EBIT margin held.… Special situation · AI enterprise software · Cyclical industrials analysed · EVH Evolent Health, Inc LOW The late-June retail bounce has fully unwound — EVH traded ~$5.76 on 2026-07-07, back under the $6.59–6.86 consensus target band and well under Truist's flat $7. Nothing carries the name now except the confirmed 2026-08-06 Q2 print, which… Earnings inflection · Managed care & health services · Oncology & immunology analysed · EXFY Expensify, Inc. LOW Legacy expense-SaaS pivot re-rated on the 2026-08-06 Q2 print: revenue $33.9M beat $33.688M, paid-member decline halved to -2% YoY, FY26 FCF guide doubled to $12M-$14M, ~7% of shares retired, and New Expensify ARR from net-new customers… Special situation · AI enterprise software analysed · EXTR Extreme Networks, Inc. LOW Legacy campus-networking name re-rating ~+140% off Feb lows on the Platform ONE / Agent ONE AI-NetOps story plus SaaS ARR +29% YoY; theme still accelerating but spot ($33.71, 07-10) has run through consensus PT $29.06 into the June bull… Special situation · Networking & optical · AI enterprise software catalyst · FAC Factorial Energy Inc. LOW Freshly de-SPAC'd solid-state battery name has fully unwound its debut mania — down ~78% from the $25.33 ATH to ~$5.67, breaking clean through the former $9.26 floor into a fresh 52-week low at $4.24. Cantor's $18 target now sits ~217%… Defensive · Solar & clean energy · Freight & logistics analysed · FBIN Fortune Brands Innovations, Inc. LOW Activist-plus-new-CEO turnaround has stopped accelerating and started digesting: after the +30% run off Garden's $40.6 buy, price has chopped $50–54 for three weeks while sell-side targets climbed past spot (Goldman $61 on 7/10, Barclays… Special situation · Housing, homebuilders & proptech · Cyclical industrials catalyst · FBRX Forte Biosciences, Inc. LOW Deal-spread endgame: HSR expired 2026-08-18 (SC 14D9/A filed 2026-08-19), leaving only the >50% minimum tender before argenx's $77.00 all-cash offer expires 2026-08-26. The 2026-08-21 close of $76.92 leaves $0.08 of gross gap. Upside is… Earnings inflection · Precision biotech & therapeutics catalyst · FCEL FuelCell Energy, Inc. LOW Street targets re-rated up to the price rather than the reverse: average PT $22.83 across 8 analysts vs the 2026-08-07 close of $20.43, after B. Riley $13→$32 (6/29) and UBS $22→$27 (7/14). The AI-power bid still works (7/30 Microsoft… Retail squeeze · AI datacenter infrastructure · Industrial power & grid catalyst · FDMT 4D Molecular Therapeutics, Inc. LOW Wet-AMD one-and-done durability narrative accelerating on the 2026-07-18 PRISM 2-year data (78% injection-burden reduction, 2.7 vs 12.0 projected, n=30) plus a 2026-07-31 Buy initiation at PT $37 and a 2026-08-13 Q2 beat. Price is 5.5% off… Earnings inflection · Precision biotech & therapeutics analysed · FIG Figma, Inc. LOW Design incumbent re-rated as an AI winner (BofA Buy, $30 PT, 7/7) rather than an AI casualty, yet the stock churns below its 100/200-day moving averages with heavy short interest into its first public earnings print on 8/5 — that print,… Earnings inflection · AI enterprise software catalyst · FIVN Five9, Inc. LOW Legacy-CCaaS AI pivot staged a sharp V-recovery: +29% off the $19.70 June swing low to $25.42, reclaiming the broken $22 shelf on a 2026-06-23 next-gen Voice AI Agents launch and an AI-first leadership overhaul. Now pressing the $26.26… Special situation · AI enterprise software catalyst · FLEX Flex Ltd. LOW AI-manufacturing re-acceleration: the 2026-07-09 Cerebras CS-3 production expansion is the first company-specific bid since the S&P-inclusion +6% pop round-tripped to ~$147, refreshing the data-center power/EMS narrative into the ~07-29 Q1… Special situation · AI datacenter infrastructure · Industrial power & grid catalyst · FLY Firefly Aerospace Inc. fresh LOW Narrative and price have fully decoupled: FLY stacked a $144M CLPS award, a Moon BASE seat and a $13M Mars subcontract into a -47% drawdown, falling 9.6% on 7/16 on the awards headline itself. At $19.27 vs a $45 IPO price and 31% below the… Defensive · Space economy catalyst · FN Fabrinet LOW Optical cluster re-accelerated in July (AAOI +390% YTD, LITE +138%, COHR +107%) while Fabrinet sits ~$478, +0.7% YTD and ~36% under its $748.89 high. Revenue compounds at +30% but the tape has decoupled from its own theme — a… Cyclical recovery · Networking & optical · AI datacenter infrastructure analysed · FOUR Shift4 Payments, Inc. LOW Payments roll-up at ~$50, a hair above its $46.26 52-week low set on a 2026 guide-down. The Global Blue tax-free-shopping integration ("Shift4 One," launched 2026-07-14) is the transformation leg, but the 2026-07-30 Q2 print is the binary… Earnings inflection · Fintech & consumer credit · Travel & leisure catalyst · FPS Forgent Power Solutions, Inc. LOW Second secondary in five weeks — ~43.6M shares at $49 on July 2, now including company primary dilution — confirms the recurring-supply pattern and dragged the stock from its $65.56 June-4 ATH back to the offering line. The… Theme leader · Industrial power & grid · AI datacenter infrastructure catalyst · FRD Friedman Industries Inc. LOW Tariff-driven HRC steel prices at multi-year highs powered record FY2026 (EPS $2.76, sales +46%); FRD hit an all-time-high close $37.42 on 2026-06-18 and was flagged overbought the same day. The narrative is maturing and priced near the… Defensive · Cyclical industrials · Critical materials & rare earths catalyst · FTRE Fortrea Holdings Inc. LOW Post-spin margin-repair narrative is now fully written into sell-side models and no longer into the tape: five target raises through 2026-08-04 (TD Cowen $23) met a slide from $19.17 (7/31) to $17.41 (8/14), surrendering the July… Special situation · Oncology & immunology · Precision biotech & therapeutics catalyst · FWRD Forward Air Corporation LOW Busted-merger workout losing its bid: the +48% June bounce to $14.87 (on a speculative Amazon-bolt-on thesis) has faded ~13% to ~$13, whole-company sale is now reported "unlikely," and the 2026-07-10 chairman exit forfeited… Earnings inflection · Cyclical industrials · Freight & logistics analysed · G Genpact Limited LOW Agentic-operations pivot keeps compounding in the segment data — ATS +24.1% to $363M, FY guide lifted to at least 25% on 2026-08-06 — while the 73% legacy book grew 1.9% and caps consolidated growth near 7%. The 10-Q filed 2026-08-07… Special situation · AI enterprise software · Managed care & health services catalyst · GBTG Global Business Travel Group, Inc. LOW Take-private in its final leg: stockholders adopted the $9.50 Long Lake merger on 2026-08-03, and the 2026-08-14 close of $9.46 leaves $0.04 gross against a roughly 37% break tail to the unaffected $5.93. Only undated offshore regulatory… Earnings inflection · M&A & special situations · Consumer discretionary rotation analysed · GCMG GCM Grosvenor Inc. LOW Alternatives-manager re-rate stalled — GCMG printed a new $14.38 high on the 2026-07-13 Piper upgrade, then reversed ~15% to a $12.20 close into the 2026-08-06 Q2 binary. The AI-datacenter infra/private-credit fundraising thesis is intact… Theme leader · AI datacenter infrastructure · Biofuels & low-carbon fuels catalyst · GCO Genesco Inc. LOW The operating turnaround is real but priced, and its one asymmetric leg — the activist proxy fight — lost its teeth: ISS (2026-07-07) backed all nine board directors and urged holders to withhold from the two Radoff/Jumana nominees, so the… Earnings inflection · Consumer discretionary rotation · Cyclical industrials catalyst · GENI Genius Sports Limited LOW Sports-data toll-booth under the prediction-market boom, but the boom arrived and the toll didn't: Kalshi/Polymarket cleared $50B+ of World Cup volume (Coindesk, 2026-07-14) while GENI slid $6.43 → $6.30 and printed $5.98 intraday July 17.… Cyclical recovery · Prediction markets & betting · AI datacenter infrastructure catalyst · GFS GlobalFoundries Inc. LOW Photonics/CHIPS delivery kept accelerating — comms/data-center revenue +62% YoY in Q2 (2026-08-05), $300M Commerce LoI 2026-07-29 — while the multiple collapsed 39.2% from the $89.83 52wk high to $54.58 on 2026-08-14. What's on offer is a… Cyclical recovery · Semi foundry & equipment analysed · GGAL Grupo Financiero Galicia S.A. LOW Argentina disinflation is still working — June CPI printed 1.9% MoM on Jul 14, an improvement on May's 2.1% — but the ADR faded the good print, dropping ~7% on the week to ~$50 and losing both the $51.07 50-day and the $52.86 200-day.… Compounder · Emerging markets catalyst · GLUE Monte Rosa Therapeutics, Inc. LOW ZEUS (ziltivekimab, MACE HR 0.99) failed on 2026-07-31 and took GLUE −27.16% to $16.52, its worst session on record, because the hsCRP-to-outcomes link under MRT-8102's ASCVD story is exactly what ZEUS could not demonstrate. Platform,… Earnings inflection · Precision biotech & therapeutics · Oncology & immunology analysed · GOLF Acushnet Holdings Corp. LOW Premium-golf consumable franchise (Titleist Pro V1) that ran to a $119.65 all-time high on a defensive-quality rotation, then bled ~11% of the mania premium back to the ~$104–105 June breakout shelf ($104.66 on 2026-07-24). The 2026-08-06… Compounder · Consumer discretionary rotation · Cybersecurity catalyst · GOOG Alphabet Inc. LOW Q2 (2026-07-22) beat — revenue $119.8B +24%, Cloud +82%, backlog $514B — and the stock still fell on capex raised to $195–205B; the ~$370 shelf broke and has not been reclaimed. The leg on offer is Cloud backlog conversion against a tape… Compounder · Mega-cap AI platforms analysed · GRPN Groupon, Inc. LOW The prior $20 break condition registered on the 2026-08-21 weekly close of $19.59, the second shelf lost in eight sessions after $22 went on 2026-08-14. RSI(14) at 4.6 with the reported short base UP to 13.73M shares — it built into the… Retail squeeze · Squeeze & momentum setups · Consumer discretionary rotation catalyst · GSHD Goosehead Insurance, Inc. LOW Post-print re-rating extended on no new information: the 2026-08-21 close of $72.52 is above UBS's $72, above KBW's $72 and above the ~$71 aggregator consensus, while founder-side Class B conversions sell into it. No dated company catalyst… Earnings inflection · Managed care & health services · Small-cap value rotation analysed · GSM Ferroglobe PLC LOW US trade-remedy leg: the 2026-08-03 USITC affirmative vote forces AD/CVD orders on Australian and Norwegian silicon metal, on top of Angola/Laos orders live since 2026-03-17. Q2 (2026-08-04) delivered the sequential recovery — $13.1M adj… Cyclical recovery · Critical materials & rare earths analysed · GTM ZoomInfo Technologies Inc LOW Legacy B2B data business trying to re-price as the data layer under AI go-to-market agents. The 2026-08-05 post-print gap is intact but unextended — $3.97 on 2026-08-21, RSI(14) cooled 76.9→58.9 — and the 2026-08-11 Microsoft Copilot MCP… Special situation · AI enterprise software · AI datacenter infrastructure catalyst · GTN Gray Media, Inc. LOW August's double catalyst — FCC 2-1 repeal of the 39% ownership cap (2026-08-06) and a Q2 beat-and-raise (2026-08-07) — has stopped extending: the 2026-08-21 close of $4.94 lost the $5.00 handle and sits 18.7% under the $6.07 52-week high.… Special situation · Fintech & consumer credit · Precision biotech & therapeutics analysed · GTX Garrett Motion Inc. LOW Turbo cash-cow re-rated (~8–9x → ~18x) on a datacenter/industrial oil-free cooling narrative; the parabolic Feb→June leg (~$20→$36) is spent, shares faded ~11% to the 50-day near $32.30, and the ~late-July Q2 print is the first chance to… Special situation · AI datacenter infrastructure · Cyclical industrials catalyst · GWRE Guidewire Software, Inc. LOW The August breakout extended to $189.19 on 2026-08-21 (RSI 76.2, +34.9% over three months), with Oppenheimer lifting its target to $200 on 2026-08-17 — but price now sits ~6% under the ~$201 consensus and above two of the five most recent… Theme leader · AI enterprise software catalyst · HAE Haemonetics Corporation LOW Legacy medtech pivot moved from promised to reported: the 2026-08-06 Q1 FY2027 beat ($339.4M vs $327.9M, adj EPS $1.14 vs $1.08) turned Interventional Technologies positive (+2.8% organic vs −10.3% in Q4) and lifted FY2027 organic guidance… Special situation · Medtech & diagnostics analysed · HELE Helen of Troy Limited LOW Deleveraging-stub leg broke out: 2026-08-14 close $30.22 is a 52-week closing high with no dated news behind it, above the $26.50 consensus target and both published targets. Forward P/E re-rated 7.55→8.25 on an unchanged $3.25–$3.75 FY27… Special situation · Consumer discretionary rotation · M&A & special situations catalyst · HELP Cybin Inc. fresh LOW Post-dilution CNS microcap re-firing with the psychedelic cohort (ATAI, CMPS all moving 2026-07-16) after a June social-velocity blowoff and a 10.3M-share secondary at $4.85. Both covering shops cut targets in July while holding Buy. No… Retail squeeze · Precision biotech & therapeutics analysed · HIMS Hims & Hers Health, Inc. LOW GLP-1 reaccel gets marked to market on 2026-08-10: guide $680-700M (+25-28%) vs Q1's +4%, street at $698.9M. Since the last note the FTC/CA/UT sued (2026-07-29, N.D. Cal.), BofA cut $37 to $30, and Amazon ($50/mo Medicare GLP-1,… Retail squeeze · Managed care & health services · Precision biotech & therapeutics analysed · HIVE HIVE Digital Technologies Ltd. LOW BTC-miner→AI-compute re-rating has its first blue-chip proof — BUZZ HPC's $220M Bell/Cohere sovereign-AI GPU deal (~$70M ARR) on top of $35M contracted ARR — but the stock stalled ~$3.79 below its early-June highs as BTC bled ~45-50% off… Special situation · Bitcoin miners · GPU cloud & neoclouds catalyst · HNST The Honest Company, Inc. LOW Margin re-rate is consolidating rather than fading: $5.05 on 2026-08-21 is 7.5% under the 2026-08-07 high of $5.46 with RSI down from 83.3 to 72.2, and Morgan Stanley's 2026-08-13 raise to $5.7 restored a target above the market. Nothing… Special situation · Consumer discretionary rotation catalyst · HOV Hovnanian Enterprises, Inc. Class A LOW The housing-bill leg is spent — the Act auto-enacted 2026-07-11 and nothing dated has replaced it — yet HOV has re-rated to $137.78 (2026-08-07), 11.8% off the $156.16 high, on no company news. The confirmed 2026-08-20 Q3 print (quarter… Earnings inflection · Housing, homebuilders & proptech · Cyclical industrials catalyst · HROW Harrow, Inc. LOW Post-Q2 this is a leverage-and-execution show-me: the reaffirmed $350–365M FY guide needs H2 to roughly double the $114.9M booked in H1, against $292.4M loans payable net and $14.8M equity. The 2026-08-20 IHEEZO comfort data supports the… Earnings inflection · Precision biotech & therapeutics · Managed care & health services analysed · HTFL Heartflow, Inc. LOW AI coronary diagnostics re-rated on the 2026-08-13 Q2 print: revenue +48% YoY to $64.1M, FY26 guide lifted to $246–250M from $228–232M, Plaque revenue $7.8M running ~$4M ahead of plan, six targets raised on 2026-08-14. Narrative is… Compounder · Medtech & diagnostics analysed · HTLD Heartland Express, Inc. LOW Margin-recovery leg is already printed — Q2 OR 91.0% vs 105.9% — but flattered by $25.0M of equipment-disposal gains, and the beat drew no sustained bid (Barclays cut to $12 on 2026-08-13, after it). Price has since stabilised near $12–$13… Special situation · Freight & logistics · Cyclical industrials catalyst · HUBS Hubspot, Inc. LOW Agentic-monetization leg still broken since the 2026-08-05 print (7,000 net adds vs 9,000–10,000 guided; Q3 guided +14%), but price has retraced from the 2026-08-07 close of $210.45 to $240.01 on 2026-08-21 with zero new company data —… Special situation · AI enterprise software catalyst · HZO MarineMax, Inc. fresh LOW Deal pin rather than a growth story: the $53.00 all-cash Safe Harbor/Blackstone Infrastructure take-private, signed 2026-08-09, leaves $0.80 to terms at the 2026-08-21 close of $52.20. What trades now is HSR/FDI clearance and a shareholder… Earnings inflection · Consumer discretionary rotation catalyst · IART Integra LifeSciences Holdings Corporation LOW Med-device turnaround re-rating is now fully banked into Hold-grade targets: BMO initiated Market Perform $19 (Jul 9) and Citi raised to Neutral $19 (Jul 8), both landing on the tape (~$18.76). The distressed-to-fair leg is done; only… Special situation · Medtech & diagnostics analysed · ICHR Ichor Holdings LOW Memory-capex WFE subsystem re-rating broke on the 2026-08-03 Q2 print: revenue $294.8M missed $300.2M consensus, the $78 June shelf failed, and the 2026-08-07 close was $68.32 against a $112.28 high. Q3 guidance still beats ($315–345M vs… Cyclical recovery · Semi foundry & equipment · AI chips & memory analysed · IHRT iHeartMedia, Inc. LOW M&A leg is dead — no SiriusXM headline since the 2026-05-29 NYT "stalled" report and the April spike fully round-tripped ($6.33 high → $3.86 on 2026-08-07, -39%). What is left is a binary: Q2 print 2026-08-10 after the close is the first… Earnings inflection · Cyclical industrials · M&A & special situations analysed · IMMX Immix Biopharma, Inc. fresh LOW Single-asset CAR-T regulatory story: NXC-201 posted a 95% CR rate (19/20) in NEXICART-2 on 2026-05-21 and holds FDA Breakthrough Therapy Designation from 2026-01-28, with a BLA guided for 2026. Price closed 2026-08-21 at its 52-week high… Earnings inflection · Oncology & immunology catalyst · IMRX Immuneering Corporation LOW Busted-catalyst pancreatic biotech: atebimetinib's 17.3-mo single-arm 1L OS is real, but the Phase 3 binary is mid-2028 and the tape keeps fading post-ASCO ($5.11→$4.32 in two weeks) even as targets climb to $18–$30. Cheap… Earnings inflection · Oncology & immunology · M&A & special situations analysed · INBX Inhibrx Biosciences, Inc. LOW Non-dilutive bridge into the 2027-04-14 PDUFA, with one item pulled forward: the 2026-08-13 Q2 release moved the INBRX-106 HNSCC PFS readout into Q3 2026 and dated the CRC registrational FDA meeting to Q4 2026. But the two-week advance… Earnings inflection · Precision biotech & therapeutics · Binary-catalyst biotech analysed · INDI indie Semiconductor, Inc. LOW Automotive ADAS-silicon design-win story keeps improving on paper ($7.4B backlog, $25M radar order, ams OSRAM sensor buy) while the tape stays broken below the ~$4.00 50-day MA; TD Cowen's 2026-07-13 lift to a $4.50 Hold is a thaw, not a… Cyclical recovery · Analog semiconductors · AI chips & memory analysed · INFQ Infleqtion, Inc. LOW Neutral-atom quantum with accelerating government-funded revenue: Q2 revenue $12.633M beat at +116% YoY and FY26 guidance went to ~$43M on 2026-08-12, but the 2026-08-14 close of $12.86 is 50.4% under the $25.95 high after ~$443.7M of… Compounder · Quantum computing analysed · INHD Inno Holdings Inc. LOW The frozen tape resolved against the story: T12 lifted 2026-07-31 at noon ET and the reopen has been one-way — $8.46 on 2026-08-14 (-21.96% that session, RSI 13.8) versus the $39.49 halt print. The June AI-agent narrative is broken, a $60M… Retail squeeze · Squeeze & momentum setups · AI datacenter infrastructure catalyst · INOD Innodata Inc. LOW AI training-data pure-play with a still-accelerating fundamental story (Q1 rev +54%, 40%+ FY26 guide reaffirmed 06-17) but a fully broken chart: ~-51% from the June $125.14 ATH to ~$61, with the CEO filing a fresh 200k-share sale on 07-16… Cyclical recovery · AI datacenter infrastructure · AI enterprise software catalyst · INTA Intapp, Inc. LOW Agentic-AI attach on a compliance-locked professional-firm base, now with a number: Q4 FY26 (2026-08-04) put AI bookings above 20% of net new, and the 2026-08-13 10-K disclosed $833.0M RPO. But the 2026-08-21 close of $41.35 is 25% above… Theme leader · AI enterprise software analysed · IPAR Interparfums, Inc. LOW Quality-defensive re-rating has rolled over: the 2026-08-04 binary passed with a $0.95 EPS miss and an FY guide reaffirmed BELOW consensus ($1.480B/$4.85 vs $1.503B/$4.87), then TD Cowen and Goldman both cut to Hold/Neutral on 2026-08-10… Compounder · Consumer discretionary rotation catalyst · IPX IperionX Limited LOW US critical-minerals sovereignty name whose funding overhang cleared the ugly way: a 2026-07-08 US$50M ADS raise priced at $21.98, ~22% below the ~$28 pre-deal level, resetting the stock to $22.94 near its $21.66 52-week low. Pre-revenue,… Compounder · Critical materials & rare earths · Defense & aerospace catalyst · IQ iQIYI, Inc. LOW Long-form streaming growth is broken in the reported numbers (Q1 2026 revenue -13% YoY, operating income to a RMB228.4m loss), so what is left is the micro-drama/overseas pivot — newly branded as Undercurrent Theater in early August 2026 —… Special situation · AI enterprise software · Squeeze & momentum setups analysed · IRWD Ironwood Pharmaceuticals, Inc. LOW Post-print drift: the 2026-08-06 binary resolved with FY26 guidance raised (revenue $460–485M, adjusted EBITDA above $310M) but both reported lines missing consensus, and two weeks on the stock is unchanged at $4.29, 20.4% under the $5.39… Earnings inflection · Precision biotech & therapeutics · M&A & special situations analysed · IT Gartner, Inc. LOW Post-derate re-rating still working on price but the information flow has stopped: since the 2026-08-04 gap (+23.7%) the only new data is BMO cutting its target to $206 on 2026-08-18 and three insider sales at $184–$191. The 2026-08-21… Special situation · AI enterprise software · AI datacenter infrastructure analysed · ITGR Integer Holdings Corporation LOW Signed-deal instrument since 2026-08-03: KKR's $127.00 all-cash agreement leaves $1.80 above the 2026-08-21 close of $125.20 (~1.4%), unchanged from two weeks earlier. The paperwork stage has begun with no paperwork — no merger proxy on… Earnings inflection · M&A & special situations · Medtech & diagnostics analysed · IVA Inventiva S.A. LOW Single-asset MASH binary, still dormant: zero company news in the 30 days to 2026-08-23, with the undated Q4 2026 NATiV3 topline carrying the whole equity. RSI(14) firmed to 66.7 at the $4.68 close on no flow, while the $4.40 June offering… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics catalyst · JACK Jack In The Box Inc. LOW June's move was a float mechanic — Russell Microcap inclusion (effective 2026-06-30) into a 40%-short float drove $8.92 to $18.13, and it is unwinding ($14.98 on 2026-07-17, -7.76%). SSS is genuinely inflecting (-6.7% → -3.8%), but price… Retail squeeze · Squeeze & momentum setups · Consumer discretionary rotation catalyst · JBIO Jade Biosciences, Inc. LOW The post-Q2 revision leg round-tripped: $24.71 on 2026-08-14 back to $21.34 on 2026-08-21, with the 2026-08-11 target raises (Wedbush $47, Jefferies $48 from $40) marking the high rather than starting a leg. The July shelf near $21 is now… Earnings inflection · Precision biotech & therapeutics · Oncology & immunology analysed · JBLU JetBlue Airways Corporation LOW Fuel-reversion bull leg broke: Brent re-spiked to ~$86 (Jul 17) on renewed Mideast conflict, reversing the sub-$73 tailwind the whole trade needed. Raymond James (Jul 6) cut to Underperform flagging a Chapter 11 that wipes equity; $9.3B… Earnings inflection · Travel & leisure · Consumer discretionary rotation catalyst · JOBY Joby Aviation, Inc. LOW eVTOL cert story still advancing (FAA TIA testing, 2026 Dubai target) but the trade rolled over: ~$8 testing support, down ~33% since June 1, recovery base gone, CFO sold ~half his stake June 8, consolidation coverage marks sentiment… Earnings inflection · EV & autonomous mobility · Defense & aerospace analysed · JWEL Jowell Global Ltd. LOW Low-float China e-commerce microcap that repriced +106% intraday on 2026-08-10 with no filing behind it; the leg being bought is float scarcity (2.38M shares out, $7.3M market cap) plus a 0.04x sales optic. Nothing on the calendar resolves… Retail squeeze · Consumer discretionary rotation · Semi foundry & equipment analysed · KALU Kaiser Aluminum Corporation LOW Section 232 aluminum supply-shock (50% duty through 2027) plus a Q1 earnings inflection already repriced KALU ~+175% YoY to a $195 high; the move is maturing toward saturated with price at/above every published target. The estimated… Special situation · Cyclical industrials · Critical materials & rare earths analysed · KALV KalVista Pharmaceuticals, Inc. LOW Resolved cash takeout, not a live security: Chiesi's $27.00/share acquisition closed 2026-06-11, KALV delisted the same morning, Form 15-12G filed 2026-06-22, and Rule 12g-4 registration termination lands ~2026-09-20. The 2026-06-10 close… Earnings inflection · M&A & special situations · Rare disease & gene therapy catalyst · KARO Karooooo Ltd. LOW Record-subscriber-adds narrative intact but fully priced: KARO closed $63.96 on 2026-08-21, 3.0% under the $65.91 high and at the ~$63 six-analyst average, while founder-CEO Calisto kept selling — six disclosed dates 2026-08-10 to… Compounder · Emerging markets · AI enterprise software catalyst · KC Kingsoft Cloud Holdings Limited LOW China AI-compute capacity story is intact on fundamentals — AI gross billing +90% YoY and past half of public-cloud revenue in Q1 (reported 2026-05-27) — but the price leg broke: -32.3% from the $18.21 high with RSI(14) back at 70.0. The… Cyclical recovery · AI datacenter infrastructure · Emerging markets catalyst · KEEL Keel Infrastructure Corp. LOW Former Bitfarms miner→AI/HPC-datacenter pivot has rolled over: June's push to ~$6.14 into Citizens' $10 initiation retraced to a ~$4.975 ref by 07-06, losing the $5.00 convert shelf and drifting toward the $4.00–4.20 base. Still zero… Special situation · AI datacenter infrastructure · Bitcoin miners analysed · KELYA Kelly Services, Inc. LOW Post-Q2 re-rate extended to a new 52-week high at the 2026-08-21 close of $17.09, but the last dated sponsorship input was Noble's 2026-08-12 estimate raise — price is now running ahead of the research behind it. July temp-help payrolls… Special situation · Small-cap value rotation · Managed care & health services catalyst · KFRC Kforce Inc. LOW Cyclical staffing recovery is fully printed — Q1 returned to YoY growth, Q2 guided +~4% — but price ran ~24% in three weeks to a fresh all-time high near $58.6, ~38% above the $42.33 consensus PT, into the confirmed 2026-07-27 Q2 print. A… Special situation · Managed care & health services · AI enterprise software catalyst · KGS Kodiak Gas Services, Inc. LOW Post-print bounce failed: the ~21% rally off the 2026-08-07 low of $53.90 stalled at the 2026-08-14 close of $65.35, and the 2026-08-21 close of $61.46 sits just above the $59 break level. Record Q2 EBITDA and a raised FY26 guide are in… Special situation · Industrial power & grid · AI datacenter infrastructure analysed · KLAC KLA Corporation LOW The $190 weekly level named in prior coverage broke — 2026-08-21 close $183.99, 38.9% under the $301.37 52-week high — and the three-month change of -2.5% makes the June advance a completed round trip. saturated: the $4.0B ±$200M September… Cyclical recovery · Semi foundry & equipment · AI chips & memory catalyst · KLC KinderCare Learning Companies, Inc. LOW Distressed post-IPO childcare name has retraced ~180% off its $1.75 spring low to $4.93 as growth shifts to B2B/employer care and before-after-school (Champions +17% YoY), while the core ECE business still shrinks (−3% enrollment). The ~13… Special situation · Consumer discretionary rotation · Cybersecurity analysed · KNX Knight-Swift Transportation Holdings Inc. LOW Beat-and-raise verified on 2026-07-22 ($0.63 adj vs $0.35 y/y; Q3 guided $0.71–$0.77), yet no new high followed and the driver is decelerating: all-mode tender rejections 17.22% mid-July → 14.88% early Aug → ~13.46% late Aug. Compounder · Freight & logistics · Cyclical industrials analysed · KOD Kodiak Sciences Inc LOW Binary-catalyst redemption arc now inside its final month: DAYBREAK wet-AMD one-year topline guided September 2026. Price keeps stepping down through good news — $42.64 (07-17) to $41.35 (08-14) to $38.33 (08-21), -17.5% from the $46.44… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics catalyst · KOS Kosmos Energy Ltd. LOW Jubilee ramping toward ~90,000 bopd gross (J76 online, J77/J50 imminent) with GTA LNG volumes climbing. Highest-beta E&P expression bounced ~15% off the $2.00 June low; re-accelerating but still a ~$2.30, 'CCC'-rated, most-levered… Compounder · Oil, energy & geopolitical catalyst · KRT Karat Packaging Inc. LOW Tariff-refund re-rating has now run past almost every published target: the 2026-08-21 close of $48.05 sits under only Lake Street's $50 (raised 2026-08-07) and 41% above B. of A.'s $34. A 10% owner sold at $47.33 on 2026-08-20, and… Defensive · Cyclical industrials · Semi foundry & equipment catalyst · KSS Kohls Corporation LOW Squeeze leg has stalled: Morgan Stanley's 2026-07-06 Underweight/$15 reinit broke the one-way upgrade cluster and knocked the stock -5.9% on 07-08. Price ~$17.18 still holds above the 50- and 200-day, but with the sell-side now two-sided… Retail squeeze · Consumer discretionary rotation · Squeeze & momentum setups catalyst · KURA Kura Oncology, Inc. LOW The binary already fired: KOMZIFTI's 2025-11-13 approval and ~40% R/R NPM1 share are priced, and the $24–28 targets need a frontline Phase 3 that doesn't read until 2028. The tape is drifting — $10.39, lower third of the H1 range. A… Earnings inflection · Oncology & immunology · Precision biotech & therapeutics analysed · KVYO Klaviyo, Inc. LOW Aug 5 binary resolved: Q2 revenue $370.576M (+26%) beat $362.110M and FY26 guide rose to $1.526–1.534B, yet shares fell 13.3% to $16.73 on 2026-08-06 before recovering to $18.49. The growth-compounder narrative is broken — deceleration to… Theme leader · AI enterprise software catalyst · LAC Lithium Americas Corp. LOW Post-Q2 bounce failed: the 2026-08-21 close of $3.14 came while the GFEX carbonate benchmark rose to 152,250 CNY/t — commodity up, equity down. The 2026-08-17 S-3ASR registers 72,553,609 Yorkville resale shares, 19.99% of shares… Compounder · Critical materials & rare earths · Freight & logistics catalyst · LAR Lithium Argentina AG LOW Commodity-beta bounce stopped transmitting: GFEX 2609 extended to CNY 156,140/t on 2026-08-22 while the shares went $6.82 (08-14) to $6.83 (08-21) and RSI cooled 66.8 to 58.6. Lithium-recovery narrative reads saturated; two price targets… Compounder · Critical materials & rare earths · M&A & special situations analysed · LEGN Legend Biotech Corporation LOW In-vivo CAR-T re-rate has matured into digestion: EHA (6/13) confirmed LB2501's 100% ORR and clean durability, but the 6/17 $226M raise at $29.35 capped the leg and JPM's 7/13 Neutral $35 reinstatement caps the Street. No fresh catalyst… Compounder · Rare disease & gene therapy · Precision biotech & therapeutics catalyst · LGIH LGI Homes, Inc. LOW Legislative-spike homebuilder fading into rising rates: LGIH gave back over half its 2026-06-24 ROAD-to-Housing gap, closing $58.52 on 2026-07-17 as ~6.65% mortgage rates dragged the whole builder cohort lower. Q2 closings grew +8.8% YoY,… Compounder · Housing, homebuilders & proptech · Cyclical industrials catalyst · LGN Legence Corp. LOW AI-datacenter MEP/HVAC pick-and-shovel story still improving on fundamentals (record $5.38B backlog, FY guide raised to $4.1–4.3B), but the tape has decoupled: ~33% off the $102 May close high, LGN sliced the $76 breakout shelf and rolled… Cyclical recovery · AI datacenter infrastructure · Industrial power & grid analysed · LIFE Ethos Technologies Inc. LOW Q2 re-rating intact but the leg has gone quiet: the 2026-08-21 close of $34.16 versus $34.02 a week earlier with RSI(14) cooling 91.6→82.3, while four Form 4 filers — President Wang, Sequoia's Nalrena/Spelunker, the CEO and the CAO — sold… Defensive · Small-cap value rotation analysed · LILA Liberty Latin America Ltd. LOW Break-up leg intact but the news flow has flipped from company action to downgrades: Morgan Stanley cut to Underweight $7.00 on 2026-08-20, leaving the 2026-08-21 close of $8.47 above all three dated targets ($6.50/$7.00/$8.00). RSI 51.9… Defensive · M&A & special situations · Emerging markets catalyst · LILAK Liberty Latin America Ltd. LOW Post-catalyst drift: the $500M preferred special dividend and the June Malone/Nair insider cluster already drove a ~70% run off $4.76 to ~$8.30, and the tape has stalled at $7.33. Citi cut to Neutral 2026-07-10 with a $8 target already… Defensive · M&A & special situations · Emerging markets catalyst · LMND Lemonade, Inc. LOW Second straight beat-and-raise was sold: Q2 (2026-07-29) delivered revenue $294.4M (+79%) and a 60% gross loss ratio, but soft full-year in-force-premium guidance and an unchanged $47–51M FY adjusted-EBITDA loss guide took the stock -26%… Theme leader · Fintech & consumer credit analysed · LNC Lincoln National Corp. LOW Legacy-risk-transfer re-rating: the 2026-07-30 Talcott deal cedes ~$5.8B of GUL statutory reserves for ~$200M all-in statutory capital, alongside a Q2 adjusted EPS beat at $2.24 vs $1.96. But the information is out, price sits 2.1% under… Special situation · M&A & special situations · Managed care & health services catalyst · LOVE The Lovesac Company LOW The ~$17 reclaim failed: a $17.29 close on 2026-08-14 gave way to $16.07 on 2026-08-21, back under the 50-day at $16.79, while short interest decayed to 3.03M shares (28.35% of float) from ~4.05M on Jan–Mar data. The ~2026-09-10 Q2 FY27… Earnings inflection · Consumer discretionary rotation · Small-cap value rotation catalyst · LPRO Open Lending Corporation LOW Terminal, not fading: ANV's $3.15 all-cash tender expired 2026-07-27 with ~85.65% tendered, shares accepted 2026-07-28, §251(h) merger consummated 2026-07-30. Last public close $3.14 on 2026-07-29. As of 2026-08-23 nothing has reopened it… Earnings inflection · Fintech & consumer credit · M&A & special situations analysed · LQDA Liquidia Corporation LOW The prior break level triggered: LQDA closed the week at $68.62 on 2026-08-21, through the $70 July shelf and the 08-13 low close of $72.10, despite six post-print targets at $90–$111. Q2 sales grew +31% QoQ, but the re-rating leg is… Earnings inflection · Precision biotech & therapeutics · Binary-catalyst biotech analysed · LUNR Intuitive Machines, Inc. fresh LOW The June 30 NASA Moon BASE award ($148.3M Nova-C) bought exactly one green session before the stock broke: seven straight down days into 2026-07-13 for -24.5%, -36.5% on the month, $13.80 on 2026-07-18 versus a $38.55 May high. A live… Retail squeeze · Space economy catalyst · LZ LegalZoom.com, Inc. LOW AI-reset narrative — a busted online legal-forms IPO repositioning as an AI-enabled SMB subscription platform (Anthropic partner, AI "digital mailroom") — drove a +29% 30-day rip into July. But it's stretched into the 2026-08-05 Q2 print,… Special situation · AI datacenter infrastructure · Cyclical industrials analysed · M Macy's Inc. LOW Morgan Stanley broke the all-Hold wall on 2026-07-06, resuming at Overweight with a $30 target and a $3 EPS-power call vs ~$2 consensus — the first real upgrade catalyst since the Q1 beat. But price faded the note ($23.99 → $22.64 by… Special situation · Consumer discretionary rotation catalyst · MAMA Mama's Creations, Inc. LOW The $16.50 shelf from prior coverage is gone: 2026-08-21 weekly close $16.44, RSI(14) 26.3, still under the $18.00 June placement price. Earnings moved forward — Q2 FY2027 lands 2026-09-03 after the close and is the binary on both the… Defensive · Fintech & consumer credit · Small-cap value rotation catalyst · MAN ManpowerGroup LOW Post-squeeze leg extended rather than filled: the $46 gap-fill break flagged in July never printed and MAN closed 2026-08-14 at $58.30, 1.3% off a 52-week high, +129.7% in 3 months. Cyclical staffing inflection confirmed by the 2026-08-07… Retail squeeze · Cyclical industrials · Managed care & health services catalyst · MANH Manhattan Associates, Inc. LOW Cloud-conversion re-rating has closed its discount to the 52-week high on no fresh news: the 2026-08-21 close of $214.56 is 2.2% under the $219.33 high with RSI(14) at 80.2, while the last dated company item is 2026-08-04 and the last… Special situation · AI enterprise software · Freight & logistics analysed · MARA MARA Holdings, Inc. LOW AI/HPC power-buildout re-rate is the leg being bought — the 2026-07-09 HIF deal adds up to 2 GW in Texas, lifting potential capacity toward ~4.8 GW — but the golden-cross base fully round-tripped to ~$11.4 as analysts cut across the board… Special situation · Bitcoin miners · AI datacenter infrastructure catalyst · MATV Mativ Holdings, Inc. LOW Deleveraging leg is holding but no longer advancing: the 2026-08-06 10-Q showed H1 operating cash flow of $68.9M against capex of just $15.9M (vs $22.6M in H1 2025), so part of the debt paydown came from underspend. Shares closed $12.47 on… Special situation · Small-cap value rotation · Managed care & health services catalyst · MAZE Maze Therapeutics, Inc. LOW APOL1 kidney precision-medicine story intact, but the 2026-08-11 Q2 print emptied 2026 of catalysts: MZE782 PKU topline pushed to 2027 and CKD Phase 2 start to H1 2027, leaving only HORIZON's three 10–15 patient cohorts in… Earnings inflection · Precision biotech & therapeutics · Rare disease & gene therapy analysed · MCHP Microchip Technology Incorporated LOW AI-data-center re-rating leg is unwinding — round-tripped from the $105.91 May ATH to the ~$84 50-day EMA under an unrebutted J Capital short thesis and a 2026-07-13 TD Cowen PT cut to $90; only the cyclical MCU/industrial recovery (~93%… Special situation · AI datacenter infrastructure · Analog semiconductors catalyst · MDB MongoDB, Inc. LOW Atlas re-acceleration (+29.4% YoY, record $117M seq add; Q1 FY27, 2026-05-28) is intact, but the +18.5% post-print breakout fully round-tripped from $444.72 to a $294.10 close as the AI-software theme sold on margin-timing fear. Sell-side… Cyclical recovery · AI enterprise software · AI datacenter infrastructure catalyst · MEDP Medpace Holdings, Inc. LOW Bookings-inflection leg (Q2 awards $795.7M, +28.2% YoY, book-to-bill 1.13x, FY26 guides raised 2026-07-22) is intact on fundamentals but stalled on the tape: the $620.59 high faded to a $578.5 close on 2026-08-14, RSI 45, while the CEO… Cyclical recovery · Precision biotech & therapeutics · Oncology & immunology analysed · MESO Mesoblast Limited LOW Platform-inflection story re-accelerated on operational news rather than data: the 2026-08-17 last-patient-treated release for the 350-patient CLBP Phase 3 carried the ADR from $15.60 (08-14) to $17.00 (08-21), reclaiming the July shelf… Earnings inflection · Binary-catalyst biotech · Rare disease & gene therapy catalyst · MGM MGM RESORTS INTERNATIONAL LOW Take-private process went live: WSJ reported substantive Diller talks 2026-07-10, MGM seated a special committee mid-July, and the board reportedly views $48.30 as too low — so the trade is now a bump handicap, not a growth story. At… Earnings inflection · M&A & special situations · Prediction markets & betting catalyst · MKSI MKS Inc. LOW Operating leg accelerating into a de-rating tape: Q2 (2026-08-05) beat at $1.248B revenue / $3.30 adj EPS, Q3 guide $1.310–1.390B tops the $1.243B Street, leverage down to 3.0x — and the stock still fell 4.49% on the print and sits 31.4%… Cyclical recovery · Semi foundry & equipment · AI datacenter infrastructure catalyst · MKTX MarketAxess Holdings, Inc. LOW ICE's $167.00 all-cash agreement (signed 2026-07-30) has fully converted MKTX into a spread instrument, and the spread has drifted wider: $167.00 less the 2026-08-21 close of $162.11 leaves $4.89 gross against an H1 2027 guided close.… Earnings inflection · M&A & special situations · Prediction markets & betting catalyst · MMYT MakeMyTrip Limited LOW MakeMyTrip's mid-year recovery bounce has stalled: after reclaiming the 200-day near $55, MMYT rolled back to ~$49, below both the 50- and 200-day, straight into an August 3 Q1 FY2027 print where consensus models EPS down ~76% YoY on ~137x… Earnings inflection · Travel & leisure · Consumer discretionary rotation analysed · MNPR Monopar Therapeutics Inc. LOW New 52-week high at $123.84 printed and sold — the 2026-08-21 close was $107.72, 13.0% under it, RSI 46.0, on no company news. The rolling NDA clock started 2026-07-22 is live but still undated, and the sell-side finished repricing in… Retail squeeze · Rare disease & gene therapy · Squeeze & momentum setups analysed · MNTN MNTN, Inc. LOW Post-IPO CTV adtech re-rating on a profitability crossover: Q2 (2026-08-04) delivered $82.5M revenue +21% YoY, 80% gross margin, $6.7M GAAP net income vs a $26.2M loss, and a $100M buyback. Shares +53.9% in three months into a 91.4 RSI… Defensive · AI enterprise software · Precision biotech & therapeutics catalyst · MOD Modine Manufacturing Co LOW Operating story still compounding — Data Centers sales $348.6M (+90% YoY) at the 2026-07-29 Q1 FY27 print, FY27 guide affirmed — but the tape broke: the 2026-08-14 close of $209.50 lost the $210 line, -31.7% from the $306.89 high. The… Cyclical recovery · AI datacenter infrastructure catalyst · MOH Molina Healthcare, Inc. LOW Medicaid-trough thesis passed its 2026-07-22 test (FY26 adjusted EPS guided to ≥$5.25), but the price leg expressing it broke: the week ending 2026-08-21 closed $200.29, under the $205 floor of the late-June breakout gap. What is left is… Special situation · Managed care & health services analysed · MOV Movado Group, Inc. LOW Tariff-relief leg is dead (Section 301 put Switzerland in a 12.5% band with no expiry on 2026-07-24); what's left is the Q1 margin re-rate (GM 57.3%, +320bp) and one date. Company confirmed 2026-08-19 that Q2 FY2027 prints before the open… Special situation · Consumer discretionary rotation · Cyclical industrials catalyst · MPC Marathon Petroleum Corporation LOW Record refining cracks are already in the tape: Q2 R&M margin $36.33/bbl vs $17.58 YoY and a 29% EPS beat on 2026-08-04, yet the stock closed 2026-08-07 at $298.20 — RSI 37.3, 6.7% under the $319.76 high — while six desks raised targets… Compounder · Oil, energy & geopolitical · AI chips & memory catalyst · MPWR Monolithic Power Systems, Inc. LOW Fundamentals still accelerating (Q2 rev $980.6M vs $890–910M guide; Q3 guided $1,140–1,160M vs ~$982M consensus) but the tape has fully retraced the print: a 2026-08-18 shareholder-investigation headline took the stock down 6.86% to… Cyclical recovery · AI datacenter infrastructure · AI chips & memory catalyst · MRAM Everspin Technologies, Inc. LOW Sympathy bid off the Micron-led memory supercycle and Russell 2000 inclusion floored the post-parabola markdown in the low-$20s, but the ~2026-07-28 Q2 print is now the binary: Everspin must show a non-casino datacenter/AI design win or… Retail squeeze · AI chips & memory · Squeeze & momentum setups analysed · MRVI Maravai LifeSciences Holdings, Inc. LOW Leg has flipped from operating leverage to mRNA-supplier read-through: Moderna's 2026-08-19 Phase 3 cancer-vaccine data took MRVI +25.8% in one session and to an $8.64 52-week-high close by 2026-08-21 with RSI 79.8 — while FY26 revenue… Cyclical recovery · Freight & logistics · Precision biotech & therapeutics analysed · MSFT Microsoft Corporation LOW AI-capex derating still in control and now colliding with a hostile print tape: Alphabet lost ~$294B on 2026-07-24 punished purely for AI spend, Tesla/Intel/Google all sold post-earnings, and MSFT reports Q4 FY26 on 2026-07-29 AMC below… Compounder · Mega-cap AI platforms analysed · MTH Meritage Homes Corporation LOW Housing-rebound-on-rate-cuts trade that carried MTH to a $85.38 52-week high has reversed: it lost the $75 June breakout shelf to $74.17 (-4.2% on 7/17) as mortgages held at 6.49% and Zelman capitulated to Neutral (7/7). Fundamentals still… Compounder · Housing, homebuilders & proptech · Cyclical industrials catalyst · MTRN Materion Corporation LOW Beryllium critical-materials scarcity narrative still building, but the parabola cracked: a new ATH of $298.76 in early July gave way to a 5.6% reversal on 2026-07-07 to $247.20, now ~$258 and still ~9% above KeyBanc's $237 top target. The… Compounder · Critical materials & rare earths · Defense & aerospace analysed · MTSI MACOM Technology Solutions Holdings, Inc. LOW AI optical-interconnect arms-dealer with fundamentals still accelerating (FY26 DC growth guide >60%, Q3 guide $331-339M) but a July-broken chart: ~36% off the $418.90 high to ~$267 on the semi selloff, Russell Value index removal, and… Cyclical recovery · Networking & optical · AI datacenter infrastructure catalyst · MTW The Manitowoc Company, Inc. LOW Order-cycle plus trade-protection plus deleveraging leg from the 2026-08-06 guidance raise is still working but is now maturing: price extended to a $20.87 52-week high while the two post-print analyst actions (Barclays $16, Wells Fargo… Defensive · Cyclical industrials · Semi foundry & equipment catalyst · MXL MaxLinear, Inc. LOW The $77 shelf from the 2026-07-23 beat-and-raise has broken: the 2026-08-21 close of $66.61 is 48.0% below the $128.03 high, after Seendripu family trusts sold or filed to sell ~$50M of stock between 2026-08-14 and 2026-08-17. The revenue… Cyclical recovery · Networking & optical · AI datacenter infrastructure catalyst · MYE Myers Industries, Inc. LOW Legacy plastics maker re-rated ~2.4x on a "Focused Transformation" — MTS distribution arm in discontinued ops, capital concentrated behind Signature/MegaDeck composite matting (Infrastructure orders +130% YoY, Q1 adj EPS $0.44 vs $0.28).… Special situation · Small-cap value rotation · Cyclical industrials catalyst · MYGN Myriad Genetics, Inc. LOW Legacy hereditary-cancer testing house executing a diagnostics pivot; shares +40% off the June $3.99 base as Prolaris+AI launched (May 26) and Precise MRD colorectal/renal was pulled forward to Q3. Structure has repaired but now… Special situation · Precision biotech & therapeutics · Medtech & diagnostics analysed · NABL N-able, Inc. LOW The cyber-pivot re-rating leg was withdrawn by the company's own 2026-08-10 guidance and nothing since has put it back: ARR fell sequentially to $544.5M, FY26 revenue cut to $539–542M, FY26 ARR to $562–565M. The bounce to $3.63… Special situation · Cybersecurity · AI enterprise software analysed · NBR Nabors Industries Ltd. LOW Leveraged ~2x oil-beta proxy on the Hormuz war premium, +90% YTD near $100 but now rolling over: Susquehanna cut its target to $85 (2026-07-08) as the sell-side stops chasing, and the ~2026-07-23 Q2 print — the first to lap the premium —… Compounder · Oil, energy & geopolitical · Managed care & health services catalyst · NCLH Norwegian Cruise Line Holdings Ltd. LOW The June oil re-rating is over: the 2026-07-30 print cut FY26 net yield to ~-5% cc and EPS to ~$1.50 (second cut after 06-03), shares -8.9%, Morgan Stanley to $13. What is left is an Elliott governance/self-help story — 5 new directors… Defensive · Travel & leisure · Consumer discretionary rotation analysed · NEO NeoGenomics, Inc. LOW Oncology-dx turnaround accelerating — NGS +26%, PTEN IHC CDx (first FDA IHC companion dx in prostate, paired to AZ's TRUQAP) launched Jul 9, and TD Cowen $14→$19 / BofA $11→$16 on Jul 13 lifted consensus to ~$15.67, back above spot. But Q2… Special situation · Precision biotech & therapeutics · Medtech & diagnostics analysed · NEXA Nexa Resources S.A. LOW Cyclical zinc-recovery confirmed and fully priced: Q1 EBITDA +126% YoY and Aripuanã's record 13kt ramp drove a run to the $16.89 high, but the equity now chops $12–13 while LME zinc printed a fresh 2026 high near US$3,622 — a bearish… Special situation · Critical materials & rare earths · Emerging markets analysed · NKE Nike, Inc. LOW The post-Q4 base failed: the 2026-08-14 weekly close of $40.73 took out the $41.35 low that framed the July read, and JPMorgan's 2026-08-04 cut to Underweight (PT $47→$40, EPS ~20% below consensus) turned two quarters of target-trimming… Special situation · Consumer discretionary rotation catalyst · NOK Nokia Corporation LOW AI-networking legacy re-rate extending on a harder catalyst leg — first commercial AI-RAN platform with Nvidia (07-15) plus Taiwan Mobile, Orange Belgium and NestAI defense wins. Theme accelerating, but the 2026-07-23 pre-open Q2 print is… Special situation · Networking & optical · AI datacenter infrastructure catalyst · NP Neptune Insurance Holdings Inc. LOW The 2026-07-21 beat-and-raise has round-tripped: the 2026-08-14 weekly close of $31.71 is under the $32 post-print shelf, BMO cut to Market Perform on 2026-07-30, and the CFO sold 100,000 shares into $30.74–$32.12 on Aug 12–13. Operations… Defensive · Managed care & health services catalyst · NSIT Insight Enterprises, Inc. LOW Genuine VAR margin-mix turnaround (Q1 GM +240bps, cloud GP +35%) but a derivative AI tag: hardware GP guided flat, sales +1%. Range-bound $102–123 since the early-June rejection; ~$110 already sits above the ~$103 street target with a… Special situation · AI datacenter infrastructure · AI enterprise software analysed · NUTX Nutex Health Inc. LOW Re-rating leg has stalled: NUTX closed $162.98 on 2026-07-17 after five straight down days, ~20% off the $204.00 high, giving back the June breakout that B. Riley's 2026-06-26 Buy/$290 initiation topped out. A $55.0M true-up of 18,950… Retail squeeze · Managed care & health services · Squeeze & momentum setups catalyst · NUVL Nuvalent, Inc. LOW Closed, not pending: GSK completed the $124 all-cash acquisition on 2026-07-15 after 91.3% of shares were tendered by the 2026-07-14 expiry; trading was suspended 2026-07-15 and Form 25 delisting requested. No US-listed NUVL equity remains… Earnings inflection · Precision biotech & therapeutics · Oncology & immunology analysed · NVEC NVE Corporation LOW One quarter re-rated the name — revenue +81% to $11.03M, gross margin 81.3% (2026-07-22) — and nothing has confirmed it since. No company datapoint arrives before the ~2026-10-21 Q2 print. Theme leader · Analog semiconductors · Physical AI & robotics catalyst · NWL Newell Brands Inc. LOW Turnaround inflection confirmed: 7/31 Q2 beat ($0.42 vs $0.20 est) plus first core-sales growth in 4+ years (+2.3%), squeezed 21.65% short float and re-rated the sell-side. But the entire FY guide raise ($0.73–0.77 from $0.56–0.60) is 2025… Special situation · Consumer discretionary rotation · Cyclical industrials catalyst · NWPX NWPX Infrastructure, Inc. LOW Legacy steel-pipe maker re-rated into a water-infrastructure + precast roll-up on a record $373M WTS backlog, an ~83% Q1 beat, and the Permalok RBJ field win. Narrative intact but the setup is extended — last near $148, ~35% above the… Special situation · AI datacenter infrastructure · Cyclical industrials analysed · NXPI NXP Semiconductors N.V. LOW The 2026-07-28 beat-and-raise still is not being paid for: the 2026-08-21 weekly close of $225.56 held the $225 break line by 56 cents, and the week's damage came from the 30-year Treasury at 5.33% (19-year high), not from analog demand.… Theme leader · Analog semiconductors · AI chips & memory analysed · OABI OmniAb, Inc. LOW Milestone-and-royalty flywheel turned visible: Q2 revenue $13.415M vs $4.693M consensus (2026-08-06) plus a Lilly ion-channel deal worth up to $370M in milestones (2026-08-17) took closes from $1.96 to $4.33 in thirteen sessions. RSI(14)… Cyclical recovery · Precision biotech & therapeutics analysed · ODD ODDITY Tech Ltd. LOW Compounder narrative is dead (Q1 revenue -26%, first orders -50%) and the drift continued on no news at all: $14.12 on 2026-08-07 to $13.22 on 2026-08-21, now sitting on the $13 shelf. The 2026-09-09 pre-market Q2 print is the only dated… Earnings inflection · Consumer discretionary rotation · Precision biotech & therapeutics catalyst · ODFL Old Dominion Freight Line, Inc. LOW Freight-cycle recovery in the top-margin LTL name is drawing a broadening upgrade cluster now printing above spot (Stifel $256 Jul 21, Truist $250 Jul 15, RJ $241 Jul 13), but growth is still rate and mix with tons/day negative. The… Defensive · Freight & logistics · Cyclical industrials catalyst · OEC Orion S.A. LOW Deep-cyclical carbon black where the 2024–25 tire-restock leg already failed (-32.5% from the $10.72 52-week high). What is left is a trough-and-deleverage read: Q2 2026 adj. EBITDA $58.2M (+26% sequential, -15% YoY), FY26 guide reaffirmed… Defensive · Cyclical industrials · Managed care & health services catalyst · OFIX Orthofix Medical Inc. LOW The CMS-reversal re-rate has fully round-tripped: after the 2026-07-02 rate restoration and a 2026-08-05 beat-and-raise, OFIX closed $10.01 on 2026-08-21 — below where it traded on the 2026-05-21 guidance-cut 8-K — with RSI(14) at 22.8 and… Special situation · Medtech & diagnostics · Small-cap value rotation analysed · OGN Organon & Co. LOW Deal-pinned arb, now purely regulatory: the $14.00 all-cash Sun Pharma offer was approved by holders 2026-07-23 and the 2026-08-21 close of $13.75 leaves $0.25, ~1.8% gross, into a stated early-2027 close. Upside is capped by contract; a… Earnings inflection · M&A & special situations · Precision biotech & therapeutics analysed · OLPX Olaplex Holdings, Inc. LOW Closed by event and now confirmed from the buyer's side: Henkel's all-cash takeout completed 2026-07-07 at $2.06 per share, Nasdaq delisting and a Form 15-12G followed, and Henkel's 2026-08-06 half-year report carries no brand-level… Earnings inflection · M&A & special situations · Managed care & health services catalyst · OMER Omeros Corporation LOW Post-print launch-ramp narrative still accelerating on fundamentals — Q2 net sales $28.5M vs $12.7M consensus (2026-08-12), NTAP effective 2026-10-01 — but the shares added 12.1% from the 2026-08-14 close of $17.19 to $19.27 on 2026-08-21… Compounder · Precision biotech & therapeutics analysed · ON ON Semiconductor Corporation LOW The AI-power re-rate is unwinding, not consolidating: ON closed $87.37 on 7/17, below the 6/26 Synaptics deal-gap floor, with targets cut twice in three weeks (TD Cowen to $95 on 7/13, Mizuho to $125 on 7/1). Merger-arb supply plus a fixed… Theme leader · Industrial power & grid · AI chips & memory catalyst · ONDS Ondas Inc. LOW Q2 (2026-08-13) beat on revenue — $83.772M vs $67.973M — and missed on EPS at $(0.19) vs $(0.05); stock fell 7%. Section 232 drone tariffs signed the same day (effective 2026-09-03) rallied the whole basket, and ONDS still closed… Retail squeeze · Defense & aerospace catalyst · OOMA Ooma, Inc. LOW Legacy residential VoIP re-rating into an SMB cloud-comms roll-up, now pinned 0.5% under the $22.14 52-week high going into the 2026-08-26 Q2 FY2027 print — the first quarter testing whether the December 2025 acquired base retains at the… Special situation · GPU cloud & neoclouds · AI enterprise software catalyst · OPEN Opendoor Technologies Inc fresh LOW Early-July retail squeeze is broken: OPEN lost the $4.88 insider shelf and $4.50 base, fell ~12% to $3.88 on 2026-07-24 on a technical breakdown plus fresh housing weakness, into an Aug 4 Q2 print. A rolled-over meme trading into an… Retail squeeze · Housing, homebuilders & proptech analysed · OPI Office Properties Income Trust Common shares of beneficial interest LOW First post-reorg print landed 2026-08-05: 77.9% leased, $1.707B debt, the book equity, no dividend. The binary passed without breaking the tape — The narrative has matured from deleveraging re-rate into asset-sale arithmetic with insider… Retail squeeze · M&A & special situations · Housing, homebuilders & proptech analysed · ORIC Oric Pharmaceuticals, Inc. LOW mCRPC PRC2 story de-risked as rinzimetostat enters registrational Phase 3 (Himalayas-1, 2026-07-14) with Bayer supplying NUBEQA and a J&J-backed enozertinib lung program behind it. But pivotal data is 2028+, so the only near-term mover is… Earnings inflection · Oncology & immunology · Binary-catalyst biotech catalyst · OTEX Open Text Corporation LOW FY27 is guided as a reinvestment year under a CEO seated 2026-04-20: revenue $5.135–5.185B versus FY26's $5.246B, adjusted EBITDA margin 32–33% versus 36.3%. The 10%-of-float buyback opened 2026-08-12; the shares closed $24.66 on… Special situation · AI enterprise software · Cyclical industrials catalyst · OTLY Oatly Group AB LOW The 2026-07-22 guidance doubling (FY constant-currency growth 8–10% from 3–5%) is now a month old with no follow-on news; RSI(14) reset from 71.0 on 2026-08-07 to 43.7 on 2026-08-21 while price held, leaving a $13.03–$13.15 shelf. Nothing… Special situation · Consumer discretionary rotation · Managed care & health services analysed · OUST Ouster, Inc. LOW Squeeze leg broke: +43% in four sessions to a $63.79 high, then management priced 3.62M shares at $55.22 (~8% discount) and closed ~$191.9M net on 2026-07-06. Price round-tripped to $37.04, under the 20- and 50-day and under the $49… Retail squeeze · Physical AI & robotics · Defense & aerospace analysed · P Everpure, Inc. LOW Hyperscaler design-win re-rating has stalled: 52-week high $118.16 on 2026-08-14, then a 2026-08-21 close of $108.55 with RSI(14) still 79.5 while TD Cowen ($170) and Wedbush ($127) raised targets into the fall. The 2026-08-26 Q2 FY2027… Cyclical recovery · AI datacenter infrastructure · AI chips & memory catalyst · PANL Pangaea Logistics Solutions Ltd. LOW Dry-bulk recovery is in the P&L but not the tape: Q1 2026 (2026-05-11) adjusted EBITDA +70% YoY to $25.2M on $15,252/day TCE, yet the stock closed $7.42 on 2026-08-07, 20.1% under the $9.29 52-week high. The 2026-08-10 Q2 print is the… Earnings inflection · Freight & logistics · Small-cap value rotation catalyst · PARR Par Pacific Holdings, Inc. LOW Record diesel cracks (above $100/bbl mid-August 2026) met a lower tape: the 2026-08-21 close of $79.03 sits 8.1% under the $86.03 high while the company's own July refining index printed $31.34/bbl versus a ~$33 Q2 average. Late-cycle —… Compounder · Oil, energy & geopolitical analysed · PATH UiPath, Inc. LOW RPA vendor left for dead, re-cast as the orchestration layer for enterprise AI agents: first GAAP operating profit ($28M, Q1 FY27 reported 2026-05-28) plus the 2026-08-19 Maestro Flow launch drove +50% in three months to a $16.39 close,… Special situation · AI enterprise software catalyst · PAY Paymentus Holdings, Inc. LOW Beaten-down bill-pay compounder: Q1 2026 revenue +30.2% YoY yet shares carved a $20.11 June 52-week low on margin-mix fear. Now ~40% off that low into a binary ~Aug-4 Q2 print — the read is a recovering base, not a chase. Cyclical recovery · Fintech & consumer credit · AI datacenter infrastructure catalyst · PAYC Paycom Software, Inc. LOW Operating-leverage re-rating on a de-rated HCM name is still working, but the fuel is two weeks stale: since the 2026-08-06/07 target raises the shares added 6.6% to $229.07 (2026-08-21) on no new company datapoint, RSI(14) 83.7, 1.1%… Special situation · AI enterprise software catalyst · PAYO Payoneer Global Inc. LOW Pure merger-arb, now fully scheduled: HSR early termination granted 2026-07-28 and the 2026-08-11 definitive proxy set the shareholder vote for 2026-09-14, yet the 2026-08-14 close of $7.13 still sits $0.27 under Nuvei's $7.40 all-cash… Earnings inflection · M&A & special situations · Fintech & consumer credit catalyst · PAYS Paysign, Inc. fresh LOW Guidance-raise leg intact but the flow has thinned: no company datapoint since the 2026-08-05 print (rev $28.252M +48.1%, FY26 lifted to $114–117M), yet price added another 7% to $14.09 on 2026-08-21, RSI 96.7 at a 52-week high and above… Defensive · Fintech & consumer credit catalyst · PBI Pitney Bowes Inc. LOW PBI broke the $17.62 shelf to a fresh 52-week high $18.62 (Jul 16) — the buyback/cost-cut re-rate is now extending, not consolidating. But revenue still shrinks ~3% YoY, consensus PT $16.43 sits below spot, and Q2 prints after close Jul… Special situation · M&A & special situations · Cyclical industrials catalyst · PCT PureCycle Technologies, Inc. LOW Post-dilution repair story: the June 10–15 raise (~$145M equity + $287.5M 4.75% converts, ~$11.08 conv) roughly halved the stock to ~$8 while the commercial ramp (Q1 record 8.4M-lb output, +161% revenue) held. The 2026-07-15 Mitsui/RM… Retail squeeze · Squeeze & momentum setups · Critical materials & rare earths catalyst · PDFS PDF Solutions, Inc. LOW Yield-analytics software re-rated on a real margin step — operating margin ~18%→25%, Platform revenue +36% YoY (Q1 reported 2026-05-07) — but the ~+280% run peaked at $69.05 on 2026-07-02 and flushed 11.5% intraday; the name is now… Cyclical recovery · Semi foundry & equipment · AI enterprise software analysed · PEB Pebblebrook Hotel Trust LOW The 2026-07-29 binary resolved bullish — Q2 RevPAR +6.5%, AFFO $0.68, FY guide raised to $345–353M EBITDAre — and the stock still has not made a new high, closing 2026-08-14 at $18.25, 7.6% under the $19.75 high with RSI 35.3. Q3 guidance… Earnings inflection · Travel & leisure · Housing, homebuilders & proptech analysed · PESI Perma-Fix Environmental Services, Inc. LOW Binary resolved 2026-08-12 in two directions: the H2C master IDIQ is signed but issues no dollars before 2027-01-01, while Q2 printed a $2.5M gross loss and unalleviated going-concern doubt. No company release since 2026-08-12 and no dated… Earnings inflection · Nuclear & uranium · Binary-catalyst biotech analysed · PGNY Progyny, Inc. LOW Post-print de-rate still extending: $25.65 close on 2026-08-21, RSI(14) 18.1, the $28.75 July shelf lost, even as Wells Fargo initiated Overweight $37 (08-20) and JPM raised to $30 (08-21). The 2026-08-06 revenue guide cut is unresolved… Special situation · Managed care & health services analysed · PI Impinj, Inc. LOW Post-correction RAIN RFID recovery has extended to $138.37 (2026-07-17), holding the reclaimed $128 April gap-fill and pressing the $144.57 post-earnings high — but the entire near-term read is the 2026-07-29 Q2 print (guide $103–106M, EPS… Earnings inflection · Freight & logistics · Consumer discretionary rotation analysed · PII Polaris Inc. LOW The $66 shelf the recovery leg stood on is gone: the 2026-06-05 low of $66.06 broke and PII closed 2026-08-21 at $64.39, three weeks after a beat-and-raise (Q2 sales $2,023M, operational adjusted EPS $1.01 vs a $0.70–0.80 guide). The… Special situation · Cyclical industrials · Consumer discretionary rotation analysed · PKOH Park-Ohio Holdings Corp. LOW The 2026-08-05 beat-and-raise leg is intact on the numbers but has stopped working on price: $52.51 on 2026-08-07 to $45.70 on 2026-08-21 (-13.0%), RSI(14) from 89.3 to 61.4, no company news since Stonegate's 2026-08-10 update and no dated… Theme leader · Industrial power & grid · Cyclical industrials analysed · PLAY Dave & Buster's Entertainment, Inc. LOW Turnaround narrative dead since the 2026-06-15 comp miss (-5.4%, EPS $0.16 vs ~$0.598); CEO seat changed hands 2026-08-03 with CFO Darin Harper replacing Tarun Lal. Price stabilized off the $9.40 July low to $10.19 on 2026-08-14, RSI 47.5,… Earnings inflection · Consumer discretionary rotation catalyst · PLSE Pulse Biosciences, Inc fresh LOW Timeline-compression leg extended by broker coverage rather than new data: Needham initiated Buy with a $58 target on 2026-08-17 and price closed 2026-08-21 at $50.42, a fresh 52-week high with RSI 82.5, above three of four published… Earnings inflection · Medtech & diagnostics analysed · PLTK Playtika Holding Corp. LOW The control-premium bid is gone and the markdown extended: the 2026-08-21 weekly close of $2.37 took out the $2.51 shelf, RSI(14) 12.9, 44.4% under the $4.26 52-week high. The one new disclosure is financing rather than a sale — 2026-08-18… Earnings inflection · M&A & special situations · Consumer discretionary rotation analysed · PLUG Plug Power, Inc. LOW The +475% hydrogen-comeback squeeze has broken: the $3.12 Q1 gap and the 50-day both failed, price is ~$2.17 (-20% in 30d), and Susquehanna cut its target $3.75 → $2.50 on 2026-07-10. The June 30 NY Gateway close resolved as a restructure… Retail squeeze · Solar & clean energy · Industrial power & grid analysed · POWI Power Integrations, Inc. LOW The 800VDC AI-power re-rate has cracked. POWI lost the $74–78 May breakout shelf in a -20% week to $70.45 (2026-07-17) and now sits below the $76.20 average target for the first time since spring. The GaN cohort broke with it — NVTS is… Theme leader · AI datacenter infrastructure · Industrial power & grid catalyst · POWL Powell Industries, Inc. LOW Record orders $934M and a 3.0x book-to-bill lifted backlog to $2.4B (+69% YoY) at the 2026-08-03 print, yet shares fell 13.4% the next pre-market on a second straight EPS/revenue miss and closed 2026-08-14 at $213.48, -33.7% off the high.… Cyclical recovery · Industrial power & grid analysed · PTEN Patterson-UTI Energy, Inc. LOW Rig-reactivation cyclical is basing, not broken: June averaged 95 US rigs (vs ~90 Q2 guide), the July EIA STEO lifted 2026 Henry Hub to $3.67, gas rigs turned up 122→126, and Piper upgraded to Overweight 07-14. Price bottomed $8.57 (07-01)… Special situation · Oil, energy & geopolitical · AI datacenter infrastructure catalyst · PTRN Pattern Group Inc. Series A LOW Squeeze leg is dead: the 2026-08-05 beat-and-raise (revenue $876.8M, +47% YoY, record 129% NRR, FY26 guide up to $3.42–3.46B) and target raises to $29–30 left the stock at $21.44 on 2026-08-14, below its post-print after-hours level.… Cyclical recovery · Managed care & health services · AI enterprise software catalyst · PVH PVH Corp. LOW The August bounce failed: $82.47 on 2026-08-14 to $78.50 on 2026-08-21, RSI(14) 25.0, after a 6.2% sector-wide apparel drop on 2026-08-17. Q2 FY26 lands after the close on 2026-09-02 and is the binary — headline EPS carries the ~$100M… Special situation · Consumer discretionary rotation · Freight & logistics catalyst · PYPL PayPal Holdings, Inc. LOW Bid became negotiation: WSJ (2026-08-14) reports Stripe/Advent in active talks and weighing a raise over the rejected $60.50 offer, while the 2026-07-28 Q2 beat (EPS $1.38 vs $1.28) and a raised FY26 guide lifted standalone value. At… Earnings inflection · Fintech & consumer credit analysed · QDEL QuidelOrtho Corporation LOW Deal-rumor leg fully retraced and still unresolved: the 2026-08-06 cut (FY26 adj EPS to $0.65–0.90 from $1.80–2.00, FCF guide withdrawn) took price back to the $13.79 pre-rumor shelf, and the $14.74 close of 2026-08-21 is drift on no… Earnings inflection · Medtech & diagnostics · Semi foundry & equipment analysed · QLYS Qualys, Inc. LOW The AI-vulnerability-surface reframe got its numbers: Q2 (2026-08-04) revenue $182.2M +11% YoY beat the guide, FY2026 raised to $732–738M, stock +14% after hours, eight targets lifted 2026-08-05. Confirmation is now in the price — the… Special situation · AI enterprise software analysed · QRVO Qorvo, Inc. LOW US antitrust cleared 2026-08-01 and Skyworks' post-print recovery to $69.62 lifted implied consideration to $99.33 (0.960 SWKS + $32.50 cash) against QRVO's $98.11 close — about 1.2% gross for underwriting China's SAMR and Korea's KFTC,… Earnings inflection · AI chips & memory analysed · QUIK QuickLogic Corporation LOW The eFPGA/defense royalty squeeze has fully unwound: QUIK is ~$13, roughly 47% below the $24.33 June high, and the $18 shelf broke exactly as the Russell inclusion passed. July's post-quantum IP announcement drew no bid — good news into no… Retail squeeze · AI chips & memory · Quantum computing catalyst · QURE uniQure N.V. LOW FDA's 2026-06-17 reversal put AMT-130 on an accelerated-approval path with a Q3 2026 BLA — the narrative is genuinely repaired, but the move is spent: $40.25 (7/17) sits below the $45.50 June offering price with the CEO selling into it on… Earnings inflection · Precision biotech & therapeutics · Rare disease & gene therapy catalyst · RAMP LiveRamp Holdings, Inc. LOW Shareholder gate cleared 2026-08-17: 51,578,202 shares voted to adopt versus 60,073 against, leaving CFIUS, HSR and non-US clearances as the only unconfirmed conditions on Publicis' $38.50 cash offer. The 2026-08-21 close of $37.58 sits… Earnings inflection · M&A & special situations · AI enterprise software analysed · RARE Ultragenyx Pharmaceutical Inc. LOW The +50% June reset rally round-tripped from ~$33.46 to $28.62 (2026-07-21), parking price back on the breakout shelf ahead of two binary FDA decisions: DTX401 (GSD Ia) PDUFA Aug 23 and UX111 (Sanfilippo A) PDUFA Sep 19. The July 30 Q2… Earnings inflection · Rare disease & gene therapy · Binary-catalyst biotech catalyst · RBLX Roblox Corporation LOW Broken growth compounder: the age-verification rollout throttled DAUs and forced FY26 bookings guidance down to +8-12%; stock is -66% from its $150 high and below the 200-day. The 2026-07-30 Q2 print is the binary — it needs a DAU… Earnings inflection · Consumer discretionary rotation · AI enterprise software catalyst · RDW Redwire Corporation LOW Post-SpaceX-IPO deflation broke RDW to a 2026-07-18 low near $8.51 (~67% off the 5/28 record). A relief bounce on Huntsville/Indiana facility news and $41.5M of H1 Stalker drone orders keeps running into a ~$850M dilution ceiling: the… Retail squeeze · Space economy catalyst · REAX The Real Brokerage, Inc. fresh LOW Hypergrowth brokerage story has decelerated (Q1 rev +32% vs 70%+ historically, a forecast miss) and the stock sits near 52-week lows after the $880M RE/MAX deal spooked investors on dilution. The read is now a binary consolidation bet, not… Earnings inflection · M&A & special situations catalyst · RFAI RF Acquisition Corp II fresh LOW Near-total redemption — 3,956,323 of 3,998,108 public shares, 98.95% — left almost no tradable float into the 2026-08-19 Nanyang Biologics approval, and RFAI ran +524.3% on the week to close $58.00. The leg being bought is a mechanical… Retail squeeze · M&A & special situations analysed · RH LOW Squeeze leg now ratified by the sell side — TD Cowen $220 (2026-08-08) and Wells Fargo $225 (2026-08-11) against B of A's reinstated Underperform $156 (2026-08-03) — and it resolves into the 2026-09-10 Q2 print with ~56.7% of float still… Retail squeeze · Consumer discretionary rotation · Squeeze & momentum setups catalyst · RHI Robert Half Inc. LOW White-collar staffing in secular decline: Q2 EPS collapsed to $0.26 (2026-07-23) as AI automation and a frozen hiring market gut permanent-placement demand. The >5% dividend yield reads as a value-trap signal rather than a floor. No… Special situation · Cyclical industrials · Prediction markets & betting catalyst · RIVN Rivian Automotive, Inc. LOW The 2026-07-30 binary resolved bullish — revenue $1.658B (+27% YoY), FY delivery guide raised to 65,000–70,000 — and the market gave the entire 2026-07-31 pop back, closing 2026-08-14 at $15.36, under the $15.50 July offering price.… Earnings inflection · EV & autonomous mobility analysed · RLMD Relmada Therapeutics, Inc. LOW The level this coverage was framed around broke: the 2026-08-21 weekly close of $4.63 is under the $4.75 March PIPE strike, and it broke on no disclosure. With the 2026 clinical calendar emptied on the 2026-08-06 call, what remains is a… Earnings inflection · Oncology & immunology · Binary-catalyst biotech analysed · RLYB Rallybio Corporation LOW No new filing since the 2026-08-06 10-Q: as of 2026-08-23 the 2026-07-15 S-4 is still not effective, with no record date or meeting date set. The 2026-08-21 close of $16.83 sits ~7% above the ~$15.68/share implied by the S-4's $83.2M Net… Earnings inflection · M&A & special situations · Precision biotech & therapeutics analysed · RMBS Rambus Inc. LOW Memory theme is ripping — Micron +68% YTD with HBM sold out through 2027 — but Rambus has decoupled, down ~42% from its 2026-06-03 high of $174.10 to $101.44 while the cycle proxy sits near records. Interface content is a DIMM-unit story,… Cyclical recovery · AI chips & memory · AI datacenter infrastructure analysed · RNG Ringcentral, Inc. LOW The late-July fade framing has been overrun: RNG ran from the post-print low-$40s to a $67.78 52-week high on 2026-08-13, closing $64.49 (08-14), +57.7% in three months. The leg is a legacy UCaaS name re-labelled on AI mix (~13% of ARR,… Special situation · AI enterprise software catalyst · RPAY Repay Holdings Corporation LOW The bid discount narrowed on an operating headline: the close ran $3.66 (2026-08-14) to $4.01 (2026-08-21) after REPAY joined Visa Platform Connect on 2026-08-19, leaving Forager's rejected $5.25 cash proposal ~31% above the tape with no… Earnings inflection · M&A & special situations · Fintech & consumer credit analysed · RUM Rumble Inc. fresh LOW The sell-the-news break is now confirmed: RUM lost the $6.46–$6.66 100/200-day shelf and closed $5.76 on 2026-07-17, -19% from the post-rebrand tape and within 25% of the $4.62 52-week low. Every moving average is overhead. The 2026-08-10… Special situation · AI datacenter infrastructure analysed · RZLT Rezolute, Inc. LOW A 10.7% week to $5.09 on 2026-08-21 with zero company news since the 2026-07-21 conference notice — the bid arrived via Friday-gainer screens, not a disclosure. The 2026-06-02 upLIFT interim (6 of 8 responders) is still the entire story,… Earnings inflection · Binary-catalyst biotech · Rare disease & gene therapy catalyst · S SentinelOne, Inc. LOW Agentic-security re-rate has cooled into its print: price $23.11 (2026-08-14) → $21.19 (2026-08-21), RSI 83.3 → 56.3, while seven target raises landed 08-17 to 08-21 and consensus caught spot at $21.52. The 2026-08-27 Q2 FY2027 print is… Theme leader · Cybersecurity · AI enterprise software catalyst · SABR Sabre Corporation LOW June's +20% deleveraging bounce has fully round-tripped: $1.99 (6/26) back to $1.73 (7/17), now under the 50-day near $1.79 after failing exactly at the $1.99 consensus PT. Balance sheet is fixed, narrative is not accelerating, and a… Special situation · Travel & leisure · AI enterprise software analysed · SAFT Safety Insurance Group, Inc. LOW Mapfre's $105.00 all-cash deal (signed 2026-07-23) has pinned the tape: the 2026-08-14 close of $103.35 leaves ~1.6% gross to the contract price, down from ~4.6% on 2026-07-24, with no publicly reported approval milestone in between. The… Earnings inflection · Fintech & consumer credit analysed · SAH Sonic Automotive, Inc. LOW GPU-normalization narrative broke at the 2026-07-30 print: revenue and adjusted EPS beat consensus, but adjusted EPS fell 17% YoY, franchised segment income −23%, and EchoPark FY26 GPU guidance was cut ~$300 at the midpoint. Shares… Special situation · Consumer discretionary rotation · EV & autonomous mobility catalyst · SAIL SailPoint, Inc. LOW Agentic-identity story intact and the post-earnings flush is basing: SAIL clawed from a $13.33 low (6/22) back to $15.68 (7/17), a higher low off the $10.30 bottom. Growth decelerated (ARR +26% vs +30%) and guidance was only affirmed, so… Theme leader · Cybersecurity · AI enterprise software catalyst · SANA Sana Biotechnology, Inc. LOW Type-1-diabetes functional-cure narrative: UP421's no-immunosuppression islet transplant is still producing insulin at 14 months (n=1), de-risking SC451's IND guided "as early as 2026." Rare-disease cell therapy is accelerating, but the… Earnings inflection · Rare disease & gene therapy · Binary-catalyst biotech catalyst · SANM Sanmina Corporation LOW The prior break level gave way: the 2026-08-21 weekly close at $188.89 retraced the entire June re-rate. FQ3 on 2026-07-27 beat and raised — $3.46B revenue, +69.7% YoY, FY26 EPS guide lifted to $11.90–12.20 — and the tape answered with a… Special situation · AI datacenter infrastructure · Cyclical industrials catalyst · SAP SAP SE LOW Post-Q2 repair leg: SAP rallied ~6% on 2026-07-24 and ~7% on 2026-07-27 despite a reported headline EPS miss, because current cloud backlog hit €22.9bn (+27%) and management guided FY26 constant-currency growth near 2025's 10.6% with… Theme leader · AI enterprise software · GPU cloud & neoclouds analysed · SATL Satellogic Inc. LOW The mania leg broke in July — the $6.33 shelf and the $4.97 range low both went — and the 2026-08-05 Q2 print handed the name a different story: revenue $15.9M (+259% YoY) vs $9.6M consensus, plus the first positive operating income and… Retail squeeze · Space economy catalyst · SBET SharpLink, Inc. LOW ETH broke $1,850–$1,950 to ~$2,280 on 2026-08-20 on a $1.9B short-liquidation cascade, carrying SBET to $7.91 with RSI 78.3 — despite a 2026-08-10 Q2 miss and a $394.3M net loss. What trades now is levered ETH beta into the 2026-09-15… Special situation · Crypto exchanges & financials catalyst · SEER Seer, Inc. LOW The take-private ladder has stalled into a stand-off: the $2.55 Radoff-JEC bid lapsed unanswered on 2026-08-10, and the group's 2026-08-13 release demanding the board disclose an evaluation timeline has drawn no company reply through the… Earnings inflection · M&A & special situations · Medtech & diagnostics analysed · SENS Senseonics Holdings, Inc. LOW Only year-long implantable CGM, clinically de-risked at ADA 2026 with revenue +71.9% YoY TTM — and the tape has spent six weeks grinding back toward the $4.79 post-catalyst low ($5.11 on Jul 17). Accelerating fundamentals against a broken… Defensive · Medtech & diagnostics analysed · SFIX Stitch Fix, Inc. LOW Turnaround intact on the income statement, inert on the tape: closes of $3.58 (2026-07-24) and $3.59 (2026-08-14) bracket three flat weeks on the $3.50 shelf, and the 2026-08-10 Form 144 shows a retiring officer selling ~70,000 sh weekly… Special situation · Consumer discretionary rotation · AI enterprise software analysed · SG Sweetgreen, Inc. LOW The turnaround narrative was retracted by management on 2026-08-06 and repriced by eight desks into a $5.00–$8.50 target band. What has run since — $6.28 on 2026-08-14 to $6.99 on 2026-08-21 — is a ~24.5%-shorted float drifting up in a… Retail squeeze · Consumer discretionary rotation · Squeeze & momentum setups catalyst · SGMT Sagimet Biosciences Inc. Series A LOW April denifanstat/acne breakout round-tripped to the $6.00 Series A offering floor; SGMT bases near $7 (last close $7.06, 2026-06-26) with no trend. Dermatology pivot (China NMPA acne NDA accepted Dec 2025, US IND due mid-2026) is real but… Defensive · Precision biotech & therapeutics analysed · SHOO Steven Madden, Ltd. LOW Tariff-recovery leg has stalled into a $39.71–$47.11 range with insiders selling every rally and zero buys; the whole story now hinges on the confirmed 2026-07-30 Q2 print. Consensus targets sit at or below spot ($43.75, 07-16), adjusted… Special situation · Consumer discretionary rotation · Freight & logistics catalyst · SIDU Sidus Space, Inc. LOW Q2 (2026-08-14) cleared the calendar: revenue $583,096, -54% YoY, against $166.5M cash and no term debt. The SpaceX-proxy leg died when SPCX listed 2026-06-12 and the 2026-06-26 Russell add faded; what remains is a cash-heavy micro-cap… Retail squeeze · Space economy catalyst · SITM SiTime Corporation LOW MEMS-timing picks-and-shovels story is fundamentally intact — Q1 datacenter revenue +158% YoY to 67% of sales, Renesas timing deal closed July 1 — but the momentum leg has broken: ~$550 on July 18 is ~39% off the May 11 all-time-high close… Cyclical recovery · AI datacenter infrastructure · Networking & optical analysed · SKM SK Telecom Co., Ltd. LOW Post-Q2 re-rating extended to a $40.29 close on 2026-08-21 with RSI(14) at 74.0, but the 2026-08-07 6-K stretched the funding-disclosure commitment from one month to three — the ~₩1T primary-increase question is now unresolved and undated… Special situation · AI datacenter infrastructure · Emerging markets catalyst · SLDB Solid Biosciences Inc. LOW Post-Sarepta DMD vacuum trade now in a waiting phase: the guided mid-2026 accelerated-approval update never landed — the 2026-08-06 Q2 release moved the FDA meeting to late Q4 2026 while INSPIRE dosing grew to 53 (as of 2026-08-04). Price… Earnings inflection · Rare disease & gene therapy · Binary-catalyst biotech analysed · SLS SELLAS Life Sciences Group, Inc. LOW Cancer-vaccine sector re-rate after Merck/Moderna's 2026-08-19 Phase 3 win carried SLS to a 52-week closing high of $15.46 on 2026-08-21 (+15.4% on the session, RSI 78.7) with no SELLAS data of its own; REGAL's last published count is… Retail squeeze · Oncology & immunology · Binary-catalyst biotech catalyst · SMCI Super Micro Computer, Inc. LOW Dilution leg has broken the story: the $7B raise cleared at $27.50 on June 11 and spot is $24.18, with a live $2B ATM as forward supply. DDR contract prices +32% QoQ crush a business guiding 8.2–8.4% gross margin. Falling knife under all… Retail squeeze · AI datacenter infrastructure · AI chips & memory catalyst · SMMT Summit Therapeutics Inc. LOW Two positive headlines on 2026-08-12 — Akeso's third China approval and a Leerink upgrade — left the stock lower: the 2026-08-21 close of $13.16 sits under the 2026-08-14 close and just above the $12.55 52-week low. The dated binary is the… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics catalyst · SMTC Semtech Corporation LOW The mix-purification leg has lost its price leg: the August bounce round-tripped from a $140.35 close on 2026-08-14 to $124.09 on 2026-08-21, under the 2026-07-17 flush close. The binary moved forward — Q2 FY27 prints 2026-08-25 after the… Cyclical recovery · Analog semiconductors · AI datacenter infrastructure catalyst · SMTI Sanara MedTech Inc. LOW Merger-arb instrument since MIMEDX's 2026-07-29 agreement ($33.00 cash + 0.4735 MDXG per share). The 2026-08-11 Form 425 disclosed a 2027-07-29 outside date, a $22.5M reverse termination fee and 38.9% voting lock-up; at the $34.45 close… Earnings inflection · Medtech & diagnostics · M&A & special situations analysed · SMWB Similarweb Ltd. fresh LOW Post-print repricing has stalled: the 2026-08-12 guidance raise and ~$60M of AI-licensing contract value are in the price, and Form 4 filings dated 2026-08-17 show the CEO selling 709,597 shares (~$6.25M) into it on 08-13/14. The $10.40… Special situation · AI enterprise software analysed · SNEX StoneX Group Inc. LOW The split-momentum leg is dead. SNEX round-tripped from a $139.01 all-time-high close (2026-06-18) to $102.99 on 2026-07-17 — down 12.5% in a week, 22.4% in a month — while insiders dumped $94.2M over three months with zero buys.… Special situation · Crypto exchanges & financials · Prediction markets & betting analysed · SOPH SOPHiA GENETICS SA fresh LOW Cloud-genomics platform narrative inflected on the 2026-08-04 Q2 print: net dollar retention 117% vs 107% YoY, FY26 guide raised to $94–96M, and a two-program AstraZeneca companion-diagnostics deal. Price has already run 77.3% in three… Theme leader · Medtech & diagnostics analysed · SPIR Spire Global, Inc. LOW The 2026-08-12 print removed the binary without restoring the base: revenue $18.048M just under $18.139M consensus, adj EPS $(0.31) a beat, FY26 revenue held at $75–85M with >85% of the midpoint contracted — but both EPS guides were cut… Defensive · Space economy catalyst · SPRY ARS Pharmaceuticals, Inc. LOW Single-product epinephrine name whose one catalyst — a July no-prior-auth formulary add for neffy — came and went unpaid; the stock has since broken its old $6.66 52-week low to fresh lows near $6. The neffy ramp is real but the access… Earnings inflection · Precision biotech & therapeutics · Space economy analysed · SPT Sprout Social, Inc LOW Margin-inflection re-rate on an 11%-growth social SaaS: the 2026-08-06 Q2 print lifted FY2026 non-GAAP EPS guidance to $1.11–1.15 from $0.88–0.97 while the revenue range barely moved, and three targets were raised inside a week. Shares are… Special situation · AI enterprise software analysed · SRAD Sportradar Group AG LOW Binary resolved against the bull leg: the 2026-08-03 Q2 print missed both lines, cut FY sales guidance to $1.765–1.782B, and put only "tens of millions" of euros of 2026 prediction-market revenue on the board — then Genius Sports signed… Cyclical recovery · Prediction markets & betting · AI datacenter infrastructure analysed · STAA STAAR Surgical Company LOW Structure broken, no dated catalyst before the ~2026-10-07 pre-release window. Earnings inflection · Medtech & diagnostics · Semi foundry & equipment analysed · STM STMicroelectronics N.V. LOW The June AI-data-center re-rating has failed its retest: $62.06 on 2026-07-17 is -22% from the 2026-06-22 high of $79.82 and back under the early-June breakout base, with a $1.5B convertible overhang and a 7% selloff that ignored a BofA… Earnings inflection · Analog semiconductors · AI datacenter infrastructure catalyst · STRL Sterling Infrastructure, Inc. LOW The prior $550 break condition landed: last close $516.81 on 2026-08-21, 48% under the 2026-06-04 high, RSI 32.3 — while Q2 (2026-08-03) delivered revenue $1,168.2M (+90% YoY) and a raised $19.70–20.30 adjusted EPS guide. Targets are… Cyclical recovery · AI datacenter infrastructure · Industrial power & grid analysed · STRO Sutro Biopharma, Inc. LOW Single-asset binary now inside its own catalyst window: the STRO-004 (DAR8 Tissue Factor exatecan ADC) Phase 1 readout was guided "mid-2026" and that window is expiring undated. Price has gone flat at ~$29.7 for four weeks after the June… Earnings inflection · Binary-catalyst biotech · Oncology & immunology analysed · STUB StubHub Holdings, Inc. LOW June's busted-IPO recovery leg has fully reversed. D.C.'s RESALE Act (10% resale-markup cap, effective 2027-01-01) plus a Texas AG probe into undelivered World Cup tickets broke the experience-economy narrative; at ~$8.60 STUB trades below… Special situation · Consumer discretionary rotation · Travel & leisure catalyst · SUPV Grupo Supervielle S.A. LOW Q2 beat, tape ignored it: adjusted EPS $0.29 vs $0.13 consensus on 2026-08-10, NIM +253bps to 20.3% — yet SUPV closed $8.05 on 2026-08-14 at RSI 24, with bank ADRs leading the Merval lower and country risk back to 479bps. The company… Compounder · Emerging markets catalyst · SVV Savers Value Village, Inc. LOW Busted-IPO thrift retailer's June recovery has stalled and rolled back toward its ~$9 base as the June 27 Russell-deletion passive-bid loss bites; the July 30 Q2 print is now an imminent, FX-exposed binary rather than a five-weeks-away… Defensive · Consumer discretionary rotation catalyst · SXC Suncoke Energy Inc LOW Coal-policy sympathy trade is fully dead: SXC has gone nowhere for three weeks, $8.39 on 2026-06-27 to $8.37 on 2026-07-17, pinned to the $8 shelf with no narrative velocity. The only live variable is the Q2 print, pulled forward to… Special situation · Cyclical industrials · Critical materials & rare earths catalyst · SYNA Synaptics Incorporated LOW Standalone story ended at the 2026-06-25 all-stock takeout; The week to 2026-08-21 proved it — ON -10.2%, SYNA -10.1%, discount still ~2.5% (1.350 x $74.21 = $100.18 vs $97.66). The S-4 filed 2026-08-21 puts the vote on the clock and… Earnings inflection · M&A & special situations · Analog semiconductors catalyst · TAL TAL Education Group LOW Legacy-pivot re-rating still intact on fundamentals — Q1 FY2027 revenue +31.9% to $758.4M with selling and marketing down 5% — but the post-print impulse has largely round-tripped: $12.16 on 2026-08-11 to $11.32 on 2026-08-21, RSI 37.2,… Special situation · Semi foundry & equipment · Cyclical industrials catalyst · TASK TaskUs, Inc. LOW Mix-shift re-rating: AI Services hit $66.1M (+25.8%) in Q2 CY2026 on 2026-08-05 — seventh straight quarter above 25% — and is guided above 30% YoY in Q4 on AV/robotics work, against a 25%-of-revenue Trust & Safety book the market assumes… Special situation · AI datacenter infrastructure · Physical AI & robotics analysed · TBI Trueblue, Inc. LOW Deep-cyclical industrial staffer re-rated +140% off the $3.18 low on a staffing-demand recovery and a data-center/energy labor boom lifting PeopleReady +19% YoY. Still loss-making (Q1 net -$19.8M), margins compressed, and the… Special situation · AI datacenter infrastructure · Industrial power & grid catalyst · TBRG TruBridge, Inc. LOW Closed and now formally deregistered: the IKS Health merger became effective 2026-07-09 at $26.25/share cash, Form 25 filed the same day, Form 15-12G on 2026-07-24. The adjusted series ends 2026-07-08 at $26.24. A screen still surfacing… Earnings inflection · M&A & special situations · Managed care & health services analysed · TDOC Teladoc Health, Inc. LOW The Walmart/insurance-pivot re-rating broke at the 2026-07-29 Q2 print: revenue -4% YoY, BetterHelp -12%, FY26 revenue guide cut ~5% at the midpoint. What remains is $774M cash and a maintained $130-170M FCF guide against a shrinking top… Special situation · Managed care & health services · Precision biotech & therapeutics analysed · TDUP ThredUp Inc. LOW Tariff/de-minimis "secondhand wins" narrative broke on the 2026-08-05 Q2 print: revenue beat at $90.8M but FY2026 guidance was cut to $344.4–348.4M and Q3/Q4 guided below consensus. Price round-tripped to $3.07 on 2026-08-14, -74.6% from… Retail squeeze · Consumer discretionary rotation · Cyclical industrials analysed · TECH Bio-Techne Corp LOW Closed merger-arb pinned $0.60 under Merck KGaA's $73.00 all-cash bid — 2026-08-14 close $72.40, also the 52-week high. Q4 printed 08-12 with no call and no FY27 guidance; Wells Fargo folded to a $73 target on 08-13. Coverage is fully… Earnings inflection · Medtech & diagnostics · Precision biotech & therapeutics analysed · TEM Tempus AI, Inc. fresh LOW Second-order re-rating: Merck/Moderna's 2026-08-19 Phase 3 INTerpath-001 win — the first positive readout for an individualised neoantigen therapy — repriced TEM as the listed owner of the MRD sequencing layer via its pending $1.5B… Cyclical recovery · Medtech & diagnostics analysed · TENB Tenable Holdings, Inc. LOW Q2 (2026-07-29) confirmed the AI-platform leg — revenue $268.5M +8.6%, Tenable One 50% of new business vs 41% in Q1, FY26 raised to $1.075–1.081B — but the sell-side cut into the beat (five PT cuts, Piper downgrade to $30) and a disclosed… Special situation · Cybersecurity · AI enterprise software analysed · TENX Tenax Therapeutics, Inc. LOW Phase 3 binary resolved negative: LEVEL missed its primary (6MWD +3.5m, p=0.63) and key secondary on 2026-08-10; four desks cut within 24h and the target band went from $27–$50 to $4–$5. Narrative is dead. What is left is a balance-sheet… Earnings inflection · Binary-catalyst biotech · Precision biotech & therapeutics catalyst · TER Teradyne, Inc. LOW Parabolic AI-test leg broke hard: $483.84 closing ATH (2026-06-30) to $322.36 (2026-07-17), −33% in twelve sessions on a memory-glut scare, with the whole $446–$550 analyst band now stranded above spot. Company guided Q2 revenue DOWN… Cyclical recovery · Semi foundry & equipment · AI chips & memory catalyst · TGTX TG Therapeutics, Inc. LOW The catalyst leg is spent; what is left is whether the $46–48 shelf holds through a two-month news vacuum into year-end subcutaneous Phase 3 topline. Compounder · Oncology & immunology · Precision biotech & therapeutics analysed · TH Target Hospitality Corp. LOW The AI-datacenter-landlord re-rate has stalled: TH peaked at $20.85 and has given back ~21% to $16.36 (2026-07-17) as TDR Capital affiliates distribute shares in-kind to partners, losing the $17 secondary clearing shelf while Oppenheimer… Special situation · AI datacenter infrastructure · Cyclical industrials analysed · THC Tenet Healthcare Corporation New LOW Hospital margin-expansion re-rating extended to a new 52-week high of $280.77 (2026-08-21), now above the $273.00 average sell-side target, while revision flow thinned to one new number since 2026-08-03 and six insiders sold into the move… Special situation · Managed care & health services catalyst · TIC TIC Solutions, Inc LOW Post-merger re-rate: engineering/geospatial backlog hit a record $1.18B (+20% YoY) on 2026-08-06 while legacy inspection fell ~5.5% combined, and UBS's 2026-08-11 upgrade (Buy, PT $12.50 from $11.00) prices an inflection that Q2's +2.5%… Special situation · M&A & special situations analysed · TLN Talen Energy Corporation LOW Contracted-floor re-rating has stopped paying: the 2026-08-05 Q2 raised FY26 Adj EBITDA guidance to $2,025–2,225M and PJM's 2028/29 auction cleared >10 GW at the $325/MW-day cap, yet the stock closed $347.71 on 2026-08-07, 22% below the… Theme leader · Industrial power & grid · AI datacenter infrastructure analysed · TLRY Tilray Brands, Inc. LOW Reform binary spent without resolving: the DEA hearing closed 2026-07-15 with only a 2026-08-17 briefing deadline and no ALJ timeline, so Schedule III is now an open-ended administrative process. TLRY printed a fresh 52-week low of $4.20… Earnings inflection · Cannabis reclassification · Bitcoin miners catalyst · TMC TMC the metals company Inc. LOW The deep-sea-mining reshoring leg is broken: TMC has cut through the $3.93 prior 52-week low to a fresh $3.57 low near $3.74, roughly -67% from the $11.35 high, with no bid and no near-term catalyst. The decisive NOAA license decision is… Earnings inflection · Critical materials & rare earths · Bitcoin miners catalyst · TNDM Tandem Diabetes Care, Inc. LOW Beaten-down insulin-pump turnaround; the whole re-rate hinges on the tubeless Mobi ("Toby") 510(k) — planned for a Q2 filing but still unconfirmed after the quarter closed 2026-06-30 — plus margins scaling toward a ~60% Q4 exit. Shares… Special situation · Medtech & diagnostics analysed · TORO Toro Corp. LOW Panagiotidis shipping shell (NOT lawnmower TTC) ran 1.93→8.50 on a sub-NAV/special-dividend story that is now fully paid out and closed. Six weeks of dead tape since the 2026-06-05 payout ($3.8M cash + 5,707,246 NEW shares); on a true… Retail squeeze · Freight & logistics · M&A & special situations catalyst · TRIP TripAdvisor, Inc. LOW Activist sum-of-the-parts leg broke: Q2 revenue $441.9M missed consensus $503.9M on 2026-08-06 (~-20% day), four targets cut to $9–$12.50 by 08-11, and the $11–13 base gave way to a $10.74 close on 2026-08-14 with RSI 25. What's left is an… Special situation · M&A & special situations · Travel & leisure analysed · TSAT Telesat Corporation Class A Common Shares and Class B Variable Voting Shares LOW Legacy GEO operator re-rating on a funded LEO pivot: 2026-08-04 C$2.3B, 15-year Canadian Arctic Mil-Ka contract expands Lightspeed 156→225 satellites and lifts the 2032 revenue target to US$4.9B from US$3.2B. Price closed at the 52-week… Special situation · Space economy · Defense & aerospace analysed · TSHA Taysha Gene Therapies, Inc. LOW Clinical binary printed clean (2026-06-22: 100% milestone response N=12, zero treatment-related SAEs) but the next catalyst slipped to H1 2027 — pivotal six-month interim AND FDA BLA-pathway feedback both guided to the first half of next… Earnings inflection · Rare disease & gene therapy · Precision biotech & therapeutics analysed · TXN Texas Instruments Incorporated LOW Beat-and-raise on 2026-07-22 ($5.46B, +23% YoY, EPS $2.14 vs $1.91) was sold, and three weeks later price is still flat — $279.58 on 2026-08-14, 15.4% under the $330.59 high, RSI 51.1. Fundamentals confirmed, price discovery stalled,… Theme leader · AI datacenter infrastructure · Analog semiconductors catalyst · UCTT Ultra Clean Holdings, Inc. LOW WFE upcycle intact fundamentally but the tape broke: -35% from the $142.59 all-time close (2026-06-30) back under the ~$95 breakout shelf on sector-wide selling with no company news. Failed breakout, no support to $80.55, binary Q2 print… Cyclical recovery · Semi foundry & equipment · Freight & logistics catalyst · UI Ubiquiti Inc. LOW Broken parabola gone flat: six weeks of $530–$570 chop after the May 8 print (GM 47.0%, rev +18.7%, but EPS $3.88 vs ~$4.42 whisper) with zero scheduled catalyst until the Q4 FY26 report on 2026-08-21. Fundamentals intact, tape dead,… Earnings inflection · Networking & optical · Squeeze & momentum setups catalyst · UNIT Uniti Group Inc. LOW Hyperscaler dark-fiber demand turned the post-Windstream deleveraging grind into a growth story (~$1.5B disclosed funnel, $68.7M of Q1 IRU revenue from one hyperscaler), but the June re-rate to ~$11 has stalled in a three-week range above… Special situation · AI datacenter infrastructure · Biofuels & low-carbon fuels analysed · USO United States Oil Fund, LP LOW Hormuz has been shut since late February and USO still closed 2026-08-14 at $126.60, 17.2% under its $152.96 high — the market has stopped paying for escalation. The 2026-08-12 EIA +17.423M bbl build and OPEC's demand-growth cut to 580K… Earnings inflection · Oil, energy & geopolitical · Freight & logistics catalyst · UTZ Utz Brands, Inc. LOW Event fired and fully priced: the 2026-08-14 close of $14.17 sits $0.08 under Intersnack's $14.25 all-cash offer, and the 2026-08-05 Q2 miss moved nothing. What remains is a sub-1% gross spread to a company-guided Q4 2026 close against a… Earnings inflection · Consumer discretionary rotation analysed · VECO Veeco Instruments Inc. LOW Merger-arb tracking stock for Axcelis: fixed 0.3575 ACLS/VECO, both votes cleared 2026-02-06, only China SAMR remains before the 2026-09-30 outside date. ACLS's slide to ~$134 de-pegged VECO to a premium over the exchange ratio (~$48) —… Earnings inflection · M&A & special situations · Semi foundry & equipment analysed · VERI Veritone, Inc. LOW Enterprise-AI growth story broken: FY2026 revenue guide cut ~23% at the midpoint to $100–115M on 2026-08-13 vs $135.032M consensus, ARR flat at $62.0M. What is left is a refinancing binary — $45.6M of 1.75% converts mature 2026-11-15… Earnings inflection · AI enterprise software · AI datacenter infrastructure analysed · VERU Veru Inc. LOW The Novo squeeze is fully round-tripped and the funding answer arrived on 2026-07-02: a $21.8M at-the-market program via Oppenheimer/Canaccord. At $2.42 (07-15) that is ~9M shares against ~16M outstanding — the company will now sell stock… Retail squeeze · Precision biotech & therapeutics · Small-cap value rotation analysed · VIA Via Transportation, Inc. fresh LOW Busted-IPO transit-software re-rating: the 2026-08-06 beat-and-raise (FY26 guide up to $550–553M, adj. EBITDA loss narrowed to $3.4M, Q4 positive-EBITDA goal reiterated) turned a chart 70% below its $46 IPO price into an +80.3% three-month… Defensive · EV & autonomous mobility analysed · VIAV Viavi Solutions Inc. fresh LOW Networking-optical test theme still accelerating and the laggard test-and-measurement sleeve is finally re-rating: Susquehanna lifted its target to $66 (2026-07-01) and the small-cap-over-hyperscaler rotation flagged 2026-06-29 favors… Cyclical recovery · Networking & optical catalyst · VICR Vicor Corporation LOW Operating numbers still inflecting (Q2 guide ~$142M, book-to-bill >2.0, backlog $300.6M) but the chart has broken: $237.62 on 2026-07-17 is ~38% off the $382.65 July high, with $271 and $300 both lost and relentless CEO 10b5-1 supply. The… Cyclical recovery · Industrial power & grid analysed · VIR Vir Biotechnology, Inc. LOW Q2 (2026-08-05) printed $238.9M revenue and $0.47 diluted EPS on Astellas upfront recognition — an accounting swing, and the tape read it as one: $9.24 on 2026-08-14, still under the $10.36 Astellas equity strike, with Morgan Stanley and… Earnings inflection · Binary-catalyst biotech · Oncology & immunology analysed · VKTX Viking Therapeutics, Inc. LOW The ~$34 line from July gave way — $33.19 close on 2026-08-14, -21.2% from the $42.13 high. Only company-guided 2026 event left is the VK2735 maintenance-dose readout (3Q26); pivotal VANQUISH topline is 2027. JPMorgan cut its target to $65… Earnings inflection · Precision biotech & therapeutics analysed · VMI Valmont Industries, Inc. LOW Beat-and-raise was sold: the 2026-07-21 Q2 beat ($6.14 vs $5.75) plus a raised FY26 guide gave way to a ~13% 30-day drawdown, and the $520 weekly shelf broke. Grid fundamentals intact, the re-rating leg unwinding, no base and no dated… Theme leader · Industrial power & grid analysed · VOR Vor Biopharma Inc. LOW Legacy-pivot re-rating held its breakout through the 2026-08-11 Q2 miss — $23.36 close on 2026-08-21 against $23.67 on 08-07 — but the same release disclosed $48.4M of ATM stock sold into July strength. With UPSTREAM MG topline guided… Special situation · Oncology & immunology · Semi foundry & equipment analysed · VPG Vishay Precision Group, Inc. LOW The AI-precision re-rate broke at the print: Q2 (2026-08-05) missed on revenue ($83.936M vs $84.646M) and adjusted EPS ($0.04 vs $0.19), Q3 guide midpoint sits below consensus, and the stock gapped -26.95% to $73.78 and has since made… Theme leader · Analog semiconductors · AI datacenter infrastructure analysed · VREX Varex Imaging Corporation fresh LOW Signed all-cash takeout: Teledyne agreed on 2026-08-10 to buy Varex at $18.90/share (~$1.1B). The 2026-08-14 close of $18.49 leaves roughly $0.41 of gross gap into a closing guided for early calendar 2027 with a 2027-05-10 outside date.… Earnings inflection · Medtech & diagnostics analysed · VRNS Varonis Systems, Inc. LOW Take-private leg is aging without confirmation: two months after the 2026-06-23 Bloomberg report there is no bidder, price or 13D, an unexplained 9.3% mid-August pop round-tripped inside six sessions, and the 2026-08-21 close of $41.23… Earnings inflection · Cybersecurity · AI datacenter infrastructure catalyst · VSH Vishay Intertechnology, Inc. LOW Cycle-turn re-rate has fully round-tripped: down ~46% from $69.47 to the high-$30s, now under the $50 June placement and below every covering analyst's target. Q1's 1.34 book-to-bill and $1.6B backlog were real but sit at ~35x forward into… Earnings inflection · Industrial power & grid catalyst · VSXY Victorias Secret & Co. LOW Turnaround re-accelerated with no new number: the July mid-$70s range broke, a $99.97 52-week high printed, then 11% came back into the 2026-09-03 Q2 report. Consensus target $91.40 sits ~3% over the $89.02 close on 2026-08-14, so the… Special situation · Consumer discretionary rotation catalyst · W Wayfair Inc. LOW Margin-inflection turnaround has stalled: after the June Evercore-driven pop, W has faded ~10% back to the ~$84–85 recovery base ahead of the binary Aug 4 Q2 print. Wedbush's Jul 16 Neutral/$104 initiation and a ~$100-capped consensus mark… Special situation · Consumer discretionary rotation · Housing, homebuilders & proptech analysed · WDAY Workday, Inc. LOW The 2026-08-27 Q2 FY27 print — cRPO against a guided 13.5–14.5% band — is the binary that lands first. Earnings inflection · AI enterprise software catalyst · WEAV Weave Communications, Inc. LOW Beaten-down vertical-SaaS front-office platform for healthcare SMBs, down ~36% YTD and basing off the $4.24 low, repositioning around AI-receptionist monetization (TrueLark, 2025). Still a ~17% grower with GAAP losses, so the re-rate is… Theme leader · AI enterprise software · AI datacenter infrastructure analysed · WGS GeneDx Holdings Corp. fresh LOW Busted-growth genomics name; the recovery off the −49% May guide-cut crash has stalled in the low-$60s, below the $74.83 200-day. The confirmed Aug 3 Q2 print (blended ARR vs the ~$3,300 baseline) is the binary — the same day as the… Earnings inflection · Medtech & diagnostics analysed · WHD Cactus, Inc. LOW International wellhead order narrative from the 2026-07-29 Q2 beat is intact, but the re-rating leg is largely spent: Citigroup cut to Neutral on 2026-08-20 while raising its target to $75, and the shares closed $69.43 on 2026-08-21, 5.8%… Cyclical recovery · Oil, energy & geopolitical · AI datacenter infrastructure catalyst · WING Wingstop Inc. LOW Two analyst target cuts in ten days (Wells Fargo to $170, DA Davidson to $200) into the 2026-07-29 Q2 print signal de-risking ahead of the H2 comp-turn binary; a ~50% relief bounce off the $116.35 low is unproven, and the print — not… Earnings inflection · Consumer discretionary rotation · Managed care & health services analysed · WK Workiva Inc. LOW Earnings-power re-rate: Q2 on 2026-08-04 hit a 16.8% non-GAAP operating margin — the 2027 target, a year early — and lifted the FY26 adjusted EPS guide from $2.85–2.95 to $3.38–3.39 on a revenue guide that barely moved. Activist Irenic's… Special situation · AI enterprise software catalyst · WLFC Willis Lease Finance Corporation LOW Engine-leasing supercycle still printing records (Q1 rev +23%, EPS $4.03 vs $3.02 est), but the theme is maturing and the stock has faded ~18% off its 2026-07-06 ATH into the now-completed 3-for-1 split. The event stack has collapsed to… Cyclical recovery · Space economy · Small-cap value rotation catalyst · WPP WPP PLC LOW Post-relegation turnaround leg is now being re-rated by the sell side rather than by news: Citigroup lifted its target GBX 285→430 on 2026-08-10 while staying Neutral, and the 2026-08-06 results gap has held with the 2026-08-21 close at… Special situation · Consumer discretionary rotation · AI enterprise software catalyst · WRLD World Acceptance Corporation LOW Post-print leg has cooled, not extended: the 2026-07-24 gap ran ~$181 to ~$208 but the 2026-08-14 close of $194.75 gives back half of it, RSI 48.9, -13.0% from the $223.83 high. The 2026-08-13 $50M buyback authorization is inclusive of… Special situation · Fintech & consumer credit · Small-cap value rotation analysed · WSC WillScot Holdings Corporation LOW Cyclical modular-space leasing recovery with a small data-center kicker and an activist/M&A floor, but range-bound and digesting: shares drifted to ~$26 under the $31.88 high after the 2026-06-27 Russell growth-index removal. The confirmed… Theme leader · AI datacenter infrastructure · Industrial power & grid analysed · WSM Williams-Sonoma, Inc. LOW Sell-side re-rating leg: six price-target raises between 2026-08-04 and 2026-08-14 (Goldman $261, RBC $192→$260, Telsey $255, Citi $248, two at $240) took WSM to a 52-week high of $251.78 on multiple expansion — RBC moved to 25x from 20x… Defensive · Consumer discretionary rotation · Freight & logistics catalyst · XENE Xenon Pharmaceuticals Inc. LOW Q2 (2026-08-06) cleared the last procedural gate — FDA pre-NDA meeting completed, azetukalner FOS NDA still guided to Q3 2026, cash $1,245.1M — and the stock still closed 2026-08-14 at $62.35, 12.1% below the $70.96 July high with RSI… Earnings inflection · Precision biotech & therapeutics · Binary-catalyst biotech analysed · XGN Exagen Inc. LOW Autoimmune-diagnostics re-rating on the 2026-08-04 Q2 print: revenue $19.941M vs $17.817M consensus, FY26 guide lifted to $72–75M, adjusted EBITDA loss down to $0.1M. Price ran from a $4.68 pre-print close to $7.92 on 2026-08-21 with… Defensive · Medtech & diagnostics analysed · XHG XChange TEC.INC LOW Sub-$1 China insurance ADS re-rated ~4x in two sessions on a 2026-08-13 non-binding LOI to acquire HK AI insurtech First Cycle — terms undisclosed, subject to definitive agreements. The leg being bought is an AI-insurance pivot; the FY2025… Retail squeeze · M&A & special situations analysed · XOS Xos, Inc. LOW First-ever U.S. Air Force award (prototype OTA for the Xos Hub mobile BESS, announced 2026-08-17, terms not disclosed) took the stock ~100% on 2026-08-18 and put a defense-pivot narrative on a going-concern EV maker that just missed Q2… Retail squeeze · Defense & aerospace · EV & autonomous mobility analysed · XRAY DENTSPLY SIRONA Inc. LOW Stock faded from $13.78 pre-print to $11.59 on 2026-08-14 — the narrative leg came and went, and the $11–12 shelf is what remains. Special situation · Medtech & diagnostics · Semi foundry & equipment catalyst · XRX Xerox Holdings Corporation LOW Distressed-deleveraging special situation that round-tripped its June activist pop into a binary 2026-07-30 Q2 print. At ~$2.60 it sits below the $2.75 Hold consensus and inside the $2.25–$2.50 target band; anchor buyer STARTEEPO (8.8M sh,… Special situation · M&A & special situations · Cyclical industrials analysed · XTLB XTL Biopharmaceuticals Ltd. LOW Delisting binary fully resolved — Nasdaq confirmed compliance 2026-07-20 — and the pivot pop has bled off: no dated company release since, ADS $2.94 (2026-07-25) → $2.79 (2026-08-14), RSI 44.4. Event narrative is saturated; the next leg… Special situation · Precision biotech & therapeutics · M&A & special situations analysed · XXI Twenty One Capital, Inc. LOW The one re-rate catalyst just died: Tether's Strike–Elektron three-way merger was scrapped on 2026-07-21 and CEO Jack Mallers quit, dropping XXI to a fresh all-time low near $4.46. A leveraged-Bitcoin-treasury proxy stuck below 1.0x float… Compounder · Crypto exchanges & financials analysed · YAAS Youxin Technology Ltd LOW July's re-ignition failed: the 2026-07-14 RiverBit term sheet and 2026-07-15 Guangzhou AI agreement produced no higher low, and the response was a second reverse split (1-for-5, effective 2026-07-30). Two splits inside ten months now… Retail squeeze · Semi foundry & equipment · Crypto exchanges & financials analysed · YEXT Yext, Inc. LOW Legacy presence-management vendor repositioning into answer-engine optimization; the recovery extended to $6.35 (2026-08-21), up 72.6% in three months with RSI(14) 69.6, on no operating datapoint newer than the 2026-06-02 Q1 print. On… Special situation · AI enterprise software · Cyclical industrials catalyst · YSS York Space Systems Inc. LOW Roll-up/defense-growth leg is broken: the 2026-08-13 FY26 guide cut to $375–405M from $545–595M (vs $560.341M consensus) is the first company-sourced confirmation the revenue base moved. Close $10.93 on 2026-08-14, -54.5% over 3m, RSI… Earnings inflection · Space economy analysed · ZBRA Zebra Technologies Corporation LOW The post-print re-rating has stopped extending: after the 2026-08-04 guidance raise (adj EPS $6.35 vs $4.36; FY26 EPS to $20.75–$21.25) the shares topped at $383.06 and closed 2026-08-21 at $368.51 with RSI(14) 76.4, two open-market… Theme leader · AI enterprise software · Physical AI & robotics analysed · ZENA ZenaTech, Inc. LOW Section 232 drone tariffs signed 2026-08-13 and effective 2026-09-03 re-rated the UAS cohort; ZENA is the sub-$3, issuance-funded expression, closing 2026-08-14 at $2.14 with RSI(14) 84.7 and still 68.0% under the $6.69 52-week high.… Retail squeeze · Defense & aerospace · Cyclical industrials catalyst · ZS Zscaler, Inc. LOW Post-crash recovery leg is complete: the 2026-05-27 gap-down (~31.5% on a 16–17% FY27 growth frame) has been fully retraced to $181.75 (2026-08-21) with RSI 71.5, and six houses marked targets to $200–225 between 08-17 and 08-21 on no new… Earnings inflection · Cybersecurity · AI datacenter infrastructure catalyst · ZVRA Zevra Therapeutics, Inc. LOW The June patent re-rating fully reversed: EMA's CHMP issued a negative opinion on arimoclomol's EU application 2026-07-24 (efficacy not proven), and ZVRA gapped ~24% to the high-$9s, cutting through the $11.50 base. EU expansion is now… Earnings inflection · Rare disease & gene therapy · Binary-catalyst biotech analysed · ALVO Alvotech fresh NONE Precision biotech & therapeutics analysed · AMR Alpha Metallurgical Resources, Inc. fresh NONE Critical materials & rare earths analysed · DFDV DeFi Development Corp. fresh NONE Crypto exchanges & financials analysed · HBB Hamilton Beach Brands Holding Company fresh NONE Consumer discretionary rotation analysed · IAG IAMGold Corporation fresh NONE Critical materials & rare earths analysed · JELD JELD-WEN Holding, Inc. fresh NONE Housing, homebuilders & proptech analysed · RGEN Repligen Corporation fresh NONE Medtech & diagnostics analysed ·

Common questions

What is a FrontierPicks dossier?

A per-ticker research note written by a frontier language model: the current thesis, the archetype the name is trading as, the next dated catalyst, and an explicit kill line — the price level or event that would prove the pick wrong. Every dossier is dated and rewritten as the facts change.

How many stocks does FrontierPicks cover?

827 US tickers have a dossier right now. 819 of the 827 published dossiers carry the full shape — a dated thesis and the exact level that ends it. The remaining 8 are named rather than hidden: 7 are queued for first synthesis, and 1 publishes no kill line yet. Coverage is earned rather than fixed: a name gets a dossier when the model has something to say about it beyond the price trend. The 88 names the model holds, is researching or has just exited are re-read every trading day — none of them is more than 3 sessions behind. The wider 739-name coverage universe cycles behind them: its median name was last read 3 sessions ago, and nothing in the corpus is more than 8 sessions old.

Is AI-generated stock research reliable?

It should be judged the way any research is judged — on whether its stated confidence holds up against outcomes. FrontierPicks is built to make that measurable: every pick publishes a kill line before the outcome is known and is graded mechanically against it, and the resulting calibration record is recomputable from the published data rather than asserted. It is research to evaluate, not advice; no performance claim is made.

How often are the dossiers updated?

On a rolling cycle, not uniformly. The 88 names the model holds, is researching or has just exited are re-read every trading day — none of them is more than 3 sessions behind. The wider 739-name coverage universe cycles behind them: its median name was last read 3 sessions ago, and nothing in the corpus is more than 8 sessions old. The model re-reads a covered name against fresh price, filing and news data and rewrites the dossier when the facts move; each page shows its own last-updated date rather than a sitewide timestamp, so the cadence is checkable name by name.